data_2e2f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e2f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 7.0 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.298 0.571 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.9 tpt180 -146.02 121.44 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 25' ' ' HIS . 9.1 mm -100.18 148.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.597 -0.689 . . . . 0.0 109.933 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.29 -68.66 1.58 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.928 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.6 Cg_endo -75.2 22.6 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.748 1.394 . . . . 0.0 112.66 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.29 -28.45 15.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.638 -1.288 . . . . 0.0 107.84 178.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.408 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.8 t70 -84.15 -23.58 30.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -84.9 -45.74 11.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.92 13.49 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.17 -0.956 . . . . 0.0 109.395 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.572 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.3 -45.4 78.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 110.854 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -77.19 6.89 3.99 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.697 1.367 . . . . 0.0 110.804 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.504 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.8 mmp_? -83.14 178.4 8.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -0.99 . . . . 0.0 109.985 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.462 HG12 ' HB2' ' A' ' 17' ' ' GLU . 5.9 pt -53.34 -168.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 110.64 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -80.61 -44.1 1.31 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 111.623 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.06 -5.26 16.6 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.22 1.116 . . . . 0.0 110.213 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -92.86 -19.45 21.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.164 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 8.8 ttp180 -97.16 -45.68 6.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.537 -0.727 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -36.51 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 109.777 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -16.73 60.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 44.6 t -67.81 -50.35 57.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 74.1 m -74.81 -21.45 59.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 109.985 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.14 -16.82 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.62 -31.8 19.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 36.4 m80 -95.61 49.62 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.67 42.71 6.18 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.521 ' CG ' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -124.99 -179.88 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -1.172 . . . . 0.0 110.196 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 1.9 m -83.49 -141.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.42 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 18.1 p90 -92.16 132.14 36.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.38 -62.73 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.54 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 4.3 p90 -178.29 156.24 0.96 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -98.6 112.93 24.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -117.11 134.13 55.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.366 -0.833 . . . . 0.0 110.299 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.5 -153.04 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.83 43.92 3.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -165.71 138.96 5.51 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.471 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 2.3 ttt -101.4 167.25 10.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -1.17 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.54 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 75.1 m-85 -136.1 147.25 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 79.6 m . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.4 m . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.361 0.601 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 1.4 tpt180 -147.03 122.46 10.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.318 -0.864 . . . . 0.0 110.063 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 6.7 mm -102.53 147.61 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 109.959 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -70.24 1.11 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.544 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.6 Cg_endo -74.99 23.15 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.649 1.342 . . . . 0.0 112.792 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.49 -29.52 14.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.631 -1.293 . . . . 0.0 107.669 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.435 ' CG ' ' CA ' ' A' ' 37' ' ' GLY . 1.1 t0 -84.89 -26.87 27.04 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 3.6 mt-30 -79.43 -44.28 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.77 12.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.7 t -64.45 -44.17 74.21 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.479 -0.763 . . . . 0.0 110.841 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -77.81 6.16 4.75 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.572 1.301 . . . . 0.0 110.746 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 14' ' ' ILE . 3.0 mmt180 -83.59 -175.93 6.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.52 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 14.6 pt -54.28 -165.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.55 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.3 t -82.1 -42.4 1.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 111.607 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.97 -9.27 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.267 1.141 . . . . 0.0 110.559 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.25 -12.3 52.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.398 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.527 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 5.8 ttp180 -109.42 -55.07 2.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.483 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 4.2 m-70 -53.83 -31.9 50.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 2.5 tt0 -84.57 -23.72 29.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.375 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.518 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 11.0 t -60.39 -32.53 71.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.426 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 30' ' ' TYR . 86.1 m -76.18 -33.4 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -89.94 -8.24 52.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.327 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -86.39 -16.09 38.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 29.2 m80 -115.89 38.97 3.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 50.67 31.76 23.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HB2' HD13 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -106.31 -168.82 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -1.152 . . . . 0.0 110.273 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 16.2 m -83.34 -134.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.46 -176.33 21.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CE1' ' HE1' ' A' ' 38' ' ' MET . 0.5 OUTLIER -68.83 127.9 34.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -1.096 . . . . 0.0 110.196 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' N ' ' CD1' ' A' ' 30' ' ' TYR . . . -110.31 -68.88 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.452 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 5.3 p90 -178.61 150.37 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.514 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -90.32 118.95 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.424 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 37' ' ' GLY . 1.1 t -135.62 139.82 44.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.62 -157.05 34.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.91 43.64 3.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.571 ' HE1' ' CE1' ' A' ' 30' ' ' TYR . 1.9 ttt -98.83 168.99 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.027 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 25.7 m-85 -131.45 145.81 51.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.899 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.544 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 59.9 m . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.287 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.136 0.493 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.576 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -147.98 131.15 16.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.528 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 10.4 mm -106.41 155.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.771 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.441 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -74.24 -67.15 1.82 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.744 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.542 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.9 Cg_endo -74.66 17.95 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.629 1.331 . . . . 0.0 112.486 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 1.1 m -93.79 -26.55 16.91 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.519 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.0 p30 -88.76 -29.33 19.87 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.412 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 tm0? -76.84 -44.27 32.97 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.5 p -90.51 12.55 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.354 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.7 t -64.75 -43.78 70.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.723 -0.611 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.35 4.32 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.521 1.274 . . . . 0.0 110.852 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 mtt180 -85.09 -179.17 6.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 109.998 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.476 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 7.4 pt -53.72 -167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.629 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.4 t -82.4 -42.65 0.96 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 111.564 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.6 Cg_endo -72.09 -2.15 11.14 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.281 1.148 . . . . 0.0 110.378 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -96.42 -10.56 27.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 109.454 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' HD2' ' CD2' ' A' ' 30' ' ' TYR . 10.7 ttm180 -109.57 -47.96 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -58.26 -28.92 65.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -84.13 -20.43 32.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.923 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' A' ' 4' ' ' ILE . 11.4 t -61.95 -45.87 91.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.36 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.4 -40.12 58.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -68.88 -19.09 64.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 110.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -29.48 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.365 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -97.82 4.3 49.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.242 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . 77.22 74.48 0.98 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -135.66 -156.66 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.184 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.3 t -102.07 -89.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -153.9 151.19 22.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.584 ' CD2' ' CE ' ' A' ' 38' ' ' MET . 14.5 t80 -44.08 119.57 1.81 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.245 . . . . 0.0 110.091 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.59 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -105.5 -58.34 1.91 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.368 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.59 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 13.6 p90 -177.34 138.07 0.23 Allowed 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.025 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -87.01 102.37 14.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.095 -1.003 . . . . 0.0 110.118 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 1.4 p -81.19 161.64 23.93 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.5 -0.75 . . . . 0.0 110.25 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -43.16 -56.0 4.78 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.06 -72.85 0.41 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.516 ' HA3' ' NH2' ' A' ' 3' ' ' ARG . . . -149.19 -135.28 2.47 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.584 ' CE ' ' CD2' ' A' ' 30' ' ' TYR . 15.4 tpt -121.69 146.97 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.581 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 15.0 m-85 -128.21 141.99 51.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.993 -1.067 . . . . 0.0 111.083 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.448 ' O ' HG23 ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.48 -0.763 . . . . 0.0 110.127 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 1.8 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.319 0.58 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.524 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.2 tpt180 -146.53 122.94 11.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 110.152 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' A' ' 25' ' ' HIS . 9.0 mm -104.14 151.47 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.766 . . . . 0.0 110.02 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.53 -68.97 1.49 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.725 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.549 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.7 Cg_endo -74.95 22.23 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.778 1.41 . . . . 0.0 112.789 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.51 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.18 -29.77 14.95 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.7 t70 -82.79 -25.02 33.16 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.64 -46.26 13.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 2.0 p -90.7 14.72 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.23 -0.919 . . . . 0.0 109.348 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 t -64.1 -44.1 76.45 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.658 -0.651 . . . . 0.0 111.111 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.1 Cg_endo -77.8 8.74 3.27 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.568 1.299 . . . . 0.0 111.113 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 1.1 mmm180 -85.22 179.14 7.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 0.0 110.22 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.532 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.3 pt -53.98 -166.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.61 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -79.07 -44.7 1.74 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.49 -0.756 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.2 Cg_endo -71.02 -5.71 17.58 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.384 1.202 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.533 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 1.8 mm-40 -88.08 -21.73 24.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.36 -0.838 . . . . 0.0 109.33 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HG2' ' HE2' ' A' ' 38' ' ' MET . 4.9 ttp180 -100.11 -44.99 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -0.767 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -59.2 -31.7 69.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -82.66 -17.97 42.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.342 -0.849 . . . . 0.0 110.018 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 31.9 t -68.05 -49.69 59.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 84.3 m -75.12 -29.53 60.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -78.73 -21.82 47.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.11 24.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.299 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.583 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 10.7 m170 -102.28 51.07 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 110.403 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.06 23.2 2.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -112.29 175.51 5.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -1.231 . . . . 0.0 110.063 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 2.3 t -88.29 -143.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -72.26 -154.49 2.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.465 ' HB2' ' HE2' ' A' ' 38' ' ' MET . 22.4 p90 -105.88 144.65 32.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -1.105 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.424 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -105.07 -65.42 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.501 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 5.6 p90 -178.3 148.79 0.49 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.521 -0.737 . . . . 0.0 110.297 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -87.87 119.78 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -129.25 135.27 48.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.942 . . . . 0.0 110.473 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.99 -149.7 46.9 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.42 25.4 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -151.77 157.99 27.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.515 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 10.6 ttt -106.8 167.01 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -1.203 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 35.5 m-85 -129.19 142.11 50.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 73.5 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 30.0 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.526 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 2.9 tpt180 -147.92 117.78 7.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.585 ' CD1' ' CB ' ' A' ' 25' ' ' HIS . 13.3 mm -100.46 157.52 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 0.0 109.851 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.72 -63.8 1.88 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.636 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.552 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.9 Cg_endo -74.98 16.36 0.66 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.681 1.358 . . . . 0.0 112.476 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.3 m -93.81 -27.99 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.4 t70 -89.42 -25.38 21.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -79.83 -45.1 19.33 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 2.2 p -91.1 14.22 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.316 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.567 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.6 t -64.51 -44.33 74.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 110.995 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.7 Cg_endo -76.71 5.65 4.68 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.559 1.294 . . . . 0.0 110.996 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -85.64 -179.73 6.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -0.998 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.525 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 14.9 pt -54.55 -165.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.278 -0.889 . . . . 0.0 110.737 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.585 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.0 t -78.71 -46.57 1.87 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.3 Cg_endo -68.77 -10.76 30.02 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.294 1.155 . . . . 0.0 110.256 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.534 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -84.42 -21.91 30.6 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.348 -0.845 . . . . 0.0 109.219 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.7 mtm180 -95.89 -49.58 5.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -56.53 -19.23 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.871 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.445 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 45.1 tt0 -96.78 -22.5 16.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.512 ' CB ' HG11 ' A' ' 10' ' ' VAL . 2.9 p -59.32 -36.76 76.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.9 OUTLIER -81.21 -44.1 18.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.172 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -67.82 -13.86 62.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 110.294 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -81.33 -15.28 55.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 110.239 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.585 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 3.6 m80 -111.09 -8.21 14.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 99.15 47.71 1.83 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 6.8 mpt_? -114.1 -164.44 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -1.14 . . . . 0.0 110.158 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 -75.34 0.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.65 138.84 7.4 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.4 p90 -46.31 127.76 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.153 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -96.21 -59.08 1.91 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 7.5 p90 -178.17 160.47 1.38 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.537 -0.727 . . . . 0.0 109.933 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.6 OUTLIER -100.43 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 t -135.84 174.05 11.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 0.0 110.461 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.89 -147.79 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.21 39.34 2.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . -174.75 -164.9 30.32 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.519 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -112.35 177.42 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -1.131 . . . . 0.0 110.163 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.573 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 61.4 m-85 -143.4 135.98 27.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.463 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.576 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 23.3 m . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.154 0.502 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.5 tpt180 -147.05 121.27 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.208 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' A' ' 25' ' ' HIS . 12.5 mm -101.07 148.71 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.493 -0.754 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.66 -66.95 2.07 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.806 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.8 Cg_endo -74.57 20.25 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.688 1.362 . . . . 0.0 112.667 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.03 -24.34 17.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 107.701 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.453 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 36.0 t70 -88.57 -27.21 21.53 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 14.5 mm-40 -80.16 -44.4 19.92 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.03 13.81 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.31 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.71 -47.07 76.38 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.518 -0.739 . . . . 0.0 110.925 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -75.17 4.05 5.17 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.755 1.397 . . . . 0.0 111.133 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 22.4 mmt180 -83.42 -175.51 5.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.022 -1.048 . . . . 0.0 110.262 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.7 pt -54.09 -165.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.335 -0.853 . . . . 0.0 110.668 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -82.34 -42.17 0.96 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.11 -10.37 25.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.213 1.112 . . . . 0.0 110.472 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -83.75 -14.74 50.8 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.26 -47.82 3.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 12.8 m-70 -58.87 -37.78 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 1.6 tm-20 -79.48 -21.91 44.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 11.1 t -61.04 -40.32 93.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.316 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.465 ' HA ' HG13 ' A' ' 4' ' ' ILE . 93.5 m -75.01 -52.48 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.0 110.275 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -12.64 59.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.313 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -87.55 -16.88 33.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.583 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -102.54 -17.2 15.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.92 34.06 1.74 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.513 ' HD2' ' CG2' ' A' ' 2' ' ' VAL . 16.2 mmt180 -103.42 -161.71 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -1.118 . . . . 0.0 110.282 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.66 -38.35 5.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.351 -0.843 . . . . 0.0 110.18 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.77 167.19 37.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 29.8 p90 -69.78 146.32 51.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -1.162 . . . . 0.0 110.239 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -119.97 -66.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 5.8 p90 -178.48 163.38 1.55 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.429 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -103.99 114.87 29.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -144.86 158.41 43.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 57.69 54.26 38.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 43.35 26.96 0.67 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -146.68 -153.9 6.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.521 ' CG ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -150.98 170.59 18.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 110.319 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.514 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 89.2 m-85 -143.52 144.82 32.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 86.1 m . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.388 -0.82 . . . . 0.0 110.159 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 40' ' ' CYS . 3.6 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.324 0.583 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.8 tpt180 -146.77 119.43 8.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.331 -0.855 . . . . 0.0 110.04 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.573 ' CD1' ' CB ' ' A' ' 25' ' ' HIS . 10.6 mm -101.82 151.77 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.505 -0.747 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.15 -68.46 1.63 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.208 -0.996 . . . . 0.0 110.834 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.549 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.0 Cg_endo -75.22 21.24 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.704 1.371 . . . . 0.0 112.627 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.29 -26.19 16.7 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.667 -1.271 . . . . 0.0 107.746 178.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.519 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.0 t0 -86.57 -24.35 25.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.407 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 mt-30 -85.13 -43.43 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.61 12.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.63 -45.24 76.1 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 110.792 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.3 Cg_endo -77.58 6.02 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.687 1.362 . . . . 0.0 110.737 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -85.84 -178.15 6.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 110.176 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.531 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.5 pt -53.66 -167.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.839 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.3 t -82.39 -41.04 0.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 111.815 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.9 Cg_endo -70.52 -13.19 32.54 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.085 1.045 . . . . 0.0 110.285 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.1 OUTLIER -84.89 -11.76 54.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 0.0 109.247 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 15.0 mtp180 -100.38 -54.06 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.969 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.681 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 6.8 m-70 -57.62 -40.42 79.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 1.9 tt0 -73.34 -17.32 61.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.42 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 22.2 t -70.24 -45.9 65.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 0.0 110.446 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' HA ' HG13 ' A' ' 4' ' ' ILE . 85.7 m -74.77 -28.69 60.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.067 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.92 -17.58 35.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.072 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -87.78 -4.21 58.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.573 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.41 -54.95 2.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.86 39.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HD2' HG22 ' A' ' 2' ' ' VAL . 5.0 mmt180 -109.17 -164.49 0.94 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.351 -1.087 . . . . 0.0 110.129 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.3 m -120.11 -3.99 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . 162.79 174.13 32.32 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 12.0 p90 -95.44 146.85 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 110.193 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -112.63 -61.05 1.79 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.65 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 5.3 p90 -178.01 -161.99 0.06 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.189 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -134.74 120.85 19.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.63 162.72 19.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.329 -0.857 . . . . 0.0 110.389 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.03 129.94 44.24 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.08 -32.37 6.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 167.11 170.3 31.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.519 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -95.29 165.92 12.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.141 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 69.2 m-85 -131.61 143.34 50.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 85.0 m . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.542 HG21 ' CG ' ' A' ' 27' ' ' ARG . 18.0 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.229 0.538 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.8 tpt180 -146.8 120.66 9.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.892 . . . . 0.0 110.339 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 7.6 mm -102.24 152.99 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.505 -0.747 . . . . 0.0 109.663 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.15 -66.12 2.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.529 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.629 ' CG ' ' CE1' ' A' ' 25' ' ' HIS . 43.1 Cg_endo -76.03 21.32 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.721 1.379 . . . . 0.0 112.582 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.16 -30.76 14.46 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.502 ' HB2' ' N ' ' A' ' 38' ' ' MET . 12.5 t70 -87.9 -31.04 19.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.464 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 81.9 mt-30 -70.99 -44.55 65.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 2.3 p -90.72 11.74 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.6 t -64.96 -43.66 68.85 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 110.826 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.1 Cg_endo -77.29 4.87 5.51 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.568 1.299 . . . . 0.0 110.65 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' ILE . 2.4 mmt180 -83.31 -175.84 6.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.522 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 14.0 pt -54.13 -167.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.45 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 50.1 t -82.43 -42.35 0.95 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 111.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -71.78 -8.26 22.74 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.237 1.125 . . . . 0.0 110.168 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.522 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -94.23 -15.52 24.48 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.41 -0.806 . . . . 0.0 109.205 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 11' ' ' CYS . 8.2 mtm180 -95.33 -54.47 3.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 24.4 m-70 -62.85 -24.41 67.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -86.82 -12.58 47.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.699 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.52 ' SG ' ' CE ' ' A' ' 38' ' ' MET . 3.5 p -69.7 -38.08 76.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 0.0 110.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 m -75.16 -47.76 26.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.423 -0.798 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -73.03 -12.46 60.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -78.77 -26.44 44.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.629 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 10.6 m170 -105.18 50.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.41 37.22 3.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' CG ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -111.02 -149.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.378 -1.072 . . . . 0.0 110.391 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 m -106.35 -141.43 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.19 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.16 155.78 18.6 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.578 ' CD1' ' HE3' ' A' ' 38' ' ' MET . 2.9 t80 -48.12 121.53 4.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -1.151 . . . . 0.0 110.252 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.531 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -96.64 -61.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 110.402 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 8.1 p90 -178.29 140.54 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -85.66 112.16 20.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.131 -0.981 . . . . 0.0 109.713 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.73 135.57 54.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.63 -152.59 30.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.46 41.72 3.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -164.7 165.0 37.25 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.578 ' HE3' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -120.34 153.84 35.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.919 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 14.3 m-85 -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 35.1 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 0.0 110.343 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 40' ' ' CYS . 9.2 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.515 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 1.3 tpt180 -147.87 118.34 7.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.261 -0.899 . . . . 0.0 110.077 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.544 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 11.9 mm -100.54 157.11 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 -66.81 1.68 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.097 -1.049 . . . . 0.0 110.599 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.8 Cg_endo -75.99 20.7 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.727 1.383 . . . . 0.0 112.706 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.2 m -94.17 -28.74 15.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.609 -1.307 . . . . 0.0 107.509 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.51 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.0 t70 -88.25 -30.31 19.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.26 -45.3 56.59 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.31 12.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.34 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 t -64.88 -43.37 68.35 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.611 -0.681 . . . . 0.0 111.358 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.5 Cg_endo -75.96 5.42 4.47 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.428 1.225 . . . . 0.0 111.023 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mmt180 -84.69 179.37 7.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.1 pt -54.39 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.158 -0.964 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -78.47 -45.64 2.04 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.801 . . . . 0.0 111.721 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.7 Cg_endo -68.91 -9.84 27.46 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.239 1.126 . . . . 0.0 110.297 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -87.81 -24.35 23.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.256 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -90.14 -49.18 6.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.4 m-70 -60.47 -16.78 39.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 6.4 tt0 -96.49 -18.64 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.517 ' CB ' HG12 ' A' ' 10' ' ' VAL . 4.0 p -64.75 -37.22 86.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.497 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 1.2 m -78.95 -50.24 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 110.164 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.7 mtt-85 -64.76 -19.28 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.304 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -73.95 -22.52 59.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.446 ' HB2' HD11 ' A' ' 4' ' ' ILE . 4.7 m80 -112.33 27.08 9.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 110.029 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 59.07 69.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.06 -151.26 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.282 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -111.07 -88.83 0.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.32 140.02 9.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.675 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.9 p90 -46.72 125.23 6.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.168 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -97.83 -60.91 1.47 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.106 -0.996 . . . . 0.0 110.338 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 7.2 p90 -178.28 142.65 0.26 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.013 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.8 OUTLIER -85.36 111.91 20.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.821 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -124.22 159.57 29.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.315 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.21 -150.74 0.46 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.33 42.7 2.7 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.95 145.07 8.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.523 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 8.2 ttt -87.23 159.72 18.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 110.043 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 84.1 m-85 -125.49 143.21 51.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.515 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.388 -0.82 . . . . 0.0 110.387 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.1 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.25 0.548 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.524 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.4 tpt180 -147.04 121.36 9.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 110.285 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.524 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 5.7 mm -100.17 145.05 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.422 -0.799 . . . . 0.0 109.66 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . -57.55 -71.9 0.67 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.132 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.549 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.9 Cg_endo -76.76 25.73 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.632 1.332 . . . . 0.0 112.724 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -94.79 -21.83 18.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.73 -1.231 . . . . 0.0 108.164 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 3.7 p-10 -87.32 -24.51 24.28 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.404 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mt-30 -87.97 -42.53 12.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 109.482 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.88 -45.0 74.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 110.877 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.6 Cg_endo -77.44 8.53 3.26 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.639 1.336 . . . . 0.0 111.136 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 12.2 mmt180 -83.17 -179.17 7.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.039 -1.038 . . . . 0.0 110.049 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.524 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.6 pt -53.78 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.2 t -79.49 -44.07 1.62 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 111.22 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -72.6 -4.45 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.359 1.189 . . . . 0.0 110.285 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 3.0 mm-40 -96.31 -15.86 21.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.527 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -102.85 -50.94 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.682 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 44.5 m-70 -61.54 -35.18 77.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.111 -0.993 . . . . 0.0 109.906 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.62 -19.31 59.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.145 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 15.2 t -62.76 -41.53 99.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.007 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 81.7 m -78.65 -25.01 44.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -86.14 -15.36 41.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.458 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.23 21.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.327 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 32.3 m80 -98.34 43.34 1.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.76 19.45 10.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -100.81 173.93 6.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -1.21 . . . . 0.0 110.181 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 3.1 t -82.2 -141.96 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.16 -158.49 27.78 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.682 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -96.67 141.62 29.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -1.153 . . . . 0.0 110.385 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . . . -106.16 -60.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 31' ' ' ALA . 17.8 p90 -178.43 146.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.253 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -94.73 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.465 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 35' ' ' GLY . 16.0 p -80.59 -143.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 110.44 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -56.17 -110.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.63 41.9 2.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.64 139.02 5.81 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 1.7 tpt -104.97 153.21 21.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.861 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 13.6 m-85 -127.29 149.25 50.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 74.4 m . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.455 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.426 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 23.7 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.26 0.552 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.513 ' NH2' ' OD2' ' A' ' 8' ' ' ASP . 2.0 tpt180 -147.78 121.61 9.32 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.328 -0.858 . . . . 0.0 110.077 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.522 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 12.2 mm -99.94 152.51 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.989 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -72.76 -68.32 1.62 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.733 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.545 ' CG ' ' CE1' ' A' ' 25' ' ' HIS . 42.3 Cg_endo -76.06 23.16 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.597 1.314 . . . . 0.0 112.596 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.63 -29.84 14.64 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.673 -1.267 . . . . 0.0 107.939 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 3.0 p30 -86.47 -24.89 25.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -45.1 16.79 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.6 p -91.16 12.26 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.43 -44.75 76.35 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.54 -0.725 . . . . 0.0 110.893 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.8 Cg_endo -75.98 4.12 5.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.688 1.362 . . . . 0.0 110.647 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.5 mmp_? -83.62 -175.66 5.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 110.034 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.519 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 15.4 pt -55.72 -167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 110.724 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -82.55 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 111.642 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -72.29 -3.56 13.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.274 1.144 . . . . 0.0 110.393 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 3.7 mt-10 -96.06 -12.78 24.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.377 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.534 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 mtm-85 -105.02 -49.39 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.659 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 33.4 m-70 -60.63 -33.93 73.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 8.2 tm-20 -79.89 -14.53 58.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 13.5 t -64.31 -41.89 96.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 110.33 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.2 m -76.52 -46.24 27.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -64.84 -22.23 66.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -84.9 -22.5 29.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.24 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.545 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 12.2 m-70 -105.97 7.91 32.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.484 ' O ' ' CD ' ' A' ' 27' ' ' ARG . . . 80.38 64.48 1.83 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 3.9 mpt_? -135.17 -178.23 5.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.1 m -87.92 -88.06 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -141.81 144.86 14.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.659 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 10.8 p90 -44.54 124.75 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.209 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -96.27 -60.57 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.554 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 11.0 p90 -178.18 158.39 1.18 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.066 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -106.56 106.62 17.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.796 179.567 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -106.59 137.92 43.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.84 -150.74 0.86 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.78 48.35 3.96 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -167.35 137.09 4.44 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.498 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 6.3 ttt -104.4 170.56 7.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.528 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 67.6 m-85 -143.71 153.05 42.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CA ' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.588 ' CG2' ' CB ' ' A' ' 40' ' ' CYS . 30.2 m . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.202 0.525 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.525 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.0 tpt180 -147.7 121.32 9.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 110.18 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 7' ' ' CYS . 26.6 mm -101.71 156.31 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 4' ' ' ILE . . . -77.27 -66.61 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.88 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.0 Cg_endo -76.21 20.98 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.713 1.375 . . . . 0.0 112.736 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.529 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 8.5 t -94.49 -28.6 15.37 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.687 -1.258 . . . . 0.0 108.012 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.516 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 5.1 t0 -85.8 -24.21 26.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.99 -45.28 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.87 13.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.0 109.442 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.5 t -64.49 -41.94 62.28 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.539 -0.726 . . . . 0.0 111.501 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 44.3 Cg_endo -74.77 3.64 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.393 1.207 . . . . 0.0 110.999 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.502 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.56 177.83 7.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.041 -1.037 . . . . 0.0 109.794 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.522 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 9.5 pt -53.75 -166.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 110.731 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.8 t -77.69 -45.32 2.48 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 0.0 111.526 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.0 Cg_endo -68.53 -9.94 27.56 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.268 1.141 . . . . 0.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.521 ' OE1' ' CG2' ' A' ' 10' ' ' VAL . 9.2 mm-40 -91.69 -19.4 22.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.372 -0.83 . . . . 0.0 109.066 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 47.3 mtp180 -91.34 -45.39 8.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.506 -0.746 . . . . 0.0 109.766 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.598 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -64.56 -18.84 65.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 110.242 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 2.3 tp10 -80.12 -13.54 59.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.709 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 9.2 p -69.8 -38.02 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.282 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 4.7 m -84.16 -46.67 11.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.368 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.477 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -70.92 -39.44 72.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.12 -0.987 . . . . 0.0 110.317 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.536 ' CE1' ' CD ' ' A' ' 6' ' ' PRO . 9.7 m170 -98.88 33.64 2.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 110.231 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 50.36 76.82 0.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.1 tpt180 -141.29 -157.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -1.156 . . . . 0.0 110.25 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 1.6 t -102.94 -140.56 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -98.2 143.59 16.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.598 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -43.2 134.29 3.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -1.127 . . . . 0.0 110.49 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -106.49 -59.25 1.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.553 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 9.3 p90 -178.11 142.75 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.491 -0.756 . . . . 0.0 110.129 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -86.57 117.17 25.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.985 . . . . 0.0 110.02 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -131.28 136.86 48.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.86 -156.35 24.0 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.12 49.77 4.16 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 39' ' ' TYR . . . 175.72 133.77 1.81 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 30' ' ' TYR . 10.0 ttt -86.27 176.41 7.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -1.227 . . . . 0.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 37' ' ' GLY . 76.6 m-85 -140.71 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.588 ' CB ' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.25 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 36.0 m . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.207 0.527 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.8 tpt180 -146.13 121.14 10.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -101.42 150.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.627 -0.671 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.25 -68.95 1.49 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.83 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.545 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.41 22.46 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.656 1.345 . . . . 0.0 112.757 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.54 -24.39 17.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.64 -1.287 . . . . 0.0 107.77 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -88.87 -24.51 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 15.3 mt-30 -85.03 -43.02 14.31 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.35 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -64.81 -42.23 61.86 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.608 -0.683 . . . . 0.0 111.308 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -75.74 4.47 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.36 1.19 . . . . 0.0 110.825 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.528 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 3.1 mmp_? -83.31 177.06 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.854 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.5 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.3 pt -53.54 -168.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.938 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 t -78.28 -45.06 2.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 111.303 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.7 Cg_endo -70.21 -7.21 20.64 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.384 1.202 . . . . 0.0 110.301 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -91.85 -13.7 30.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.446 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 2.2 mtm180 -103.41 -44.79 5.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 109.813 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.531 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -60.39 -36.06 77.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -75.92 -14.35 60.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -0.837 . . . . 0.0 110.376 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 26.9 t -70.7 -48.01 56.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 86.7 m -75.13 -22.98 57.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -90.1 -19.77 23.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.181 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.17 24.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.411 ' HB3' ' CD1' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -99.3 43.12 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 110.354 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 47.41 39.6 14.69 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.507 ' CG ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -120.75 -179.32 3.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -1.109 . . . . 0.0 110.186 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -140.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.002 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . -92.87 -178.69 40.57 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 1.2 p90 -76.99 137.33 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.206 -1.173 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB3' ' C ' ' A' ' 40' ' ' CYS . . . -106.99 -65.21 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 110.612 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 4.9 p90 -178.11 153.13 0.76 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.313 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -95.8 112.51 24.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.898 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.82 139.49 47.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.37 -149.89 0.87 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.04 45.09 3.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -162.94 151.93 21.87 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -115.09 163.16 16.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.366 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' N ' ' SD ' ' A' ' 38' ' ' MET . 51.8 m-85 -135.08 154.19 51.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.063 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 86.0 m . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.876 . . . . 0.0 110.598 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 6.0 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.178 0.513 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.3 tpt180 -147.16 119.11 8.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 0.0 110.201 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.546 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 11.1 mm -101.35 160.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 109.723 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.57 -66.01 1.67 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.565 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.566 ' CG ' ' CE1' ' A' ' 25' ' ' HIS . 42.6 Cg_endo -76.54 20.01 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.633 1.333 . . . . 0.0 112.594 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.546 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.2 m -94.28 -28.16 15.74 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.532 ' HB2' ' N ' ' A' ' 38' ' ' MET . 2.4 t70 -87.75 -31.1 19.83 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -46.0 51.6 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.29 11.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.336 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 t -64.79 -44.05 71.49 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.71 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.6 Cg_endo -75.25 3.83 5.4 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.523 1.275 . . . . 0.0 110.923 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.522 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -83.2 177.35 8.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.072 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.523 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 12.9 pt -52.92 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 0.0 110.939 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.9 t -76.52 -47.22 3.23 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 111.451 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.5 Cg_endo -67.97 -9.63 26.29 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.304 1.16 . . . . 0.0 110.151 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.522 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.0 mm-40 -94.69 -16.39 23.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.849 . . . . 0.0 109.195 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -93.93 -49.89 5.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.807 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -65.05 -20.68 66.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 109.954 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -89.07 -10.03 48.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.521 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.516 ' CB ' HG13 ' A' ' 10' ' ' VAL . 5.5 p -72.16 -37.87 69.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.056 -1.028 . . . . 0.0 110.067 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -82.41 -35.4 27.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 110.237 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -74.12 -30.68 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.424 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.95 66.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.566 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 29.1 m80 -112.27 9.45 19.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 110.299 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.4 82.65 0.22 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.74 -143.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -1.182 . . . . 0.0 110.178 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 p -112.79 -74.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.191 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -167.6 138.47 5.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 4.5 t80 -42.94 121.97 2.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -1.118 . . . . 0.0 110.178 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB2' ' CD2' ' A' ' 32' ' ' TYR . . . -101.97 -61.12 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 31' ' ' ALA . 14.0 p90 -178.42 134.17 0.14 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.184 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -79.78 112.27 16.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 109.523 179.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 9.7 p -88.29 31.75 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.35 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.59 126.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.97 -32.51 4.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.39 144.71 9.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.532 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 5.9 ttt -93.27 154.47 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -1.131 . . . . 0.0 110.021 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.527 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 13.6 m-85 -123.71 137.56 54.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.468 ' O ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 110.656 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 4.6 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.047 0.451 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.7 tpt180 -147.29 123.03 10.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 39.6 mm -99.57 156.95 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.657 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.67 -64.54 1.68 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.567 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.0 Cg_endo -75.53 14.23 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.729 1.384 . . . . 0.0 112.624 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 1.8 t -94.62 -21.4 18.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.565 -1.334 . . . . 0.0 107.959 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.465 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 3.4 t70 -87.04 -23.32 25.0 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -90.12 -44.87 9.5 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.567 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.96 13.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.215 -0.928 . . . . 0.0 109.674 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.26 -43.71 73.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.0 111.231 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.0 Cg_endo -76.29 5.03 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.454 1.239 . . . . 0.0 110.797 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.497 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -85.9 -176.82 6.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 110.196 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.7 pt -53.15 -167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.181 -0.949 . . . . 0.0 110.995 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.619 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.0 t -80.6 -42.26 1.27 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 0.0 111.739 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.66 -12.41 31.15 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.27 1.142 . . . . 0.0 110.289 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.1 OUTLIER -81.51 -24.27 36.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 9.2 mtm180 -94.57 -46.07 7.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.447 -0.783 . . . . 0.0 109.987 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.571 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -59.97 -18.95 49.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.0 110.076 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.8 OUTLIER -88.96 -22.26 23.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 4.9 p -59.16 -37.26 76.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 57.8 m -77.88 -42.26 33.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 0.0 110.289 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -22.61 67.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' OE2' ' A' ' 20' ' ' GLU . . . -81.88 -22.53 36.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.462 ' HB2' HD12 ' A' ' 4' ' ' ILE . 29.0 m80 -110.4 22.28 15.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.323 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.46 71.91 0.66 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' CG ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -125.3 -154.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -1.133 . . . . 0.0 110.197 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.05 -45.9 2.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.338 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.421 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -179.5 135.15 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 9.2 p90 -45.02 148.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 110.382 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -120.33 -60.98 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.542 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 10.3 p90 -178.11 145.41 0.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -88.18 115.95 26.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 110.111 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -110.26 128.07 55.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 110.566 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 43.82 -146.31 1.34 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.2 3.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA2' ' CZ ' ' A' ' 3' ' ' ARG . . . -165.07 119.47 0.87 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 39' ' ' TYR . 1.5 tmt? -84.39 161.08 20.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 58.1 m-85 -131.13 143.45 50.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 9.8 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.4 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.281 0.563 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.48 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.2 tpt180 -146.94 117.63 7.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.921 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.577 HD12 ' CG ' ' A' ' 25' ' ' HIS . 6.0 mm -100.68 144.43 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 0.0 109.764 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.27 -69.43 1.28 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.086 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.546 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.0 Cg_endo -73.9 19.7 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.6 1.316 . . . . 0.0 112.749 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.543 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -94.15 -21.92 18.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.715 -1.241 . . . . 0.0 107.731 178.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.519 ' HB2' ' N ' ' A' ' 38' ' ' MET . 11.8 t70 -92.58 -29.58 16.09 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.464 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 tt0 -78.91 -40.12 33.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.41 9.55 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.38 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.4 t -65.08 -40.34 44.8 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.582 -0.699 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.7 Cg_endo -76.34 3.64 6.11 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.185 1.097 . . . . 0.0 110.526 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 9.6 mmt180 -86.94 -177.0 5.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.984 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.0 pt -53.79 -167.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 87.9 t -81.49 -41.69 1.08 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.567 -0.708 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.4 Cg_endo -69.94 -13.59 34.42 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 122.963 0.98 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -82.86 -12.16 57.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.266 -0.896 . . . . 0.0 109.187 178.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -102.38 -58.1 1.94 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.535 -0.728 . . . . 0.0 110.069 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.617 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 20.4 m-70 -58.4 -36.64 73.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -73.42 -23.27 60.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.514 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 6.9 t -67.8 -29.77 69.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 30' ' ' TYR . 92.7 m -74.97 -34.25 62.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.017 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.22 -11.8 39.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.64 -14.51 56.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.577 ' CG ' HD12 ' A' ' 4' ' ' ILE . 1.2 m80 -107.27 -79.1 0.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.64 28.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HG3' HG12 ' A' ' 4' ' ' ILE . 10.2 mmt180 -102.04 -158.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.25 -54.77 2.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 22' ' ' CYS . . . -149.16 -159.86 8.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.617 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 15.8 p90 -98.29 161.68 13.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -132.53 -67.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.971 . . . . 0.0 110.633 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.542 ' CE1' ' CB ' ' A' ' 39' ' ' TYR . 4.3 p90 -178.42 156.25 0.93 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.266 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -99.89 101.1 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 109.903 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -90.56 149.6 22.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 110.224 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.94 112.38 1.91 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.23 -44.0 1.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' CA ' ' OD2' ' A' ' 8' ' ' ASP . . . -167.29 -176.04 37.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.543 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 7.8 tpt -110.06 167.44 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -1.076 . . . . 0.0 109.523 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.542 ' CB ' ' CE1' ' A' ' 32' ' ' TYR . 42.5 m-85 -133.68 139.91 46.73 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.011 -1.056 . . . . 0.0 110.377 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 55.7 m . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.452 -0.78 . . . . 0.0 110.124 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.08 0.467 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.559 ' NH2' ' CA ' ' A' ' 37' ' ' GLY . 2.7 tpt180 -148.25 116.2 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 110.124 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.532 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 15.5 mm -99.93 152.6 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.782 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.18 -64.88 2.12 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.934 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.3 Cg_endo -74.88 17.5 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.625 1.329 . . . . 0.0 112.642 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HB3' ' CB ' ' A' ' 38' ' ' MET . 1.2 m -93.86 -29.92 15.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.522 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 21.2 t70 -84.2 -31.48 25.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -73.47 -47.01 44.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.68 13.54 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.088 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.0 t -64.37 -43.51 72.51 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.679 -0.638 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.7 Cg_endo -76.29 5.08 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.536 1.282 . . . . 0.0 110.865 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 1.6 mmt180 -84.71 177.68 7.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 110.18 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.523 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 14.2 pt -53.68 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.895 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.595 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.4 t -81.54 -43.19 1.11 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.452 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -71.85 -4.19 14.63 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.288 1.152 . . . . 0.0 110.195 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 4.1 mm-40 -98.54 -8.56 26.36 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.383 -0.823 . . . . 0.0 109.43 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 11' ' ' CYS . 3.1 ttp180 -108.46 -46.38 3.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.077 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -62.41 -30.22 71.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -80.35 -13.47 59.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 6.7 t -68.92 -45.15 71.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 110.148 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.26 -39.36 59.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 110.238 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -20.72 66.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.97 -30.09 21.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 110.186 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLY . 32.0 m80 -101.4 46.32 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.53 64.34 1.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HG3' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -131.61 -178.23 4.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.249 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -93.74 -91.31 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -143.99 141.68 10.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.551 ' CD1' ' HE1' ' A' ' 38' ' ' MET . 7.0 t80 -46.69 136.54 7.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.58 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -112.39 -54.75 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.58 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 8.4 p90 -177.86 144.64 0.36 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.538 -0.726 . . . . 0.0 109.946 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -85.67 113.4 21.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.103 -0.998 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -146.61 176.26 9.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.751 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 47.52 57.49 7.37 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 40.96 38.79 1.77 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.559 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -173.97 -170.24 37.11 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.551 ' HE1' ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -115.13 157.66 23.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.064 -1.257 . . . . 0.0 110.413 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.528 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 19.0 m-85 -128.6 134.54 48.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.396 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 5.6 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.331 0.586 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 3.5 tpt180 -147.91 120.17 8.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.226 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.522 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 11.8 mm -99.71 146.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.924 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.55 -67.24 2.05 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.014 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.555 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.5 Cg_endo -74.91 20.27 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.634 1.334 . . . . 0.0 112.617 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.36 -27.47 16.05 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.614 -1.304 . . . . 0.0 108.034 178.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 -22.41 25.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.91 -44.22 11.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.0 11.92 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.412 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.53 -42.46 65.76 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.589 -0.694 . . . . 0.0 111.306 -179.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.26 6.31 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.45 1.237 . . . . 0.0 111.001 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -85.18 -177.71 6.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 0.0 110.12 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.518 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.5 pt -54.29 -165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.611 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.1 t -80.81 -44.04 1.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 111.7 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -70.8 -10.71 28.28 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.372 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -81.31 -22.91 38.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.239 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 2.3 ttm180 -97.74 -47.26 5.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 109.684 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -34.08 66.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.989 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -82.41 -19.14 39.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 30.5 t -61.2 -43.59 98.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.49 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.06 -24.94 58.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 110.307 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -83.58 -19.91 34.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -13.14 43.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.095 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.485 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 7.5 m80 -117.55 39.18 3.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 0.0 110.134 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 44.35 63.79 2.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HD3' ' CD1' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -132.52 -152.05 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -1.136 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 47.0 m -119.99 -130.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.151 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -98.81 135.76 12.32 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.459 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 24.7 p90 -41.65 130.32 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.104 . . . . 0.0 110.249 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -98.64 -60.75 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.643 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.558 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 11.7 p90 -178.16 148.56 0.5 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.144 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -93.16 113.26 25.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 109.855 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.7 165.48 11.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.66 120.85 23.24 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.1 -21.59 15.3 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 160.2 177.03 32.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 11.6 ttt -100.45 167.2 10.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -1.114 . . . . 0.0 109.922 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.558 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 65.0 m-85 -139.09 148.23 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 18.6 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.236 0.541 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.51 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.2 tpt180 -147.94 120.11 8.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 110.259 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.532 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 13.0 mm -100.1 151.06 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.97 -66.61 2.0 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.551 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.06 18.42 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.661 1.348 . . . . 0.0 112.679 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.532 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.1 m -94.08 -30.01 14.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.629 -1.294 . . . . 0.0 107.912 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.455 ' N ' ' HB2' ' A' ' 38' ' ' MET . 23.8 t0 -84.16 -22.92 30.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.73 -46.45 10.69 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.2 p -91.1 12.91 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -64.33 -42.61 68.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 111.289 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.9 Cg_endo -75.49 4.2 5.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.333 1.175 . . . . 0.0 110.909 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.2 mmt-85 -84.42 -179.82 7.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.087 -1.008 . . . . 0.0 109.84 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 6.1 pt -53.63 -168.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.9 t -81.38 -43.05 1.13 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.776 . . . . 0.0 111.379 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -71.9 -3.73 13.75 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.306 1.161 . . . . 0.0 110.256 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -91.21 -13.51 32.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -0.807 . . . . 0.0 109.32 179.085 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 6.1 ttm180 -109.7 -41.55 4.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 110.036 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -31.38 64.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.067 -1.02 . . . . 0.0 109.835 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 23.2 tt0 -85.83 -19.64 30.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.52 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 13.0 t -59.14 -42.65 91.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.3 m -77.59 -38.62 47.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.995 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -20.92 66.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -85.61 -18.03 34.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.524 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 19.1 m80 -111.0 34.93 3.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.09 58.36 7.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.492 ' CG ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -118.86 -151.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -1.115 . . . . 0.0 110.243 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -86.99 0.63 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -0.832 . . . . 0.0 110.257 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.53 136.4 6.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.553 ' CG ' ' O ' ' A' ' 30' ' ' TYR . 16.1 p90 -43.54 122.73 2.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -1.159 . . . . 0.0 110.253 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . . . -96.41 -59.56 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.56 ' CD2' ' HB3' ' A' ' 31' ' ' ALA . 8.4 p90 -178.25 151.29 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 110.226 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -93.12 114.0 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.721 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.456 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -104.25 161.82 13.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.389 -0.819 . . . . 0.0 110.31 -179.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 122.62 30.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -27.1 9.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 166.47 176.37 37.56 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.537 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -93.65 165.01 12.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.163 . . . . 0.0 110.023 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 49.8 m-85 -138.02 142.81 40.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 110.052 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 31.3 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.253 0.549 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.465 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.1 tpt180 -148.23 118.87 7.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.526 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 11.1 mm -102.77 153.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.988 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.73 -68.1 1.65 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.823 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.539 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.15 20.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.671 1.353 . . . . 0.0 112.663 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.14 -29.01 15.36 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 107.78 178.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.512 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.5 p30 -85.83 -25.5 26.24 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.96 -44.32 15.44 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 11.24 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.43 -44.01 73.86 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 111.057 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -76.78 5.58 4.76 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.544 1.286 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 14' ' ' ILE . 26.4 mmt180 -85.93 -175.48 5.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.093 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.523 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 6.8 pt -53.83 -167.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.8 t -81.55 -43.16 1.11 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 111.485 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.18 -5.22 16.53 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.286 1.15 . . . . 0.0 110.264 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.523 ' OE2' ' CD1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -87.44 -14.39 40.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.278 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 ttm180 -106.26 -49.57 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.474 -0.766 . . . . 0.0 110.021 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.7 m-70 -55.01 -38.92 68.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.018 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -79.0 -19.98 50.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.913 . . . . 0.0 110.32 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 18.4 t -59.85 -40.3 88.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 110.502 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.14 -32.11 61.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -78.61 -16.97 56.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 110.233 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.44 -19.58 29.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -115.35 33.5 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 110.292 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . 53.36 71.13 0.74 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' CG ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -140.27 -153.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -1.178 . . . . 0.0 110.298 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 84.6 p -120.06 -134.52 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.34 135.2 12.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.619 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -46.62 131.76 11.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -1.163 . . . . 0.0 110.332 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -97.54 -56.22 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.595 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 9.9 p90 -177.0 -177.49 0.76 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.61 -0.681 . . . . 0.0 109.988 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -125.06 115.25 20.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.23 147.62 29.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.212 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.87 127.03 19.12 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.02 -44.9 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.87 169.67 42.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.512 ' N ' ' HB3' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -95.64 163.87 13.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -1.168 . . . . 0.0 110.029 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 82.3 m-85 -134.94 149.2 50.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.316 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 1.1 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.6 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.274 0.559 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.52 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.1 tpt180 -147.51 122.33 9.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.578 HD13 ' CG ' ' A' ' 25' ' ' HIS . 10.2 mm -99.26 150.26 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.687 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.54 -67.33 1.89 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.087 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.552 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.25 17.81 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.638 1.336 . . . . 0.0 112.804 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.2 m -94.24 -27.13 16.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.642 -1.286 . . . . 0.0 108.031 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.459 ' HB2' ' N ' ' A' ' 38' ' ' MET . 30.0 t0 -86.1 -23.2 26.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 tm0? -88.03 -44.67 10.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -91.12 11.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.98 . . . . 0.0 109.598 179.328 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.57 -42.29 64.18 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.777 . . . . 0.0 111.242 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.2 Cg_endo -76.58 5.46 4.75 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.456 1.24 . . . . 0.0 110.858 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -85.36 -177.75 6.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 110.18 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.7 pt -55.5 -164.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.668 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 46.3 t -81.3 -45.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.528 -0.733 . . . . 0.0 111.497 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.37 -4.14 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.272 1.143 . . . . 0.0 110.436 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.47 ' OE2' ' CD1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -89.89 -14.78 33.53 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.241 -0.912 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -108.12 -42.46 4.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.739 . . . . 0.0 110.034 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.436 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -59.17 -32.26 69.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.188 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 37.7 tt0 -86.68 -12.28 48.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 12.8 t -70.67 -36.61 73.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 30' ' ' TYR . 1.3 m -78.23 -49.6 13.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.205 -0.935 . . . . 0.0 110.463 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -64.52 -34.5 78.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.21 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -68.13 -18.6 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.206 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.578 ' CG ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -97.87 -74.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.167 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.84 34.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.514 ' CG ' HD11 ' A' ' 4' ' ' ILE . 2.7 mmt180 -104.4 -153.07 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -1.232 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -119.57 -43.65 2.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.132 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -169.0 130.63 2.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 30' ' ' TYR . 1.7 p90 -43.9 126.14 4.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -1.137 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -96.05 -56.63 2.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 9.6 p90 -177.7 -175.25 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.13 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -126.52 114.49 18.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.884 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.32 162.97 12.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 110.278 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.35 116.63 9.31 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.34 -28.87 6.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 171.88 175.26 39.98 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.512 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -99.88 164.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.126 179.919 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 46.0 m-85 -134.52 149.73 50.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 110.352 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB3' HG22 ' A' ' 2' ' ' VAL . 1.7 t . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.413 -0.804 . . . . 0.0 110.206 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.8 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.309 0.575 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 1.5 tpt180 -147.36 121.02 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.523 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -102.7 148.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.0 -70.85 0.94 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.814 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.542 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.3 Cg_endo -75.72 24.38 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.724 1.381 . . . . 0.0 112.832 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.51 -23.16 17.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.63 -1.294 . . . . 0.0 107.881 178.419 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 14.5 t70 -88.56 -28.33 20.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.4 tt0 -79.64 -43.92 21.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.15 11.35 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.453 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.6 t -65.11 -43.96 68.55 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -76.45 4.71 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.582 1.306 . . . . 0.0 110.697 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 29.3 mmt180 -83.06 -178.65 7.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.944 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.7 pt -54.2 -165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 54.7 t -81.62 -43.03 1.09 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 111.704 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.8 Cg_endo -70.91 -11.4 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.191 1.101 . . . . 0.0 110.345 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.51 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.4 OUTLIER -82.42 -20.19 37.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.357 -0.839 . . . . 0.0 109.46 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.511 ' CZ ' ' O ' ' A' ' 11' ' ' CYS . 4.2 mtm180 -99.02 -49.32 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.463 -0.773 . . . . 0.0 109.888 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.685 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 7.5 m-70 -57.14 -37.36 71.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.864 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 53.6 tt0 -77.02 -20.33 56.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.084 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 24.3 t -64.34 -45.84 86.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 58.8 m -75.87 -40.43 54.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -73.25 -16.22 61.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.175 -0.953 . . . . 0.0 110.366 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -87.6 -32.55 19.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.491 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 9.2 m80 -94.87 54.48 1.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.296 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.52 26.35 0.65 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -106.11 172.67 6.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -1.196 . . . . 0.0 110.051 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -84.07 -143.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.907 . . . . 0.0 110.167 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -71.17 -151.58 0.9 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.685 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 13.5 p90 -113.94 151.76 31.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -1.169 . . . . 0.0 110.189 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -110.48 -63.83 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.496 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 7.2 p90 -178.15 -161.42 0.05 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.276 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -138.5 109.3 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -85.82 41.87 0.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.46 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . 77.96 -108.16 2.57 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.83 49.46 4.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.15 102.45 0.16 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.523 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.6 169.74 11.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 110.183 -179.853 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.57 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 70.8 m-85 -142.02 146.68 35.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 110.295 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.52 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 98.0 m . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 0.0 110.298 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.449 HG22 ' HG3' ' A' ' 27' ' ' ARG . 4.0 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.21 0.529 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -148.33 131.52 16.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.318 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 16.9 mm -110.99 160.84 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.461 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -85.86 -63.37 1.54 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.519 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.559 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 40.6 Cg_endo -74.6 15.74 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.645 1.339 . . . . 0.0 112.372 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.3 m -93.25 -22.74 18.83 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.539 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 p30 -88.23 -29.61 20.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.451 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -79.09 -45.24 20.48 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.302 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -91.11 13.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.393 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 t -64.43 -44.99 77.21 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.474 -0.766 . . . . 0.0 110.701 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.4 Cg_endo -77.13 5.77 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.592 1.312 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 4.2 mmp_? -83.29 179.28 7.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 110.064 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.5 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 7.6 pt -54.09 -166.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -78.76 -45.71 1.87 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 111.6 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -69.62 -6.82 19.45 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.282 1.148 . . . . 0.0 110.53 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' OE2' ' CD1' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -89.18 -19.57 25.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.102 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 7.0 ttm180 -99.31 -52.32 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.875 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 19.2 m-70 -57.51 -33.64 68.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.896 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.23 -21.21 46.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 110.179 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' ' 4' ' ' ILE . 10.0 t -65.42 -45.29 84.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.902 . . . . 0.0 110.205 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.91 -43.99 33.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.53 -21.78 66.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.867 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -21.27 25.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -102.45 14.91 30.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 27' ' ' ARG . . . 71.46 64.49 2.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' CZ ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -134.66 -158.3 0.87 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -1.175 . . . . 0.0 110.159 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 -89.71 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -145.61 144.87 13.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.686 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -42.58 119.86 1.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -1.158 . . . . 0.0 110.2 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -99.65 -56.18 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.488 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 13.4 p90 -178.03 129.29 0.14 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.373 -178.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -74.25 115.86 14.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 179.374 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.31 167.4 10.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.254 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.98 143.29 11.65 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.77 -50.73 2.0 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 8' ' ' ASP . . . -173.09 -139.34 2.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.536 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 9.5 ttt -126.81 162.58 25.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -1.17 . . . . 0.0 109.913 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 50.2 m-85 -135.24 148.07 49.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 111.015 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.497 -0.752 . . . . 0.0 110.171 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 34.5 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.07 0.462 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.5 tpt180 -146.85 121.16 9.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 25' ' ' HIS . 6.3 mm -101.17 149.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.557 -0.714 . . . . 0.0 109.545 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.32 -70.51 1.05 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.163 -1.017 . . . . 0.0 110.788 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.536 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.18 25.66 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.757 1.398 . . . . 0.0 112.746 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -94.78 -26.92 16.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.62 -1.3 . . . . 0.0 107.915 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 37' ' ' GLY . 1.8 t70 -87.32 -24.32 24.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.409 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 28.7 mt-30 -84.57 -41.66 16.22 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.66 12.1 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.586 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 22.8 t -64.96 -41.37 54.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.0 Cg_endo -76.83 5.28 5.0 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.344 1.181 . . . . 0.0 110.74 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.1 mmt180 -83.25 179.42 7.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.127 -0.983 . . . . 0.0 110.182 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.0 pt -54.23 -165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.652 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.6 t -79.3 -45.19 1.68 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 111.448 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.3 Cg_endo -70.99 -4.51 14.99 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.287 1.151 . . . . 0.0 110.361 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 3.1 mm-40 -93.18 -15.74 25.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.524 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtm180 -104.85 -50.31 3.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.08 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 19.1 m-70 -61.49 -37.07 82.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.24 -0.913 . . . . 0.0 110.117 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 1.6 tt0 -74.53 -20.0 60.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 15.5 t -62.0 -40.93 97.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 83.9 m -76.18 -50.18 15.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -14.09 62.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -87.49 -33.27 19.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.928 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 11.9 m-70 -96.51 50.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.146 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.83 43.24 6.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -119.53 -167.37 1.4 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -1.117 . . . . 0.0 110.216 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 4.8 t -102.14 -144.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.19 169.27 53.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.673 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 17.8 p90 -71.01 147.26 48.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -1.117 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -113.27 -69.6 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.442 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 12.1 p90 -178.6 152.19 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.425 -178.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 91.2 m -97.96 113.09 24.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' GLY . 5.2 p -93.88 30.16 1.91 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.934 . . . . 0.0 110.525 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.89 127.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.47 -19.75 30.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.42 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 177.78 139.41 3.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.534 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 8.4 ttt -103.18 169.9 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -1.13 . . . . 0.0 110.014 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 25.5 m-85 -134.45 154.2 51.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 70.8 m . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.7 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.177 0.513 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.484 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.7 tpt180 -147.08 118.26 7.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 110.117 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.521 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 mm -99.85 147.91 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -0.771 . . . . 0.0 109.862 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.467 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -64.2 -69.66 1.27 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.391 -0.909 . . . . 0.0 110.953 -179.059 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.569 ' CG ' ' CE1' ' A' ' 25' ' ' HIS . 42.4 Cg_endo -75.26 22.79 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.553 1.291 . . . . 0.0 112.658 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.6 -26.14 16.49 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.737 -1.227 . . . . 0.0 107.931 178.532 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.543 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.4 p30 -88.6 -30.19 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 34.6 tt0 -75.92 -43.83 43.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 9.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.417 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.07 -41.97 57.79 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 111.075 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 50.0 Cg_endo -79.42 21.02 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.441 1.232 . . . . 0.0 111.522 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -104.87 -169.59 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.795 -1.191 . . . . 0.0 110.031 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 8.7 pt -52.92 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.279 -0.888 . . . . 0.0 110.641 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.595 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.6 t -82.55 -42.87 0.94 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.8 Cg_endo -72.06 -7.83 21.76 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.214 1.113 . . . . 0.0 110.278 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -85.95 -15.2 42.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.035 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtp180 -104.16 -54.02 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.097 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' A' ' 30' ' ' TYR . 24.5 m-70 -59.43 -35.59 74.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.1 -20.61 57.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 110.095 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 7.7 t -67.1 -39.28 86.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 73.0 m -75.1 -29.31 60.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.319 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -87.65 -16.23 35.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.368 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.32 -29.68 21.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.569 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 25.5 m-70 -95.13 45.81 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.84 41.36 5.81 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -116.56 -163.34 0.9 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 0.0 110.376 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.8 p -95.18 -140.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -90.2 -146.11 14.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.573 ' CD2' ' HE3' ' A' ' 38' ' ' MET . 1.9 t80 -114.37 124.82 52.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.337 -1.096 . . . . 0.0 110.151 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -98.86 -57.91 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.146 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 9.3 p90 -178.19 -172.65 0.32 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.323 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.46 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -127.22 114.84 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.607 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -94.65 147.92 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 110.336 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.07 104.55 0.83 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -30.19 4.32 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.64 152.02 17.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.573 ' HE3' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -93.0 160.53 14.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.157 . . . . 0.0 110.095 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.566 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 27.2 m-85 -131.04 140.74 50.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.346 -0.846 . . . . 0.0 110.388 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.542 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 95.7 m . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.119 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.296 0.57 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 7.0 m -123.41 -161.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.181 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.9 tpt180 -146.02 121.44 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 25' ' ' HIS . 9.1 mm -100.18 148.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.597 -0.689 . . . . 0.0 109.933 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.29 -68.66 1.58 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.928 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.6 Cg_endo -75.2 22.6 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.748 1.394 . . . . 0.0 112.66 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.29 -28.45 15.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.638 -1.288 . . . . 0.0 107.84 178.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.408 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.8 t70 -84.15 -23.58 30.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -84.9 -45.74 11.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.92 13.49 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.17 -0.956 . . . . 0.0 109.395 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.572 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.3 -45.4 78.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 110.854 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -77.19 6.89 3.99 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.697 1.367 . . . . 0.0 110.804 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.504 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.8 mmp_? -83.14 178.4 8.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -0.99 . . . . 0.0 109.985 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.462 HG12 ' HB2' ' A' ' 17' ' ' GLU . 5.9 pt -53.34 -168.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 110.64 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.589 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -80.61 -44.1 1.31 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 111.623 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.06 -5.26 16.6 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.22 1.116 . . . . 0.0 110.213 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -92.86 -19.45 21.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.164 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 8.8 ttp180 -97.16 -45.68 6.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.537 -0.727 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -36.51 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 109.777 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -16.73 60.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 44.6 t -67.81 -50.35 57.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 74.1 m -74.81 -21.45 59.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 109.985 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.14 -16.82 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.62 -31.8 19.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 36.4 m80 -95.61 49.62 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.67 42.71 6.18 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.521 ' CG ' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -124.99 -179.88 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -1.172 . . . . 0.0 110.196 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 1.9 m -83.49 -141.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.42 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 18.1 p90 -92.16 132.14 36.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.38 -62.73 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.54 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 4.3 p90 -178.29 156.24 0.96 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -98.6 112.93 24.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -117.11 134.13 55.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.366 -0.833 . . . . 0.0 110.299 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.5 -153.04 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.83 43.92 3.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -165.71 138.96 5.51 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.471 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 2.3 ttt -101.4 167.25 10.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -1.17 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.54 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 75.1 m-85 -136.1 147.25 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 79.6 m -108.66 166.16 11.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.154 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.3 0.571 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.4 m -133.54 -168.7 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 110.512 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 1.4 tpt180 -147.03 122.46 10.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.318 -0.864 . . . . 0.0 110.063 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 6.7 mm -102.53 147.61 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 109.959 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -70.24 1.11 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.544 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.6 Cg_endo -74.99 23.15 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.649 1.342 . . . . 0.0 112.792 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.49 -29.52 14.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.631 -1.293 . . . . 0.0 107.669 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' CG ' ' CA ' ' A' ' 37' ' ' GLY . 1.1 t0 -84.89 -26.87 27.04 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 3.6 mt-30 -79.43 -44.28 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.77 12.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.7 t -64.45 -44.17 74.21 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.479 -0.763 . . . . 0.0 110.841 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -77.81 6.16 4.75 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.572 1.301 . . . . 0.0 110.746 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 14' ' ' ILE . 3.0 mmt180 -83.59 -175.93 6.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.52 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 14.6 pt -54.28 -165.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.55 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.3 t -82.1 -42.4 1.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 111.607 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.97 -9.27 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.267 1.141 . . . . 0.0 110.559 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.25 -12.3 52.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.398 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.527 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 5.8 ttp180 -109.42 -55.07 2.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.483 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 4.2 m-70 -53.83 -31.9 50.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 2.5 tt0 -84.57 -23.72 29.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.375 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.518 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 11.0 t -60.39 -32.53 71.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.426 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 30' ' ' TYR . 86.1 m -76.18 -33.4 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -89.94 -8.24 52.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.327 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -86.39 -16.09 38.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 29.2 m80 -115.89 38.97 3.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 50.67 31.76 23.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HB2' HD13 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -106.31 -168.82 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -1.152 . . . . 0.0 110.273 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.511 ' CB ' ' OXT' ' A' ' 41' ' ' ASN . 16.2 m -83.34 -134.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.46 -176.33 21.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CE1' ' HE1' ' A' ' 38' ' ' MET . 0.5 OUTLIER -68.83 127.9 34.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -1.096 . . . . 0.0 110.196 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB2' ' N ' ' A' ' 41' ' ' ASN . . . -110.31 -68.88 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.452 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 5.3 p90 -178.61 150.37 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.514 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -90.32 118.95 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.424 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 37' ' ' GLY . 1.1 t -135.62 139.82 44.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.62 -157.05 34.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.91 43.64 3.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.571 ' HE1' ' CE1' ' A' ' 30' ' ' TYR . 1.9 ttt -98.83 168.99 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.027 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 25.7 m-85 -131.45 145.81 51.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.899 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.544 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 59.9 m -109.43 123.01 48.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.287 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.511 ' OXT' ' CB ' ' A' ' 28' ' ' SER . 1.2 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.348 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.196 0.522 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 m -125.48 -178.45 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.576 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -147.98 131.15 16.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.528 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 10.4 mm -106.41 155.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.771 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.441 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -74.24 -67.15 1.82 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.744 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.542 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.9 Cg_endo -74.66 17.95 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.629 1.331 . . . . 0.0 112.486 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 1.1 m -93.79 -26.55 16.91 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.519 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.0 p30 -88.76 -29.33 19.87 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.412 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 tm0? -76.84 -44.27 32.97 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.5 p -90.51 12.55 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.354 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.7 t -64.75 -43.78 70.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.723 -0.611 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.35 4.32 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.521 1.274 . . . . 0.0 110.852 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 mtt180 -85.09 -179.17 6.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 109.998 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.476 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 7.4 pt -53.72 -167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.629 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.4 t -82.4 -42.65 0.96 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 111.564 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.6 Cg_endo -72.09 -2.15 11.14 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.281 1.148 . . . . 0.0 110.378 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -96.42 -10.56 27.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 109.454 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' HD2' ' CD2' ' A' ' 30' ' ' TYR . 10.7 ttm180 -109.57 -47.96 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -58.26 -28.92 65.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -84.13 -20.43 32.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.923 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' A' ' 4' ' ' ILE . 11.4 t -61.95 -45.87 91.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.36 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.4 -40.12 58.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -68.88 -19.09 64.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 110.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -29.48 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.365 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -97.82 4.3 49.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.242 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . 77.22 74.48 0.98 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -135.66 -156.66 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.184 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.441 ' HB3' ' OXT' ' A' ' 41' ' ' ASN . 28.3 t -102.07 -89.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -153.9 151.19 22.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.584 ' CD2' ' CE ' ' A' ' 38' ' ' MET . 14.5 t80 -44.08 119.57 1.81 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.245 . . . . 0.0 110.091 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.59 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -105.5 -58.34 1.91 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.368 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.59 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 13.6 p90 -177.34 138.07 0.23 Allowed 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.025 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -87.01 102.37 14.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.095 -1.003 . . . . 0.0 110.118 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 1.4 p -81.19 161.64 23.93 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.5 -0.75 . . . . 0.0 110.25 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -43.16 -56.0 4.78 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.06 -72.85 0.41 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' HA3' ' NH2' ' A' ' 3' ' ' ARG . . . -149.19 -135.28 2.47 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.584 ' CE ' ' CD2' ' A' ' 30' ' ' TYR . 15.4 tpt -121.69 146.97 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.581 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 15.0 m-85 -128.21 141.99 51.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.993 -1.067 . . . . 0.0 111.083 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' O ' ' OXT' ' A' ' 41' ' ' ASN . 0.5 OUTLIER -107.14 149.18 27.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.48 -0.763 . . . . 0.0 110.127 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.462 ' OXT' ' O ' ' A' ' 40' ' ' CYS . 8.1 t-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.234 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.276 0.56 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 1.8 m -126.08 -172.69 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 110.292 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.524 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.2 tpt180 -146.53 122.94 11.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 110.152 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' A' ' 25' ' ' HIS . 9.0 mm -104.14 151.47 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.766 . . . . 0.0 110.02 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.53 -68.97 1.49 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.725 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.549 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.7 Cg_endo -74.95 22.23 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.778 1.41 . . . . 0.0 112.789 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.18 -29.77 14.95 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.7 t70 -82.79 -25.02 33.16 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.64 -46.26 13.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 2.0 p -90.7 14.72 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.23 -0.919 . . . . 0.0 109.348 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 t -64.1 -44.1 76.45 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.658 -0.651 . . . . 0.0 111.111 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.1 Cg_endo -77.8 8.74 3.27 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.568 1.299 . . . . 0.0 111.113 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 1.1 mmm180 -85.22 179.14 7.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 0.0 110.22 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.532 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.3 pt -53.98 -166.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.61 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -79.07 -44.7 1.74 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.49 -0.756 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.2 Cg_endo -71.02 -5.71 17.58 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.384 1.202 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.533 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 1.8 mm-40 -88.08 -21.73 24.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.36 -0.838 . . . . 0.0 109.33 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HG2' ' HE2' ' A' ' 38' ' ' MET . 4.9 ttp180 -100.11 -44.99 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -0.767 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -59.2 -31.7 69.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -82.66 -17.97 42.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.342 -0.849 . . . . 0.0 110.018 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 31.9 t -68.05 -49.69 59.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 84.3 m -75.12 -29.53 60.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -78.73 -21.82 47.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.11 24.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.299 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.583 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 10.7 m170 -102.28 51.07 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 110.403 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.06 23.2 2.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -112.29 175.51 5.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -1.231 . . . . 0.0 110.063 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 2.3 t -88.29 -143.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -72.26 -154.49 2.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.465 ' HB2' ' HE2' ' A' ' 38' ' ' MET . 22.4 p90 -105.88 144.65 32.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -1.105 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -105.07 -65.42 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.501 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 5.6 p90 -178.3 148.79 0.49 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.521 -0.737 . . . . 0.0 110.297 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -87.87 119.78 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -129.25 135.27 48.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.942 . . . . 0.0 110.473 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.99 -149.7 46.9 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.42 25.4 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -151.77 157.99 27.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.515 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 10.6 ttt -106.8 167.01 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -1.203 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 35.5 m-85 -129.19 142.11 50.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 73.5 m -109.41 159.19 17.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.276 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.29 0.567 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 30.0 m -139.71 -161.17 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 110.146 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.526 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 2.9 tpt180 -147.92 117.78 7.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.585 ' CD1' ' CB ' ' A' ' 25' ' ' HIS . 13.3 mm -100.46 157.52 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 0.0 109.851 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.72 -63.8 1.88 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.636 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.552 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.9 Cg_endo -74.98 16.36 0.66 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.681 1.358 . . . . 0.0 112.476 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.3 m -93.81 -27.99 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.4 t70 -89.42 -25.38 21.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -79.83 -45.1 19.33 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 2.2 p -91.1 14.22 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.316 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.567 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.6 t -64.51 -44.33 74.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 110.995 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.7 Cg_endo -76.71 5.65 4.68 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.559 1.294 . . . . 0.0 110.996 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -85.64 -179.73 6.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -0.998 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.525 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 14.9 pt -54.55 -165.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.278 -0.889 . . . . 0.0 110.737 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.585 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.0 t -78.71 -46.57 1.87 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.3 Cg_endo -68.77 -10.76 30.02 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.294 1.155 . . . . 0.0 110.256 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.534 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -84.42 -21.91 30.6 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.348 -0.845 . . . . 0.0 109.219 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.7 mtm180 -95.89 -49.58 5.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -56.53 -19.23 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.871 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.445 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 45.1 tt0 -96.78 -22.5 16.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.512 ' CB ' HG11 ' A' ' 10' ' ' VAL . 2.9 p -59.32 -36.76 76.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.9 OUTLIER -81.21 -44.1 18.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.172 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -67.82 -13.86 62.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 110.294 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -81.33 -15.28 55.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 110.239 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.585 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 3.6 m80 -111.09 -8.21 14.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 99.15 47.71 1.83 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 6.8 mpt_? -114.1 -164.44 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -1.14 . . . . 0.0 110.158 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 -75.34 0.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.65 138.84 7.4 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.4 p90 -46.31 127.76 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.153 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -96.21 -59.08 1.91 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 7.5 p90 -178.17 160.47 1.38 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.537 -0.727 . . . . 0.0 109.933 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.6 OUTLIER -100.43 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 t -135.84 174.05 11.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 0.0 110.461 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.89 -147.79 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.21 39.34 2.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . -174.75 -164.9 30.32 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.519 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -112.35 177.42 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -1.131 . . . . 0.0 110.163 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.573 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 61.4 m-85 -143.4 135.98 27.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.463 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -121.9 117.67 27.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.576 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.23 179.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.279 0.562 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 23.3 m -127.72 -158.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.5 tpt180 -147.05 121.27 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.208 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' A' ' 25' ' ' HIS . 12.5 mm -101.07 148.71 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.493 -0.754 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.66 -66.95 2.07 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.806 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.8 Cg_endo -74.57 20.25 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.688 1.362 . . . . 0.0 112.667 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.03 -24.34 17.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 107.701 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.453 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 36.0 t70 -88.57 -27.21 21.53 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 14.5 mm-40 -80.16 -44.4 19.92 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.03 13.81 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.31 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.71 -47.07 76.38 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.518 -0.739 . . . . 0.0 110.925 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -75.17 4.05 5.17 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.755 1.397 . . . . 0.0 111.133 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 22.4 mmt180 -83.42 -175.51 5.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.022 -1.048 . . . . 0.0 110.262 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.7 pt -54.09 -165.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.335 -0.853 . . . . 0.0 110.668 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -82.34 -42.17 0.96 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.11 -10.37 25.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.213 1.112 . . . . 0.0 110.472 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -83.75 -14.74 50.8 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.26 -47.82 3.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 12.8 m-70 -58.87 -37.78 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 1.6 tm-20 -79.48 -21.91 44.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 11.1 t -61.04 -40.32 93.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.316 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.465 ' HA ' HG13 ' A' ' 4' ' ' ILE . 93.5 m -75.01 -52.48 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.0 110.275 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -12.64 59.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.313 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -87.55 -16.88 33.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.583 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -102.54 -17.2 15.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.92 34.06 1.74 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.513 ' HD2' ' CG2' ' A' ' 2' ' ' VAL . 16.2 mmt180 -103.42 -161.71 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -1.118 . . . . 0.0 110.282 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.66 -38.35 5.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.351 -0.843 . . . . 0.0 110.18 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.77 167.19 37.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 29.8 p90 -69.78 146.32 51.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -1.162 . . . . 0.0 110.239 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -119.97 -66.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 5.8 p90 -178.48 163.38 1.55 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.429 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -103.99 114.87 29.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -144.86 158.41 43.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 57.69 54.26 38.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 43.35 26.96 0.67 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -146.68 -153.9 6.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.521 ' CG ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -150.98 170.59 18.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 110.319 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.514 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 89.2 m-85 -143.52 144.82 32.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 86.1 m -118.09 119.26 34.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.388 -0.82 . . . . 0.0 110.159 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' CYS . 3.9 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.26 0.553 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 40' ' ' CYS . 3.6 m -141.76 -164.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.295 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.8 tpt180 -146.77 119.43 8.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.331 -0.855 . . . . 0.0 110.04 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.573 ' CD1' ' CB ' ' A' ' 25' ' ' HIS . 10.6 mm -101.82 151.77 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.505 -0.747 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.15 -68.46 1.63 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.208 -0.996 . . . . 0.0 110.834 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.549 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.0 Cg_endo -75.22 21.24 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.704 1.371 . . . . 0.0 112.627 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.29 -26.19 16.7 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.667 -1.271 . . . . 0.0 107.746 178.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.519 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.0 t0 -86.57 -24.35 25.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.407 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 mt-30 -85.13 -43.43 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.61 12.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.63 -45.24 76.1 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 110.792 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.3 Cg_endo -77.58 6.02 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.687 1.362 . . . . 0.0 110.737 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -85.84 -178.15 6.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 110.176 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.531 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.5 pt -53.66 -167.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.839 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.3 t -82.39 -41.04 0.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 111.815 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.9 Cg_endo -70.52 -13.19 32.54 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.085 1.045 . . . . 0.0 110.285 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.1 OUTLIER -84.89 -11.76 54.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 0.0 109.247 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 15.0 mtp180 -100.38 -54.06 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.969 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.681 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 6.8 m-70 -57.62 -40.42 79.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 1.9 tt0 -73.34 -17.32 61.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.42 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 22.2 t -70.24 -45.9 65.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 0.0 110.446 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' HA ' HG13 ' A' ' 4' ' ' ILE . 85.7 m -74.77 -28.69 60.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.067 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.92 -17.58 35.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.072 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -87.78 -4.21 58.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.573 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.41 -54.95 2.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.86 39.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HD2' HG22 ' A' ' 2' ' ' VAL . 5.0 mmt180 -109.17 -164.49 0.94 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.351 -1.087 . . . . 0.0 110.129 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.3 m -120.11 -3.99 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 41' ' ' ASN . . . 162.79 174.13 32.32 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 12.0 p90 -95.44 146.85 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 110.193 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -112.63 -61.05 1.79 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.65 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 5.3 p90 -178.01 -161.99 0.06 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.189 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -134.74 120.85 19.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.63 162.72 19.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.329 -0.857 . . . . 0.0 110.389 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.03 129.94 44.24 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.08 -32.37 6.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 167.11 170.3 31.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.519 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -95.29 165.92 12.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.141 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 69.2 m-85 -131.61 143.34 50.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 85.0 m -114.61 138.28 50.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 29' ' ' GLY . 2.2 t-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.19 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.529 ' CB ' ' OH ' ' A' ' 32' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.268 0.556 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.542 HG21 ' CG ' ' A' ' 27' ' ' ARG . 18.0 m -120.58 -158.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.246 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.8 tpt180 -146.8 120.66 9.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.892 . . . . 0.0 110.339 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 7.6 mm -102.24 152.99 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.505 -0.747 . . . . 0.0 109.663 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.15 -66.12 2.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.529 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.629 ' CG ' ' CE1' ' A' ' 25' ' ' HIS . 43.1 Cg_endo -76.03 21.32 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.721 1.379 . . . . 0.0 112.582 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.16 -30.76 14.46 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.502 ' HB2' ' N ' ' A' ' 38' ' ' MET . 12.5 t70 -87.9 -31.04 19.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.464 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 81.9 mt-30 -70.99 -44.55 65.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 2.3 p -90.72 11.74 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.6 t -64.96 -43.66 68.85 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 110.826 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.1 Cg_endo -77.29 4.87 5.51 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.568 1.299 . . . . 0.0 110.65 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' ILE . 2.4 mmt180 -83.31 -175.84 6.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.522 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 14.0 pt -54.13 -167.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.45 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.6 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 50.1 t -82.43 -42.35 0.95 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 111.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -71.78 -8.26 22.74 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.237 1.125 . . . . 0.0 110.168 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.522 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -94.23 -15.52 24.48 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.41 -0.806 . . . . 0.0 109.205 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 11' ' ' CYS . 8.2 mtm180 -95.33 -54.47 3.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 24.4 m-70 -62.85 -24.41 67.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -86.82 -12.58 47.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.699 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.52 ' SG ' ' CE ' ' A' ' 38' ' ' MET . 3.5 p -69.7 -38.08 76.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 0.0 110.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 m -75.16 -47.76 26.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.423 -0.798 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -73.03 -12.46 60.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -78.77 -26.44 44.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.629 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 10.6 m170 -105.18 50.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.41 37.22 3.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' CG ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -111.02 -149.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.378 -1.072 . . . . 0.0 110.391 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 41' ' ' ASN . 1.2 m -106.35 -141.43 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.19 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.16 155.78 18.6 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.578 ' CD1' ' HE3' ' A' ' 38' ' ' MET . 2.9 t80 -48.12 121.53 4.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -1.151 . . . . 0.0 110.252 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.531 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -96.64 -61.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 110.402 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 8.1 p90 -178.29 140.54 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -85.66 112.16 20.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.131 -0.981 . . . . 0.0 109.713 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.73 135.57 54.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.63 -152.59 30.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.46 41.72 3.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -164.7 165.0 37.25 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.578 ' HE3' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -120.34 153.84 35.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.919 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 14.3 m-85 -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 35.1 m -113.08 176.6 4.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 0.0 110.343 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.442 ' O ' ' OG ' ' A' ' 28' ' ' SER . 14.7 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.219 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.27 0.557 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 40' ' ' CYS . 9.2 m -144.42 -160.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.515 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 1.3 tpt180 -147.87 118.34 7.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.261 -0.899 . . . . 0.0 110.077 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.544 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 11.9 mm -100.54 157.11 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 -66.81 1.68 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.097 -1.049 . . . . 0.0 110.599 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.8 Cg_endo -75.99 20.7 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.727 1.383 . . . . 0.0 112.706 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.2 m -94.17 -28.74 15.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.609 -1.307 . . . . 0.0 107.509 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.51 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.0 t70 -88.25 -30.31 19.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.26 -45.3 56.59 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.31 12.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.34 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 t -64.88 -43.37 68.35 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.611 -0.681 . . . . 0.0 111.358 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.5 Cg_endo -75.96 5.42 4.47 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.428 1.225 . . . . 0.0 111.023 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mmt180 -84.69 179.37 7.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.1 pt -54.39 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.158 -0.964 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -78.47 -45.64 2.04 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.801 . . . . 0.0 111.721 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.7 Cg_endo -68.91 -9.84 27.46 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.239 1.126 . . . . 0.0 110.297 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -87.81 -24.35 23.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.256 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -90.14 -49.18 6.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.4 m-70 -60.47 -16.78 39.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 6.4 tt0 -96.49 -18.64 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.517 ' CB ' HG12 ' A' ' 10' ' ' VAL . 4.0 p -64.75 -37.22 86.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 1.2 m -78.95 -50.24 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 110.164 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.7 mtt-85 -64.76 -19.28 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.304 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -73.95 -22.52 59.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.446 ' HB2' HD11 ' A' ' 4' ' ' ILE . 4.7 m80 -112.33 27.08 9.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 110.029 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 59.07 69.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.06 -151.26 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.282 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -111.07 -88.83 0.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.32 140.02 9.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.675 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.9 p90 -46.72 125.23 6.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.168 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -97.83 -60.91 1.47 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.106 -0.996 . . . . 0.0 110.338 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 7.2 p90 -178.28 142.65 0.26 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.013 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.8 OUTLIER -85.36 111.91 20.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.821 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -124.22 159.57 29.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.315 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.21 -150.74 0.46 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.33 42.7 2.7 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.95 145.07 8.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.523 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 8.2 ttt -87.23 159.72 18.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 110.043 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 84.1 m-85 -125.49 143.21 51.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.515 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 0.4 OUTLIER -122.12 123.77 42.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.388 -0.82 . . . . 0.0 110.387 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 40' ' ' CYS . 12.7 t-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.208 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.22 0.533 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.1 m -123.97 -163.19 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.524 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.4 tpt180 -147.04 121.36 9.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 110.285 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.524 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 5.7 mm -100.17 145.05 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.422 -0.799 . . . . 0.0 109.66 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . -57.55 -71.9 0.67 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.132 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.549 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.9 Cg_endo -76.76 25.73 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.632 1.332 . . . . 0.0 112.724 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -94.79 -21.83 18.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.73 -1.231 . . . . 0.0 108.164 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 3.7 p-10 -87.32 -24.51 24.28 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.404 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mt-30 -87.97 -42.53 12.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 109.482 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.88 -45.0 74.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 110.877 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.6 Cg_endo -77.44 8.53 3.26 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.639 1.336 . . . . 0.0 111.136 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 12.2 mmt180 -83.17 -179.17 7.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.039 -1.038 . . . . 0.0 110.049 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.524 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.6 pt -53.78 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.2 t -79.49 -44.07 1.62 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 111.22 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -72.6 -4.45 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.359 1.189 . . . . 0.0 110.285 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 3.0 mm-40 -96.31 -15.86 21.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.527 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -102.85 -50.94 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.682 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 44.5 m-70 -61.54 -35.18 77.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.111 -0.993 . . . . 0.0 109.906 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.62 -19.31 59.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.145 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 15.2 t -62.76 -41.53 99.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.007 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 81.7 m -78.65 -25.01 44.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -86.14 -15.36 41.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.458 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.23 21.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.327 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 32.3 m80 -98.34 43.34 1.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.76 19.45 10.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -100.81 173.93 6.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -1.21 . . . . 0.0 110.181 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 3.1 t -82.2 -141.96 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.16 -158.49 27.78 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.682 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -96.67 141.62 29.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -1.153 . . . . 0.0 110.385 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . . . -106.16 -60.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 31' ' ' ALA . 17.8 p90 -178.43 146.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.253 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -94.73 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.465 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 35' ' ' GLY . 16.0 p -80.59 -143.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 110.44 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -56.17 -110.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.63 41.9 2.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.64 139.02 5.81 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 1.7 tpt -104.97 153.21 21.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.861 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 13.6 m-85 -127.29 149.25 50.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 74.4 m -108.49 167.14 10.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.455 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 28' ' ' SER . 1.1 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.259 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.253 0.549 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.426 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 23.7 m -145.12 -166.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' NH2' ' OD2' ' A' ' 8' ' ' ASP . 2.0 tpt180 -147.78 121.61 9.32 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.328 -0.858 . . . . 0.0 110.077 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.522 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 12.2 mm -99.94 152.51 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.989 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -72.76 -68.32 1.62 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.733 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.545 ' CG ' ' CE1' ' A' ' 25' ' ' HIS . 42.3 Cg_endo -76.06 23.16 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.597 1.314 . . . . 0.0 112.596 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.63 -29.84 14.64 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.673 -1.267 . . . . 0.0 107.939 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 3.0 p30 -86.47 -24.89 25.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -45.1 16.79 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.6 p -91.16 12.26 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.43 -44.75 76.35 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.54 -0.725 . . . . 0.0 110.893 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.8 Cg_endo -75.98 4.12 5.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.688 1.362 . . . . 0.0 110.647 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.5 mmp_? -83.62 -175.66 5.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 110.034 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.519 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 15.4 pt -55.72 -167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 110.724 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -82.55 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 111.642 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -72.29 -3.56 13.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.274 1.144 . . . . 0.0 110.393 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 3.7 mt-10 -96.06 -12.78 24.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.377 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 mtm-85 -105.02 -49.39 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.659 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 33.4 m-70 -60.63 -33.93 73.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 8.2 tm-20 -79.89 -14.53 58.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 13.5 t -64.31 -41.89 96.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 110.33 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.2 m -76.52 -46.24 27.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -64.84 -22.23 66.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -84.9 -22.5 29.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.24 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.545 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 12.2 m-70 -105.97 7.91 32.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.484 ' O ' ' CD ' ' A' ' 27' ' ' ARG . . . 80.38 64.48 1.83 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 3.9 mpt_? -135.17 -178.23 5.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.409 ' HB2' ' OXT' ' A' ' 41' ' ' ASN . 12.1 m -87.92 -88.06 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -141.81 144.86 14.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.659 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 10.8 p90 -44.54 124.75 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.209 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -96.27 -60.57 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.554 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 11.0 p90 -178.18 158.39 1.18 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.066 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -106.56 106.62 17.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.796 179.567 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -106.59 137.92 43.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.84 -150.74 0.86 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.78 48.35 3.96 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -167.35 137.09 4.44 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.498 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 6.3 ttt -104.4 170.56 7.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.528 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 67.6 m-85 -143.71 153.05 42.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CA ' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -115.24 151.42 34.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.409 ' OXT' ' HB2' ' A' ' 28' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.274 0.559 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.588 ' CG2' ' CB ' ' A' ' 40' ' ' CYS . 30.2 m -144.27 -165.52 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 110.276 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.525 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.0 tpt180 -147.7 121.32 9.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 110.18 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 7' ' ' CYS . 26.6 mm -101.71 156.31 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 4' ' ' ILE . . . -77.27 -66.61 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.88 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.0 Cg_endo -76.21 20.98 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.713 1.375 . . . . 0.0 112.736 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.529 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 8.5 t -94.49 -28.6 15.37 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.687 -1.258 . . . . 0.0 108.012 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 5.1 t0 -85.8 -24.21 26.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.99 -45.28 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.87 13.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.0 109.442 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.5 t -64.49 -41.94 62.28 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.539 -0.726 . . . . 0.0 111.501 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 44.3 Cg_endo -74.77 3.64 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.393 1.207 . . . . 0.0 110.999 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.502 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.56 177.83 7.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.041 -1.037 . . . . 0.0 109.794 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.522 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 9.5 pt -53.75 -166.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 110.731 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.602 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.8 t -77.69 -45.32 2.48 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 0.0 111.526 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.0 Cg_endo -68.53 -9.94 27.56 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.268 1.141 . . . . 0.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.521 ' OE1' ' CG2' ' A' ' 10' ' ' VAL . 9.2 mm-40 -91.69 -19.4 22.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.372 -0.83 . . . . 0.0 109.066 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 47.3 mtp180 -91.34 -45.39 8.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.506 -0.746 . . . . 0.0 109.766 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.598 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -64.56 -18.84 65.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 110.242 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 2.3 tp10 -80.12 -13.54 59.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.709 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 9.2 p -69.8 -38.02 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.282 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 4.7 m -84.16 -46.67 11.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.368 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.477 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -70.92 -39.44 72.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.12 -0.987 . . . . 0.0 110.317 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.536 ' CE1' ' CD ' ' A' ' 6' ' ' PRO . 9.7 m170 -98.88 33.64 2.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 110.231 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 50.36 76.82 0.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.1 tpt180 -141.29 -157.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -1.156 . . . . 0.0 110.25 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 1.6 t -102.94 -140.56 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -98.2 143.59 16.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.598 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -43.2 134.29 3.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -1.127 . . . . 0.0 110.49 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -106.49 -59.25 1.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.553 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 9.3 p90 -178.11 142.75 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.491 -0.756 . . . . 0.0 110.129 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -86.57 117.17 25.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.985 . . . . 0.0 110.02 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -131.28 136.86 48.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.86 -156.35 24.0 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.12 49.77 4.16 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 39' ' ' TYR . . . 175.72 133.77 1.81 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 30' ' ' TYR . 10.0 ttt -86.27 176.41 7.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -1.227 . . . . 0.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 37' ' ' GLY . 76.6 m-85 -140.71 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.588 ' CB ' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -109.57 156.31 20.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.25 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.281 -179.874 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 36.0 m -128.08 -155.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 0.0 110.185 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.8 tpt180 -146.13 121.14 10.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -101.42 150.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.627 -0.671 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.25 -68.95 1.49 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.83 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.545 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.41 22.46 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.656 1.345 . . . . 0.0 112.757 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.54 -24.39 17.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.64 -1.287 . . . . 0.0 107.77 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -88.87 -24.51 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 15.3 mt-30 -85.03 -43.02 14.31 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.35 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -64.81 -42.23 61.86 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.608 -0.683 . . . . 0.0 111.308 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -75.74 4.47 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.36 1.19 . . . . 0.0 110.825 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.528 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 3.1 mmp_? -83.31 177.06 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.854 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.5 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.3 pt -53.54 -168.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.938 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 t -78.28 -45.06 2.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 111.303 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.7 Cg_endo -70.21 -7.21 20.64 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.384 1.202 . . . . 0.0 110.301 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -91.85 -13.7 30.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.446 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 2.2 mtm180 -103.41 -44.79 5.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 109.813 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.531 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -60.39 -36.06 77.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -75.92 -14.35 60.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -0.837 . . . . 0.0 110.376 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 26.9 t -70.7 -48.01 56.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 86.7 m -75.13 -22.98 57.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -90.1 -19.77 23.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.181 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.17 24.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.411 ' HB3' ' CD1' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -99.3 43.12 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 110.354 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 47.41 39.6 14.69 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' CG ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -120.75 -179.32 3.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -1.109 . . . . 0.0 110.186 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.459 ' HB2' ' OXT' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -80.52 -140.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.002 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . -92.87 -178.69 40.57 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 1.2 p90 -76.99 137.33 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.206 -1.173 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB3' ' C ' ' A' ' 40' ' ' CYS . . . -106.99 -65.21 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 110.612 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 4.9 p90 -178.11 153.13 0.76 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.313 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -95.8 112.51 24.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.898 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.82 139.49 47.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.37 -149.89 0.87 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.04 45.09 3.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -162.94 151.93 21.87 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -115.09 163.16 16.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.366 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.508 ' N ' ' SD ' ' A' ' 38' ' ' MET . 51.8 m-85 -135.08 154.19 51.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.063 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 86.0 m -114.24 141.87 47.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.876 . . . . 0.0 110.598 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.459 ' OXT' ' HB2' ' A' ' 28' ' ' SER . 1.2 t-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.313 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.236 0.541 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 6.0 m -141.62 -165.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 110.056 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.3 tpt180 -147.16 119.11 8.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 0.0 110.201 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.546 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 11.1 mm -101.35 160.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 109.723 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.57 -66.01 1.67 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.565 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.566 ' CG ' ' CE1' ' A' ' 25' ' ' HIS . 42.6 Cg_endo -76.54 20.01 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.633 1.333 . . . . 0.0 112.594 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.546 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.2 m -94.28 -28.16 15.74 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.532 ' HB2' ' N ' ' A' ' 38' ' ' MET . 2.4 t70 -87.75 -31.1 19.83 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -46.0 51.6 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.29 11.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.336 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 t -64.79 -44.05 71.49 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.71 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.6 Cg_endo -75.25 3.83 5.4 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.523 1.275 . . . . 0.0 110.923 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.522 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -83.2 177.35 8.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.072 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.523 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 12.9 pt -52.92 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 0.0 110.939 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.9 t -76.52 -47.22 3.23 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 111.451 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.5 Cg_endo -67.97 -9.63 26.29 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.304 1.16 . . . . 0.0 110.151 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.522 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.0 mm-40 -94.69 -16.39 23.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.849 . . . . 0.0 109.195 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -93.93 -49.89 5.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.807 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -65.05 -20.68 66.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 109.954 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -89.07 -10.03 48.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.521 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.516 ' CB ' HG13 ' A' ' 10' ' ' VAL . 5.5 p -72.16 -37.87 69.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.056 -1.028 . . . . 0.0 110.067 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -82.41 -35.4 27.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 110.237 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -74.12 -30.68 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.424 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.95 66.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.566 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 29.1 m80 -112.27 9.45 19.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 110.299 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.4 82.65 0.22 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.74 -143.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -1.182 . . . . 0.0 110.178 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 p -112.79 -74.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.191 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -167.6 138.47 5.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 4.5 t80 -42.94 121.97 2.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -1.118 . . . . 0.0 110.178 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB2' ' CD2' ' A' ' 32' ' ' TYR . . . -101.97 -61.12 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 31' ' ' ALA . 14.0 p90 -178.42 134.17 0.14 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.184 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -79.78 112.27 16.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 109.523 179.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 9.7 p -88.29 31.75 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.35 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.59 126.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.97 -32.51 4.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.39 144.71 9.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.532 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 5.9 ttt -93.27 154.47 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -1.131 . . . . 0.0 110.021 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.527 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 13.6 m-85 -123.71 137.56 54.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.468 ' O ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -110.84 127.14 55.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 110.656 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.429 ' OXT' ' O ' ' A' ' 40' ' ' CYS . 3.2 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.091 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.279 0.561 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 4.6 m -141.71 -159.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.148 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.7 tpt180 -147.29 123.03 10.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 39.6 mm -99.57 156.95 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.657 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.67 -64.54 1.68 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.567 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 41.0 Cg_endo -75.53 14.23 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.729 1.384 . . . . 0.0 112.624 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 1.8 t -94.62 -21.4 18.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.565 -1.334 . . . . 0.0 107.959 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 3.4 t70 -87.04 -23.32 25.0 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -90.12 -44.87 9.5 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.567 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.96 13.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.215 -0.928 . . . . 0.0 109.674 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.26 -43.71 73.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.0 111.231 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.0 Cg_endo -76.29 5.03 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.454 1.239 . . . . 0.0 110.797 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.497 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -85.9 -176.82 6.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 110.196 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.7 pt -53.15 -167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.181 -0.949 . . . . 0.0 110.995 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.619 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.0 t -80.6 -42.26 1.27 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 0.0 111.739 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.66 -12.41 31.15 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.27 1.142 . . . . 0.0 110.289 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.1 OUTLIER -81.51 -24.27 36.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 9.2 mtm180 -94.57 -46.07 7.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.447 -0.783 . . . . 0.0 109.987 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.571 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -59.97 -18.95 49.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.0 110.076 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.8 OUTLIER -88.96 -22.26 23.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 4.9 p -59.16 -37.26 76.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 57.8 m -77.88 -42.26 33.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 0.0 110.289 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -22.61 67.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' OE2' ' A' ' 20' ' ' GLU . . . -81.88 -22.53 36.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.462 ' HB2' HD12 ' A' ' 4' ' ' ILE . 29.0 m80 -110.4 22.28 15.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.323 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.46 71.91 0.66 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' CG ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -125.3 -154.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -1.133 . . . . 0.0 110.197 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.05 -45.9 2.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.338 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -179.5 135.15 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 9.2 p90 -45.02 148.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 110.382 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -120.33 -60.98 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.542 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 10.3 p90 -178.11 145.41 0.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -88.18 115.95 26.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 110.111 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -110.26 128.07 55.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 110.566 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 43.82 -146.31 1.34 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.2 3.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' HA2' ' CZ ' ' A' ' 3' ' ' ARG . . . -165.07 119.47 0.87 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 39' ' ' TYR . 1.5 tmt? -84.39 161.08 20.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.542 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 58.1 m-85 -131.13 143.45 50.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 9.8 t -121.2 132.13 54.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.199 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.242 0.544 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.4 m -134.08 -169.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.313 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.48 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.2 tpt180 -146.94 117.63 7.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.921 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.577 HD12 ' CG ' ' A' ' 25' ' ' HIS . 6.0 mm -100.68 144.43 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 0.0 109.764 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.27 -69.43 1.28 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.086 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.0 Cg_endo -73.9 19.7 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.6 1.316 . . . . 0.0 112.749 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.543 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -94.15 -21.92 18.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.715 -1.241 . . . . 0.0 107.731 178.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.519 ' HB2' ' N ' ' A' ' 38' ' ' MET . 11.8 t70 -92.58 -29.58 16.09 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.464 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 tt0 -78.91 -40.12 33.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.41 9.55 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.38 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.4 t -65.08 -40.34 44.8 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.582 -0.699 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.7 Cg_endo -76.34 3.64 6.11 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.185 1.097 . . . . 0.0 110.526 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 9.6 mmt180 -86.94 -177.0 5.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.984 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.0 pt -53.79 -167.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.605 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 87.9 t -81.49 -41.69 1.08 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.567 -0.708 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.4 Cg_endo -69.94 -13.59 34.42 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 122.963 0.98 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -82.86 -12.16 57.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.266 -0.896 . . . . 0.0 109.187 178.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -102.38 -58.1 1.94 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.535 -0.728 . . . . 0.0 110.069 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.617 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 20.4 m-70 -58.4 -36.64 73.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -73.42 -23.27 60.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.514 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 6.9 t -67.8 -29.77 69.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 30' ' ' TYR . 92.7 m -74.97 -34.25 62.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.017 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.22 -11.8 39.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.64 -14.51 56.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.577 ' CG ' HD12 ' A' ' 4' ' ' ILE . 1.2 m80 -107.27 -79.1 0.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.64 28.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HG3' HG12 ' A' ' 4' ' ' ILE . 10.2 mmt180 -102.04 -158.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -114.25 -54.77 2.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 22' ' ' CYS . . . -149.16 -159.86 8.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.617 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 15.8 p90 -98.29 161.68 13.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -132.53 -67.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.971 . . . . 0.0 110.633 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.542 ' CE1' ' CB ' ' A' ' 39' ' ' TYR . 4.3 p90 -178.42 156.25 0.93 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.266 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HA ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -99.89 101.1 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 109.903 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -90.56 149.6 22.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 110.224 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.94 112.38 1.91 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.23 -44.0 1.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' CA ' ' OD2' ' A' ' 8' ' ' ASP . . . -167.29 -176.04 37.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.543 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 7.8 tpt -110.06 167.44 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -1.076 . . . . 0.0 109.523 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.542 ' CB ' ' CE1' ' A' ' 32' ' ' TYR . 42.5 m-85 -133.68 139.91 46.73 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.011 -1.056 . . . . 0.0 110.377 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 55.7 m -110.67 141.53 43.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.452 -0.78 . . . . 0.0 110.124 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 28' ' ' SER . 18.5 t30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.308 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.311 0.576 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 t -118.91 157.42 20.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.218 -0.926 . . . . 0.0 109.884 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.559 ' NH2' ' CA ' ' A' ' 37' ' ' GLY . 2.7 tpt180 -148.25 116.2 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 110.124 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.532 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 15.5 mm -99.93 152.6 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.782 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.18 -64.88 2.12 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.934 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.547 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.3 Cg_endo -74.88 17.5 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.625 1.329 . . . . 0.0 112.642 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HB3' ' CB ' ' A' ' 38' ' ' MET . 1.2 m -93.86 -29.92 15.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.522 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 21.2 t70 -84.2 -31.48 25.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -73.47 -47.01 44.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.68 13.54 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.088 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.0 t -64.37 -43.51 72.51 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.679 -0.638 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.7 Cg_endo -76.29 5.08 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.536 1.282 . . . . 0.0 110.865 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 1.6 mmt180 -84.71 177.68 7.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 110.18 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.523 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 14.2 pt -53.68 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.895 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.595 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.4 t -81.54 -43.19 1.11 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.452 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -71.85 -4.19 14.63 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.288 1.152 . . . . 0.0 110.195 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 4.1 mm-40 -98.54 -8.56 26.36 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.383 -0.823 . . . . 0.0 109.43 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 11' ' ' CYS . 3.1 ttp180 -108.46 -46.38 3.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.077 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -62.41 -30.22 71.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -80.35 -13.47 59.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 6.7 t -68.92 -45.15 71.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 110.148 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.26 -39.36 59.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 110.238 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -20.72 66.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.97 -30.09 21.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 110.186 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLY . 32.0 m80 -101.4 46.32 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.53 64.34 1.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HG3' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -131.61 -178.23 4.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.249 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -93.74 -91.31 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -143.99 141.68 10.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.551 ' CD1' ' HE1' ' A' ' 38' ' ' MET . 7.0 t80 -46.69 136.54 7.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.58 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -112.39 -54.75 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.58 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 8.4 p90 -177.86 144.64 0.36 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.538 -0.726 . . . . 0.0 109.946 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -85.67 113.4 21.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.103 -0.998 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -146.61 176.26 9.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.751 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 47.52 57.49 7.37 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 40.96 38.79 1.77 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.559 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -173.97 -170.24 37.11 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.551 ' HE1' ' CD1' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -115.13 157.66 23.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.064 -1.257 . . . . 0.0 110.413 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.528 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 19.0 m-85 -128.6 134.54 48.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -111.58 171.5 7.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.396 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.223 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' HG11 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.171 0.51 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 5.6 m -141.04 -167.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.38 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 3.5 tpt180 -147.91 120.17 8.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.226 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.522 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 11.8 mm -99.71 146.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.924 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.55 -67.24 2.05 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.014 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.555 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.5 Cg_endo -74.91 20.27 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.634 1.334 . . . . 0.0 112.617 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.36 -27.47 16.05 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.614 -1.304 . . . . 0.0 108.034 178.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 -22.41 25.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.91 -44.22 11.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.0 11.92 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.412 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.53 -42.46 65.76 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.589 -0.694 . . . . 0.0 111.306 -179.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.26 6.31 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.45 1.237 . . . . 0.0 111.001 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -85.18 -177.71 6.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 0.0 110.12 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.518 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.5 pt -54.29 -165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.611 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.1 t -80.81 -44.04 1.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 111.7 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -70.8 -10.71 28.28 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.372 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -81.31 -22.91 38.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.239 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 2.3 ttm180 -97.74 -47.26 5.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 109.684 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -34.08 66.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.989 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -82.41 -19.14 39.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 30.5 t -61.2 -43.59 98.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.49 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.06 -24.94 58.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 110.307 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -83.58 -19.91 34.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -13.14 43.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.095 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.485 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 7.5 m80 -117.55 39.18 3.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 0.0 110.134 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 44.35 63.79 2.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HD3' ' CD1' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -132.52 -152.05 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -1.136 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 47.0 m -119.99 -130.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.151 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -98.81 135.76 12.32 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.459 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 24.7 p90 -41.65 130.32 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.104 . . . . 0.0 110.249 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -98.64 -60.75 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.643 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.558 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 11.7 p90 -178.16 148.56 0.5 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.144 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -93.16 113.26 25.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 109.855 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.7 165.48 11.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.66 120.85 23.24 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.1 -21.59 15.3 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 160.2 177.03 32.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 11.6 ttt -100.45 167.2 10.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -1.114 . . . . 0.0 109.922 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.558 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 65.0 m-85 -139.09 148.23 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -119.13 176.05 5.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 3.4 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.208 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.217 0.532 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 18.6 m -122.92 -161.23 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.956 . . . . 0.0 110.366 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.51 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.2 tpt180 -147.94 120.11 8.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 110.259 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.532 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 13.0 mm -100.1 151.06 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.97 -66.61 2.0 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.551 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.06 18.42 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.661 1.348 . . . . 0.0 112.679 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.1 m -94.08 -30.01 14.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.629 -1.294 . . . . 0.0 107.912 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.455 ' N ' ' HB2' ' A' ' 38' ' ' MET . 23.8 t0 -84.16 -22.92 30.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.73 -46.45 10.69 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.2 p -91.1 12.91 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -64.33 -42.61 68.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 111.289 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.9 Cg_endo -75.49 4.2 5.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.333 1.175 . . . . 0.0 110.909 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.2 mmt-85 -84.42 -179.82 7.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.087 -1.008 . . . . 0.0 109.84 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 6.1 pt -53.63 -168.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.592 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.9 t -81.38 -43.05 1.13 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.776 . . . . 0.0 111.379 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -71.9 -3.73 13.75 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.306 1.161 . . . . 0.0 110.256 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -91.21 -13.51 32.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -0.807 . . . . 0.0 109.32 179.085 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 6.1 ttm180 -109.7 -41.55 4.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 110.036 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -31.38 64.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.067 -1.02 . . . . 0.0 109.835 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 23.2 tt0 -85.83 -19.64 30.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.52 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 13.0 t -59.14 -42.65 91.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.3 m -77.59 -38.62 47.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.995 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -20.92 66.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -85.61 -18.03 34.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.524 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 19.1 m80 -111.0 34.93 3.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.09 58.36 7.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.492 ' CG ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -118.86 -151.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -1.115 . . . . 0.0 110.243 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.461 ' OG ' ' OXT' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -117.69 -86.99 0.63 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -0.832 . . . . 0.0 110.257 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.53 136.4 6.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.553 ' CG ' ' O ' ' A' ' 30' ' ' TYR . 16.1 p90 -43.54 122.73 2.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -1.159 . . . . 0.0 110.253 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HB3' ' CD2' ' A' ' 32' ' ' TYR . . . -96.41 -59.56 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.56 ' CD2' ' HB3' ' A' ' 31' ' ' ALA . 8.4 p90 -178.25 151.29 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 110.226 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -93.12 114.0 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.721 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.456 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -104.25 161.82 13.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.389 -0.819 . . . . 0.0 110.31 -179.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 122.62 30.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -27.1 9.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 166.47 176.37 37.56 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.537 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -93.65 165.01 12.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.163 . . . . 0.0 110.023 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 49.8 m-85 -138.02 142.81 40.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.3 OUTLIER -115.55 -175.62 2.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 110.052 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.461 ' OXT' ' OG ' ' A' ' 28' ' ' SER . 4.6 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.207 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.303 0.573 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 31.3 m -131.12 -152.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.465 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.1 tpt180 -148.23 118.87 7.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.526 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 11.1 mm -102.77 153.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.988 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.73 -68.1 1.65 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.823 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.539 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.15 20.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.671 1.353 . . . . 0.0 112.663 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.14 -29.01 15.36 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 107.78 178.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.512 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.5 p30 -85.83 -25.5 26.24 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.96 -44.32 15.44 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 11.24 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.43 -44.01 73.86 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 111.057 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -76.78 5.58 4.76 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.544 1.286 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 14' ' ' ILE . 26.4 mmt180 -85.93 -175.48 5.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.093 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.523 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 6.8 pt -53.83 -167.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.603 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.8 t -81.55 -43.16 1.11 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 111.485 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.18 -5.22 16.53 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.286 1.15 . . . . 0.0 110.264 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.523 ' OE2' ' CD1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -87.44 -14.39 40.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.278 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 ttm180 -106.26 -49.57 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.474 -0.766 . . . . 0.0 110.021 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.7 m-70 -55.01 -38.92 68.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.018 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -79.0 -19.98 50.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.913 . . . . 0.0 110.32 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 18.4 t -59.85 -40.3 88.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 110.502 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.14 -32.11 61.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -78.61 -16.97 56.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 110.233 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.44 -19.58 29.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -115.35 33.5 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 110.292 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . 53.36 71.13 0.74 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' CG ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -140.27 -153.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -1.178 . . . . 0.0 110.298 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 84.6 p -120.06 -134.52 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.34 135.2 12.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.619 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -46.62 131.76 11.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -1.163 . . . . 0.0 110.332 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -97.54 -56.22 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.595 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 9.9 p90 -177.0 -177.49 0.76 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.61 -0.681 . . . . 0.0 109.988 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -125.06 115.25 20.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.23 147.62 29.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.212 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.87 127.03 19.12 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.02 -44.9 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.87 169.67 42.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.512 ' N ' ' HB3' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -95.64 163.87 13.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -1.168 . . . . 0.0 110.029 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 82.3 m-85 -134.94 149.2 50.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.316 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 1' ' ' ALA . 1.1 t -114.84 -175.12 2.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.308 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.352 0.596 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.6 m -131.93 -168.61 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.156 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.52 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.1 tpt180 -147.51 122.33 9.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.578 HD13 ' CG ' ' A' ' 25' ' ' HIS . 10.2 mm -99.26 150.26 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.687 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.54 -67.33 1.89 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.087 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.552 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.25 17.81 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.638 1.336 . . . . 0.0 112.804 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.2 m -94.24 -27.13 16.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.642 -1.286 . . . . 0.0 108.031 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' HB2' ' N ' ' A' ' 38' ' ' MET . 30.0 t0 -86.1 -23.2 26.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 tm0? -88.03 -44.67 10.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -91.12 11.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.98 . . . . 0.0 109.598 179.328 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.57 -42.29 64.18 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.777 . . . . 0.0 111.242 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 47.2 Cg_endo -76.58 5.46 4.75 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.456 1.24 . . . . 0.0 110.858 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -85.36 -177.75 6.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 110.18 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.7 pt -55.5 -164.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.668 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 46.3 t -81.3 -45.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.528 -0.733 . . . . 0.0 111.497 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.37 -4.14 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.272 1.143 . . . . 0.0 110.436 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.47 ' OE2' ' CD1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -89.89 -14.78 33.53 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.241 -0.912 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -108.12 -42.46 4.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.739 . . . . 0.0 110.034 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.436 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -59.17 -32.26 69.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.188 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 37.7 tt0 -86.68 -12.28 48.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 12.8 t -70.67 -36.61 73.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 30' ' ' TYR . 1.3 m -78.23 -49.6 13.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.205 -0.935 . . . . 0.0 110.463 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -64.52 -34.5 78.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.21 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -68.13 -18.6 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.206 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.578 ' CG ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -97.87 -74.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.167 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.84 34.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.514 ' CG ' HD11 ' A' ' 4' ' ' ILE . 2.7 mmt180 -104.4 -153.07 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -1.232 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -119.57 -43.65 2.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.132 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -169.0 130.63 2.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 30' ' ' TYR . 1.7 p90 -43.9 126.14 4.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -1.137 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -96.05 -56.63 2.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 9.6 p90 -177.7 -175.25 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.13 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -126.52 114.49 18.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.884 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.32 162.97 12.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 110.278 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.35 116.63 9.31 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.34 -28.87 6.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 171.88 175.26 39.98 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.512 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -99.88 164.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.126 179.919 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 46.0 m-85 -134.52 149.73 50.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 110.352 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB3' HG22 ' A' ' 2' ' ' VAL . 1.7 t -127.83 171.3 11.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.413 -0.804 . . . . 0.0 110.206 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.242 179.998 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.238 0.542 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.8 m -144.89 -162.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 110.34 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 1.5 tpt180 -147.36 121.02 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.523 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -102.7 148.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.0 -70.85 0.94 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.814 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.542 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.3 Cg_endo -75.72 24.38 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.724 1.381 . . . . 0.0 112.832 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.51 -23.16 17.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.63 -1.294 . . . . 0.0 107.881 178.419 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 14.5 t70 -88.56 -28.33 20.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.4 tt0 -79.64 -43.92 21.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.15 11.35 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.453 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.6 t -65.11 -43.96 68.55 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -76.45 4.71 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.582 1.306 . . . . 0.0 110.697 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 29.3 mmt180 -83.06 -178.65 7.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.944 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.7 pt -54.2 -165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.598 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 54.7 t -81.62 -43.03 1.09 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 111.704 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.8 Cg_endo -70.91 -11.4 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.191 1.101 . . . . 0.0 110.345 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.51 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.4 OUTLIER -82.42 -20.19 37.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.357 -0.839 . . . . 0.0 109.46 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' CZ ' ' O ' ' A' ' 11' ' ' CYS . 4.2 mtm180 -99.02 -49.32 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.463 -0.773 . . . . 0.0 109.888 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.685 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 7.5 m-70 -57.14 -37.36 71.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.864 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 53.6 tt0 -77.02 -20.33 56.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.084 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 24.3 t -64.34 -45.84 86.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 58.8 m -75.87 -40.43 54.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -73.25 -16.22 61.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.175 -0.953 . . . . 0.0 110.366 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -87.6 -32.55 19.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.491 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . 9.2 m80 -94.87 54.48 1.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.296 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.52 26.35 0.65 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -106.11 172.67 6.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -1.196 . . . . 0.0 110.051 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -84.07 -143.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.907 . . . . 0.0 110.167 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -71.17 -151.58 0.9 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.685 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 13.5 p90 -113.94 151.76 31.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -1.169 . . . . 0.0 110.189 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' C ' ' CD2' ' A' ' 32' ' ' TYR . . . -110.48 -63.83 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.496 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 7.2 p90 -178.15 -161.42 0.05 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.276 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -138.5 109.3 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -85.82 41.87 0.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.46 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . 77.96 -108.16 2.57 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.83 49.46 4.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.15 102.45 0.16 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.523 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.6 169.74 11.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 110.183 -179.853 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.57 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 70.8 m-85 -142.02 146.68 35.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 110.295 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.52 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 98.0 m -116.28 149.25 39.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 0.0 110.298 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.248 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.274 0.559 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 1' ' ' ALA . 4.0 m -141.45 -175.23 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -148.33 131.52 16.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.318 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 16.9 mm -110.99 160.84 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.461 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -85.86 -63.37 1.54 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.519 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 40.6 Cg_endo -74.6 15.74 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.645 1.339 . . . . 0.0 112.372 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 1.3 m -93.25 -22.74 18.83 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.539 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 p30 -88.23 -29.61 20.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -79.09 -45.24 20.48 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.302 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.4 p -91.11 13.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.393 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 t -64.43 -44.99 77.21 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.474 -0.766 . . . . 0.0 110.701 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.4 Cg_endo -77.13 5.77 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.592 1.312 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 4.2 mmp_? -83.29 179.28 7.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 110.064 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.5 ' CD1' ' OE2' ' A' ' 17' ' ' GLU . 7.6 pt -54.09 -166.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -78.76 -45.71 1.87 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 111.6 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -69.62 -6.82 19.45 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.282 1.148 . . . . 0.0 110.53 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' OE2' ' CD1' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -89.18 -19.57 25.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.102 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 7.0 ttm180 -99.31 -52.32 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.875 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 19.2 m-70 -57.51 -33.64 68.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.896 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.23 -21.21 46.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 110.179 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' ' 4' ' ' ILE . 10.0 t -65.42 -45.29 84.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.902 . . . . 0.0 110.205 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.91 -43.99 33.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.53 -21.78 66.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.867 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -21.27 25.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -102.45 14.91 30.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 27' ' ' ARG . . . 71.46 64.49 2.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' CZ ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -134.66 -158.3 0.87 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -1.175 . . . . 0.0 110.159 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 -89.71 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -145.61 144.87 13.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.686 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -42.58 119.86 1.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -1.158 . . . . 0.0 110.2 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 32' ' ' TYR . . . -99.65 -56.18 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.488 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CD2' ' CB ' ' A' ' 31' ' ' ALA . 13.4 p90 -178.03 129.29 0.14 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.373 -178.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -74.25 115.86 14.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 179.374 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.31 167.4 10.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.254 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.98 143.29 11.65 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.77 -50.73 2.0 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 8' ' ' ASP . . . -173.09 -139.34 2.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.536 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 9.5 ttt -126.81 162.58 25.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -1.17 . . . . 0.0 109.913 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 50.2 m-85 -135.24 148.07 49.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 111.015 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -115.97 161.54 18.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.497 -0.752 . . . . 0.0 110.171 -179.842 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.204 -179.98 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.268 0.556 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 34.5 m -136.6 -155.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.059 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.5 tpt180 -146.85 121.16 9.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 25' ' ' HIS . 6.3 mm -101.17 149.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.557 -0.714 . . . . 0.0 109.545 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.32 -70.51 1.05 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.163 -1.017 . . . . 0.0 110.788 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.536 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.18 25.66 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.757 1.398 . . . . 0.0 112.746 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -94.78 -26.92 16.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.62 -1.3 . . . . 0.0 107.915 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 37' ' ' GLY . 1.8 t70 -87.32 -24.32 24.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.409 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 28.7 mt-30 -84.57 -41.66 16.22 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.66 12.1 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.586 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 22.8 t -64.96 -41.37 54.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.0 Cg_endo -76.83 5.28 5.0 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.344 1.181 . . . . 0.0 110.74 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.1 mmt180 -83.25 179.42 7.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.127 -0.983 . . . . 0.0 110.182 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.0 pt -54.23 -165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.652 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.6 t -79.3 -45.19 1.68 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 111.448 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.3 Cg_endo -70.99 -4.51 14.99 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.287 1.151 . . . . 0.0 110.361 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 3.1 mm-40 -93.18 -15.74 25.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtm180 -104.85 -50.31 3.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.08 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 19.1 m-70 -61.49 -37.07 82.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.24 -0.913 . . . . 0.0 110.117 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 1.6 tt0 -74.53 -20.0 60.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 15.5 t -62.0 -40.93 97.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 83.9 m -76.18 -50.18 15.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -14.09 62.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -87.49 -33.27 19.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.928 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 11.9 m-70 -96.51 50.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.146 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.83 43.24 6.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -119.53 -167.37 1.4 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -1.117 . . . . 0.0 110.216 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.455 ' HB3' ' OXT' ' A' ' 41' ' ' ASN . 4.8 t -102.14 -144.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.19 169.27 53.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.673 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 17.8 p90 -71.01 147.26 48.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -1.117 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -113.27 -69.6 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.442 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 12.1 p90 -178.6 152.19 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.425 -178.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 91.2 m -97.96 113.09 24.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' GLY . 5.2 p -93.88 30.16 1.91 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.934 . . . . 0.0 110.525 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.89 127.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.47 -19.75 30.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.42 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 177.78 139.41 3.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.534 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 8.4 ttt -103.18 169.9 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -1.13 . . . . 0.0 110.014 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 25.5 m-85 -134.45 154.2 51.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 70.8 m -113.82 130.22 56.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' CYS . 12.9 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.219 0.533 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 40' ' ' CYS . 3.7 m -145.06 -160.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.927 . . . . 0.0 110.256 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.484 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.7 tpt180 -147.08 118.26 7.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 110.117 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.521 ' CG2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 mm -99.85 147.91 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -0.771 . . . . 0.0 109.862 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.467 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -64.2 -69.66 1.27 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.391 -0.909 . . . . 0.0 110.953 -179.059 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.569 ' CG ' ' CE1' ' A' ' 25' ' ' HIS . 42.4 Cg_endo -75.26 22.79 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.553 1.291 . . . . 0.0 112.658 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.6 -26.14 16.49 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.737 -1.227 . . . . 0.0 107.931 178.532 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.543 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.4 p30 -88.6 -30.19 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 34.6 tt0 -75.92 -43.83 43.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 9.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.417 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.07 -41.97 57.79 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 111.075 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 50.0 Cg_endo -79.42 21.02 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.441 1.232 . . . . 0.0 111.522 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -104.87 -169.59 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.795 -1.191 . . . . 0.0 110.031 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 8.7 pt -52.92 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.279 -0.888 . . . . 0.0 110.641 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.595 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.6 t -82.55 -42.87 0.94 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.8 Cg_endo -72.06 -7.83 21.76 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.214 1.113 . . . . 0.0 110.278 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -85.95 -15.2 42.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.035 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtp180 -104.16 -54.02 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.097 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' A' ' 30' ' ' TYR . 24.5 m-70 -59.43 -35.59 74.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.1 -20.61 57.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 110.095 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 7.7 t -67.1 -39.28 86.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 73.0 m -75.1 -29.31 60.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.319 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -87.65 -16.23 35.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.368 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.32 -29.68 21.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.569 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 25.5 m-70 -95.13 45.81 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.84 41.36 5.81 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -116.56 -163.34 0.9 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 0.0 110.376 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.487 ' CB ' ' OXT' ' A' ' 41' ' ' ASN . 91.8 p -95.18 -140.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.179 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -90.2 -146.11 14.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.573 ' CD2' ' HE3' ' A' ' 38' ' ' MET . 1.9 t80 -114.37 124.82 52.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.337 -1.096 . . . . 0.0 110.151 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -98.86 -57.91 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.146 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 39' ' ' TYR . 9.3 p90 -178.19 -172.65 0.32 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.323 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.46 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -127.22 114.84 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.607 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -94.65 147.92 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 110.336 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.07 104.55 0.83 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -30.19 4.32 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.64 152.02 17.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.573 ' HE3' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -93.0 160.53 14.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.157 . . . . 0.0 110.095 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.566 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 27.2 m-85 -131.04 140.74 50.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.346 -0.846 . . . . 0.0 110.388 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.542 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 95.7 m -106.47 138.83 41.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.119 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.508 ' N ' ' HB1' ' A' ' 31' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.341 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.612 HG21 ' HG3' ' A' ' 27' ' ' ARG . 7.0 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.298 0.571 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.51 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.9 tpt180 -146.02 121.44 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.917 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.1 mm -100.18 148.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.597 -0.689 . . . . 0.0 109.933 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.29 -68.66 1.58 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.928 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.779 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.6 Cg_endo -75.2 22.6 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.748 1.394 . . . . 0.0 112.66 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.554 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.29 -28.45 15.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.638 -1.288 . . . . 0.0 107.84 178.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.8 t70 -84.15 -23.58 30.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -84.9 -45.74 11.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.92 13.49 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.17 -0.956 . . . . 0.0 109.395 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.3 -45.4 78.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 110.854 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -77.19 6.89 3.99 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.697 1.367 . . . . 0.0 110.804 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.643 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.8 mmp_? -83.14 178.4 8.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -0.99 . . . . 0.0 109.985 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.48 HG12 ' HB2' ' A' ' 17' ' ' GLU . 5.9 pt -53.34 -168.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 110.64 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -80.61 -44.1 1.31 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 111.623 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.06 -5.26 16.6 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.22 1.116 . . . . 0.0 110.213 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -92.86 -19.45 21.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.164 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 8.8 ttp180 -97.16 -45.68 6.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.537 -0.727 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -36.51 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 109.777 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -75.01 -16.73 60.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 110.146 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.917 ' SG ' HG21 ' A' ' 4' ' ' ILE . 44.6 t -67.81 -50.35 57.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 74.1 m -74.81 -21.45 59.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 109.985 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.14 -16.82 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.62 -31.8 19.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.575 ' HB2' HD12 ' A' ' 4' ' ' ILE . 36.4 m80 -95.61 49.62 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.67 42.71 6.18 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.612 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -124.99 -179.88 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -1.172 . . . . 0.0 110.196 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 1.9 m -83.49 -141.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.42 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 18.1 p90 -92.16 132.14 36.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.667 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.38 -62.73 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.667 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.3 p90 -178.29 156.24 0.96 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -98.6 112.93 24.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -117.11 134.13 55.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.366 -0.833 . . . . 0.0 110.299 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.5 -153.04 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.83 43.92 3.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -165.71 138.96 5.51 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.491 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 2.3 ttt -101.4 167.25 10.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -1.17 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.656 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 75.1 m-85 -136.1 147.25 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.567 ' HB2' HG23 ' A' ' 2' ' ' VAL . 79.6 m . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.763 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.4 m . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.361 0.601 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.528 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 1.4 tpt180 -147.03 122.46 10.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.318 -0.864 . . . . 0.0 110.063 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.7 mm -102.53 147.61 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 109.959 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -70.24 1.11 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.6 Cg_endo -74.99 23.15 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.649 1.342 . . . . 0.0 112.792 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.527 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.49 -29.52 14.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.631 -1.293 . . . . 0.0 107.669 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.435 ' CG ' ' CA ' ' A' ' 37' ' ' GLY . 1.1 t0 -84.89 -26.87 27.04 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 3.6 mt-30 -79.43 -44.28 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.77 12.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.586 ' SG ' ' HE3' ' A' ' 38' ' ' MET . 1.7 t -64.45 -44.17 74.21 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.479 -0.763 . . . . 0.0 110.841 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -77.81 6.16 4.75 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.572 1.301 . . . . 0.0 110.746 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.566 ' HG3' HG23 ' A' ' 10' ' ' VAL . 3.0 mmt180 -83.59 -175.93 6.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.55 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.6 pt -54.28 -165.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.55 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.626 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.3 t -82.1 -42.4 1.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 111.607 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.97 -9.27 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.267 1.141 . . . . 0.0 110.559 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.25 -12.3 52.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.398 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.578 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 5.8 ttp180 -109.42 -55.07 2.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 4.2 m-70 -53.83 -31.9 50.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -84.57 -23.72 29.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.375 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.0 t -60.39 -32.53 71.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.426 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' SER . 86.1 m -76.18 -33.4 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -89.94 -8.24 52.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.327 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.39 -16.09 38.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.562 ' HB2' HD12 ' A' ' 4' ' ' ILE . 38.7 m-70 -115.89 38.97 3.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 50.67 31.76 23.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -106.31 -168.82 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -1.152 . . . . 0.0 110.273 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 16.2 m -83.34 -134.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.46 -176.33 21.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -68.83 127.9 34.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -1.096 . . . . 0.0 110.196 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -110.31 -68.88 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.452 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.3 p90 -178.61 150.37 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.514 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -90.32 118.95 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.424 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 37' ' ' GLY . 1.1 t -135.62 139.82 44.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.62 -157.05 34.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.91 43.64 3.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.586 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 1.9 ttt -98.83 168.99 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.027 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 25.7 m-85 -131.45 145.81 51.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.899 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.763 ' HB2' HG23 ' A' ' 2' ' ' VAL . 59.9 m . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.287 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.136 0.493 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.577 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -147.98 131.15 16.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.791 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.4 mm -106.41 155.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.771 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.441 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -74.24 -67.15 1.82 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.744 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.9 Cg_endo -74.66 17.95 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.629 1.331 . . . . 0.0 112.486 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.1 m -93.79 -26.55 16.91 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.536 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.0 p30 -88.76 -29.33 19.87 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 tm0? -76.84 -44.27 32.97 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.5 p -90.51 12.55 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.354 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.7 t -64.75 -43.78 70.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.723 -0.611 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.35 4.32 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.521 1.274 . . . . 0.0 110.852 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 mtt180 -85.09 -179.17 6.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 109.998 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 7.4 pt -53.72 -167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.629 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.63 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.4 t -82.4 -42.65 0.96 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 111.564 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.6 Cg_endo -72.09 -2.15 11.14 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.281 1.148 . . . . 0.0 110.378 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -96.42 -10.56 27.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 109.454 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.596 ' HD2' ' CD2' ' A' ' 30' ' ' TYR . 10.7 ttm180 -109.57 -47.96 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -58.26 -28.92 65.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -84.13 -20.43 32.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.923 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.4 t -61.95 -45.87 91.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.36 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.4 -40.12 58.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -68.88 -19.09 64.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 110.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -29.48 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.365 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -97.82 4.3 49.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.242 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . 77.22 74.48 0.98 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -135.66 -156.66 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.184 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.3 t -102.07 -89.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -153.9 151.19 22.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.672 ' CD2' ' HE2' ' A' ' 38' ' ' MET . 14.5 t80 -44.08 119.57 1.81 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.245 . . . . 0.0 110.091 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -105.5 -58.34 1.91 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.368 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.779 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 13.6 p90 -177.34 138.07 0.23 Allowed 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.025 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -87.01 102.37 14.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.095 -1.003 . . . . 0.0 110.118 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 35' ' ' GLY . 1.4 p -81.19 161.64 23.93 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.5 -0.75 . . . . 0.0 110.25 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -43.16 -56.0 4.78 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.06 -72.85 0.41 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA3' ' NH2' ' A' ' 3' ' ' ARG . . . -149.19 -135.28 2.47 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.672 ' HE2' ' CD2' ' A' ' 30' ' ' TYR . 15.4 tpt -121.69 146.97 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.898 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.0 m-85 -128.21 141.99 51.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.993 -1.067 . . . . 0.0 111.083 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.48 -0.763 . . . . 0.0 110.127 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 40' ' ' CYS . 1.8 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.319 0.58 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.2 tpt180 -146.53 122.94 11.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 110.152 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -104.14 151.47 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.766 . . . . 0.0 110.02 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.53 -68.97 1.49 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.725 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.773 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.7 Cg_endo -74.95 22.23 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.778 1.41 . . . . 0.0 112.789 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.638 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.18 -29.77 14.95 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.7 t70 -82.79 -25.02 33.16 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.64 -46.26 13.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.0 p -90.7 14.72 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.23 -0.919 . . . . 0.0 109.348 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 t -64.1 -44.1 76.45 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.658 -0.651 . . . . 0.0 111.111 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.1 Cg_endo -77.8 8.74 3.27 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.568 1.299 . . . . 0.0 111.113 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.629 ' HG3' HG23 ' A' ' 10' ' ' VAL . 1.1 mmm180 -85.22 179.14 7.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 0.0 110.22 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.3 pt -53.98 -166.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.61 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -79.07 -44.7 1.74 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.49 -0.756 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.2 Cg_endo -71.02 -5.71 17.58 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.384 1.202 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.56 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 1.8 mm-40 -88.08 -21.73 24.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.36 -0.838 . . . . 0.0 109.33 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 4.9 ttp180 -100.11 -44.99 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -0.767 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -59.2 -31.7 69.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -82.66 -17.97 42.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.342 -0.849 . . . . 0.0 110.018 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 4' ' ' ILE . 31.9 t -68.05 -49.69 59.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 84.3 m -75.12 -29.53 60.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -78.73 -21.82 47.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.11 24.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.299 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.687 ' CB ' HD12 ' A' ' 4' ' ' ILE . 1.9 m80 -102.28 51.07 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 110.403 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.06 23.2 2.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -112.29 175.51 5.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -1.231 . . . . 0.0 110.063 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 2.3 t -88.29 -143.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -72.26 -154.49 2.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.48 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 22.4 p90 -105.88 144.65 32.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -1.105 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -105.07 -65.42 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.501 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.74 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.6 p90 -178.3 148.79 0.49 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.521 -0.737 . . . . 0.0 110.297 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -87.87 119.78 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -129.25 135.27 48.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.942 . . . . 0.0 110.473 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.99 -149.7 46.9 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.42 25.4 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -151.77 157.99 27.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.521 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 10.6 ttt -106.8 167.01 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -1.203 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 35.5 m-85 -129.19 142.11 50.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.683 ' HB2' HG23 ' A' ' 2' ' ' VAL . 73.5 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 40' ' ' CYS . 30.0 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 2.9 tpt180 -147.92 117.78 7.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.74 HG21 ' SG ' ' A' ' 7' ' ' CYS . 13.3 mm -100.46 157.52 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 0.0 109.851 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.72 -63.8 1.88 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.636 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.792 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.9 Cg_endo -74.98 16.36 0.66 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.681 1.358 . . . . 0.0 112.476 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.74 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.3 m -93.81 -27.99 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.516 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.4 t70 -89.42 -25.38 21.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -79.83 -45.1 19.33 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.2 p -91.1 14.22 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.316 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 t -64.51 -44.33 74.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 110.995 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.7 Cg_endo -76.71 5.65 4.68 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.559 1.294 . . . . 0.0 110.996 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.563 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -85.64 -179.73 6.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -0.998 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.59 HD11 ' OE1' ' A' ' 17' ' ' GLU . 14.9 pt -54.55 -165.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.278 -0.889 . . . . 0.0 110.737 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.606 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.0 t -78.71 -46.57 1.87 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.3 Cg_endo -68.77 -10.76 30.02 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.294 1.155 . . . . 0.0 110.256 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.59 ' OE1' HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -84.42 -21.91 30.6 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.348 -0.845 . . . . 0.0 109.219 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.7 mtm180 -95.89 -49.58 5.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -56.53 -19.23 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.871 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -96.78 -22.5 16.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' HB3' HG11 ' A' ' 10' ' ' VAL . 2.9 p -59.32 -36.76 76.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.9 OUTLIER -81.21 -44.1 18.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.172 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -67.82 -13.86 62.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 110.294 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.33 -15.28 55.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 110.239 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.712 ' CB ' HD12 ' A' ' 4' ' ' ILE . 2.0 m-70 -111.09 -8.21 14.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 99.15 47.71 1.83 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.652 ' HG3' HG21 ' A' ' 2' ' ' VAL . 6.8 mpt_? -114.1 -164.44 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -1.14 . . . . 0.0 110.158 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 -75.34 0.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.65 138.84 7.4 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.4 p90 -46.31 127.76 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.153 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -96.21 -59.08 1.91 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.858 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.5 p90 -178.17 160.47 1.38 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.537 -0.727 . . . . 0.0 109.933 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.6 OUTLIER -100.43 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 t -135.84 174.05 11.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 0.0 110.461 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.89 -147.79 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.21 39.34 2.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . -174.75 -164.9 30.32 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.537 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -112.35 177.42 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -1.131 . . . . 0.0 110.163 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.906 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 61.4 m-85 -143.4 135.98 27.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.973 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.576 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.964 HG21 ' HD2' ' A' ' 27' ' ' ARG . 23.3 m . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.154 0.502 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.508 ' CD ' ' O ' ' A' ' 38' ' ' MET . 4.5 tpt180 -147.05 121.27 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.208 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.903 HG21 ' SG ' ' A' ' 21' ' ' CYS . 12.5 mm -101.07 148.71 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.493 -0.754 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.66 -66.95 2.07 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.806 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.75 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.8 Cg_endo -74.57 20.25 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.688 1.362 . . . . 0.0 112.667 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.03 -24.34 17.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 107.701 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.458 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 36.0 t70 -88.57 -27.21 21.53 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 14.5 mm-40 -80.16 -44.4 19.92 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.03 13.81 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.31 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.71 -47.07 76.38 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.518 -0.739 . . . . 0.0 110.925 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -75.17 4.05 5.17 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.755 1.397 . . . . 0.0 111.133 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 22.4 mmt180 -83.42 -175.51 5.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.022 -1.048 . . . . 0.0 110.262 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.664 HD11 ' OE2' ' A' ' 17' ' ' GLU . 13.7 pt -54.09 -165.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.335 -0.853 . . . . 0.0 110.668 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -82.34 -42.17 0.96 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.11 -10.37 25.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.213 1.112 . . . . 0.0 110.472 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.664 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -83.75 -14.74 50.8 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.26 -47.82 3.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.488 ' NE2' ' CE1' ' A' ' 30' ' ' TYR . 22.4 m80 -58.87 -37.78 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.6 tm-20 -79.48 -21.91 44.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.903 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.1 t -61.04 -40.32 93.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.316 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.468 ' HA ' HG13 ' A' ' 4' ' ' ILE . 93.5 m -75.01 -52.48 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.0 110.275 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -12.64 59.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.313 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.55 -16.88 33.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -102.54 -17.2 15.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.92 34.06 1.74 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.964 ' HD2' HG21 ' A' ' 2' ' ' VAL . 16.2 mmt180 -103.42 -161.71 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -1.118 . . . . 0.0 110.282 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.66 -38.35 5.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.351 -0.843 . . . . 0.0 110.18 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.77 167.19 37.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CE1' ' NE2' ' A' ' 19' ' ' HIS . 29.8 p90 -69.78 146.32 51.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -1.162 . . . . 0.0 110.239 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -119.97 -66.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.826 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.8 p90 -178.48 163.38 1.55 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.429 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -103.99 114.87 29.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -144.86 158.41 43.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 57.69 54.26 38.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 43.35 26.96 0.67 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -146.68 -153.9 6.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.526 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -150.98 170.59 18.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 110.319 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.819 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 89.2 m-85 -143.52 144.82 32.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.808 ' O ' HG22 ' A' ' 2' ' ' VAL . 86.1 m . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.388 -0.82 . . . . 0.0 110.159 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 40' ' ' CYS . 3.6 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.324 0.583 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 38' ' ' MET . 4.8 tpt180 -146.77 119.43 8.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.331 -0.855 . . . . 0.0 110.04 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.882 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.6 mm -101.82 151.77 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.505 -0.747 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.15 -68.46 1.63 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.208 -0.996 . . . . 0.0 110.834 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -75.22 21.24 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.704 1.371 . . . . 0.0 112.627 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.661 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.29 -26.19 16.7 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.667 -1.271 . . . . 0.0 107.746 178.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.527 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.0 t0 -86.57 -24.35 25.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.42 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 mt-30 -85.13 -43.43 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.61 12.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.63 -45.24 76.1 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 110.792 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.3 Cg_endo -77.58 6.02 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.687 1.362 . . . . 0.0 110.737 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -85.84 -178.15 6.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 110.176 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.545 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.5 pt -53.66 -167.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.839 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.652 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.3 t -82.39 -41.04 0.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 111.815 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.9 Cg_endo -70.52 -13.19 32.54 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.085 1.045 . . . . 0.0 110.285 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.1 OUTLIER -84.89 -11.76 54.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 0.0 109.247 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 15.0 mtp180 -100.38 -54.06 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.969 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.7 m80 -57.62 -40.42 79.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.9 tt0 -73.34 -17.32 61.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.42 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.882 ' SG ' HG21 ' A' ' 4' ' ' ILE . 22.2 t -70.24 -45.9 65.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 0.0 110.446 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HA ' HG13 ' A' ' 4' ' ' ILE . 85.7 m -74.77 -28.69 60.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.067 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.92 -17.58 35.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.072 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.78 -4.21 58.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.612 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.41 -54.95 2.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.86 39.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.497 ' NE ' HD11 ' A' ' 4' ' ' ILE . 5.0 mmt180 -109.17 -164.49 0.94 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.351 -1.087 . . . . 0.0 110.129 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.3 m -120.11 -3.99 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . 162.79 174.13 32.32 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.718 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 12.0 p90 -95.44 146.85 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 110.193 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -112.63 -61.05 1.79 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.65 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.781 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.3 p90 -178.01 -161.99 0.06 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.189 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -134.74 120.85 19.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.63 162.72 19.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.329 -0.857 . . . . 0.0 110.389 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.03 129.94 44.24 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.08 -32.37 6.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 167.11 170.3 31.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.527 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -95.29 165.92 12.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.141 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 69.2 m-85 -131.61 143.34 50.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.758 ' O ' HG22 ' A' ' 2' ' ' VAL . 85.0 m . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.628 HG21 ' HG3' ' A' ' 27' ' ' ARG . 18.0 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.229 0.538 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.544 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 2.8 tpt180 -146.8 120.66 9.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.892 . . . . 0.0 110.339 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.651 HG21 ' SG ' ' A' ' 7' ' ' CYS . 7.6 mm -102.24 152.99 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.505 -0.747 . . . . 0.0 109.663 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.15 -66.12 2.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.529 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.715 ' O ' HG12 ' A' ' 10' ' ' VAL . 43.1 Cg_endo -76.03 21.32 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.721 1.379 . . . . 0.0 112.582 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.16 -30.76 14.46 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 12.5 t70 -87.9 -31.04 19.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 81.9 mt-30 -70.99 -44.55 65.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.3 p -90.72 11.74 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 t -64.96 -43.66 68.85 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 110.826 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.1 Cg_endo -77.29 4.87 5.51 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.568 1.299 . . . . 0.0 110.65 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.4 mmt180 -83.31 -175.84 6.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.558 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.0 pt -54.13 -167.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.45 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 50.1 t -82.43 -42.35 0.95 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 111.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -71.78 -8.26 22.74 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.237 1.125 . . . . 0.0 110.168 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -94.23 -15.52 24.48 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.41 -0.806 . . . . 0.0 109.205 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 8.2 mtm180 -95.33 -54.47 3.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 24.4 m-70 -62.85 -24.41 67.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.739 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -86.82 -12.58 47.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.699 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HE2' ' A' ' 38' ' ' MET . 3.5 p -69.7 -38.08 76.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 0.0 110.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 m -75.16 -47.76 26.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.423 -0.798 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -73.03 -12.46 60.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -78.77 -26.44 44.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.614 ' HB2' HD12 ' A' ' 4' ' ' ILE . 2.1 m80 -105.18 50.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.41 37.22 3.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.628 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -111.02 -149.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.378 -1.072 . . . . 0.0 110.391 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 m -106.35 -141.43 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.19 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.16 155.78 18.6 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CE1' ' SD ' ' A' ' 38' ' ' MET . 2.9 t80 -48.12 121.53 4.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -1.151 . . . . 0.0 110.252 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.87 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.64 -61.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 110.402 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.87 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.1 p90 -178.29 140.54 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -85.66 112.16 20.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.131 -0.981 . . . . 0.0 109.713 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.73 135.57 54.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.63 -152.59 30.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.46 41.72 3.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -164.7 165.0 37.25 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.584 ' HE2' ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -120.34 153.84 35.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.919 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.8 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.3 m-85 -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 35.1 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 0.0 110.343 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.977 HG22 ' O ' ' A' ' 40' ' ' CYS . 9.2 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.538 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 1.3 tpt180 -147.87 118.34 7.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.261 -0.899 . . . . 0.0 110.077 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.741 HG21 ' SG ' ' A' ' 7' ' ' CYS . 11.9 mm -100.54 157.11 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 -66.81 1.68 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.097 -1.049 . . . . 0.0 110.599 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.765 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.8 Cg_endo -75.99 20.7 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.727 1.383 . . . . 0.0 112.706 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.741 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.17 -28.74 15.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.609 -1.307 . . . . 0.0 107.509 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.0 t70 -88.25 -30.31 19.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -73.26 -45.3 56.59 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.765 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.31 12.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.34 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 t -64.88 -43.37 68.35 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.611 -0.681 . . . . 0.0 111.358 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.5 Cg_endo -75.96 5.42 4.47 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.428 1.225 . . . . 0.0 111.023 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mmt180 -84.69 179.37 7.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.1 pt -54.39 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.158 -0.964 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -78.47 -45.64 2.04 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.801 . . . . 0.0 111.721 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.7 Cg_endo -68.91 -9.84 27.46 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.239 1.126 . . . . 0.0 110.297 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -87.81 -24.35 23.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.256 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -90.14 -49.18 6.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.62 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -60.47 -16.78 39.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 tt0 -96.49 -18.64 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.57 ' HB3' HG11 ' A' ' 10' ' ' VAL . 4.0 p -64.75 -37.22 86.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.497 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 1.2 m -78.95 -50.24 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 110.164 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.7 mtt-85 -64.76 -19.28 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.304 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -73.95 -22.52 59.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.466 ' HB2' HD12 ' A' ' 4' ' ' ILE . 2.4 m-70 -112.33 27.08 9.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 110.029 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 59.07 69.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.06 -151.26 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.282 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -111.07 -88.83 0.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.32 140.02 9.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.62 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.9 p90 -46.72 125.23 6.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.168 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.86 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -97.83 -60.91 1.47 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.106 -0.996 . . . . 0.0 110.338 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.86 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.2 p90 -178.28 142.65 0.26 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.013 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.8 OUTLIER -85.36 111.91 20.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.821 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -124.22 159.57 29.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.315 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.21 -150.74 0.46 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.33 42.7 2.7 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.95 145.07 8.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.538 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 8.2 ttt -87.23 159.72 18.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 110.043 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.761 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.1 m-85 -125.49 143.21 51.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.977 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.388 -0.82 . . . . 0.0 110.387 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.1 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.25 0.548 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.4 tpt180 -147.04 121.36 9.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 110.285 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.889 HG21 ' SG ' ' A' ' 21' ' ' CYS . 5.7 mm -100.17 145.05 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.422 -0.799 . . . . 0.0 109.66 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . -57.55 -71.9 0.67 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.132 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.9 Cg_endo -76.76 25.73 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.632 1.332 . . . . 0.0 112.724 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -94.79 -21.83 18.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.73 -1.231 . . . . 0.0 108.164 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 3.7 p-10 -87.32 -24.51 24.28 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mt-30 -87.97 -42.53 12.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 109.482 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.88 -45.0 74.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 110.877 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 48.6 Cg_endo -77.44 8.53 3.26 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.639 1.336 . . . . 0.0 111.136 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.541 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 12.2 mmt180 -83.17 -179.17 7.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.039 -1.038 . . . . 0.0 110.049 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.543 HD12 ' HG2' ' A' ' 16' ' ' PRO . 13.6 pt -53.78 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.2 t -79.49 -44.07 1.62 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 111.22 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -72.6 -4.45 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.359 1.189 . . . . 0.0 110.285 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 3.0 mm-40 -96.31 -15.86 21.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -102.85 -50.94 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.481 ' NE2' ' CD1' ' A' ' 30' ' ' TYR . 47.3 m80 -61.54 -35.18 77.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.111 -0.993 . . . . 0.0 109.906 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.62 -19.31 59.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.145 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.889 ' SG ' HG21 ' A' ' 4' ' ' ILE . 15.2 t -62.76 -41.53 99.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.007 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 81.7 m -78.65 -25.01 44.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -86.14 -15.36 41.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.458 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.23 21.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.327 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.595 ' CB ' HD12 ' A' ' 4' ' ' ILE . 32.3 m80 -98.34 43.34 1.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.76 19.45 10.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -100.81 173.93 6.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -1.21 . . . . 0.0 110.181 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 3.1 t -82.2 -141.96 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.16 -158.49 27.78 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -96.67 141.62 29.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -1.153 . . . . 0.0 110.385 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -106.16 -60.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.74 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 17.8 p90 -178.43 146.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.253 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -94.73 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.465 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 35' ' ' GLY . 16.0 p -80.59 -143.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 110.44 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -56.17 -110.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.63 41.9 2.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.64 139.02 5.81 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.534 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 1.7 tpt -104.97 153.21 21.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.861 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 13.6 m-85 -127.29 149.25 50.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.721 ' HB2' HG23 ' A' ' 2' ' ' VAL . 74.4 m . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.455 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.749 HG21 ' HG3' ' A' ' 27' ' ' ARG . 23.7 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.26 0.552 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.513 ' NH2' ' OD2' ' A' ' 8' ' ' ASP . 2.0 tpt180 -147.78 121.61 9.32 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.328 -0.858 . . . . 0.0 110.077 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.922 HG21 ' SG ' ' A' ' 21' ' ' CYS . 12.2 mm -99.94 152.51 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.989 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -72.76 -68.32 1.62 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.733 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.76 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.06 23.16 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.597 1.314 . . . . 0.0 112.596 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.63 -29.84 14.64 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.673 -1.267 . . . . 0.0 107.939 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 3.0 p30 -86.47 -24.89 25.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -81.25 -45.1 16.79 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -91.16 12.26 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.43 -44.75 76.35 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.54 -0.725 . . . . 0.0 110.893 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.8 Cg_endo -75.98 4.12 5.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.688 1.362 . . . . 0.0 110.647 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.589 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.5 mmp_? -83.62 -175.66 5.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 110.034 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.57 HD12 ' HG2' ' A' ' 16' ' ' PRO . 15.4 pt -55.72 -167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 110.724 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.629 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -82.55 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 111.642 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -72.29 -3.56 13.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.274 1.144 . . . . 0.0 110.393 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HB3' HG22 ' A' ' 10' ' ' VAL . 3.7 mt-10 -96.06 -12.78 24.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.377 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 mtm-85 -105.02 -49.39 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.47 ' NE2' ' CE1' ' A' ' 30' ' ' TYR . 49.9 m80 -60.63 -33.93 73.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.89 -14.53 58.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.922 ' SG ' HG21 ' A' ' 4' ' ' ILE . 13.5 t -64.31 -41.89 96.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 110.33 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.2 m -76.52 -46.24 27.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -64.84 -22.23 66.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.9 -22.5 29.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.525 ' CB ' HD12 ' A' ' 4' ' ' ILE . 6.8 m80 -105.97 7.91 32.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.484 ' O ' ' CD ' ' A' ' 27' ' ' ARG . . . 80.38 64.48 1.83 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.749 ' HG3' HG21 ' A' ' 2' ' ' VAL . 3.9 mpt_? -135.17 -178.23 5.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.1 m -87.92 -88.06 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -141.81 144.86 14.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 10.8 p90 -44.54 124.75 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.209 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.835 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.27 -60.57 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.835 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 11.0 p90 -178.18 158.39 1.18 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.066 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -106.56 106.62 17.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.796 179.567 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -106.59 137.92 43.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.84 -150.74 0.86 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.78 48.35 3.96 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -167.35 137.09 4.44 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.534 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 6.3 ttt -104.4 170.56 7.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.828 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 67.6 m-85 -143.71 153.05 42.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.618 HG21 ' HG3' ' A' ' 27' ' ' ARG . 30.2 m . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.202 0.525 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.0 tpt180 -147.7 121.32 9.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 110.18 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 25' ' ' HIS . 26.6 mm -101.71 156.31 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.27 -66.61 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.88 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.764 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -76.21 20.98 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.713 1.375 . . . . 0.0 112.736 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 8.5 t -94.49 -28.6 15.37 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.687 -1.258 . . . . 0.0 108.012 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.506 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 5.1 t0 -85.8 -24.21 26.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.99 -45.28 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.87 13.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.0 109.442 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.5 t -64.49 -41.94 62.28 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.539 -0.726 . . . . 0.0 111.501 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 44.3 Cg_endo -74.77 3.64 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.393 1.207 . . . . 0.0 110.999 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.56 177.83 7.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.041 -1.037 . . . . 0.0 109.794 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 9.5 pt -53.75 -166.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 110.731 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.8 t -77.69 -45.32 2.48 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 0.0 111.526 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.0 Cg_endo -68.53 -9.94 27.56 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.268 1.141 . . . . 0.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 9.2 mm-40 -91.69 -19.4 22.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.372 -0.83 . . . . 0.0 109.066 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 47.3 mtp180 -91.34 -45.39 8.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.506 -0.746 . . . . 0.0 109.766 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -18.84 65.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 110.242 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 2.3 tp10 -80.12 -13.54 59.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.709 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 9.2 p -69.8 -38.02 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.282 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 4.7 m -84.16 -46.67 11.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.368 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.477 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -70.92 -39.44 72.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.12 -0.987 . . . . 0.0 110.317 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.601 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -98.88 33.64 2.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 110.231 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 50.36 76.82 0.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG3' HG21 ' A' ' 2' ' ' VAL . 1.1 tpt180 -141.29 -157.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -1.156 . . . . 0.0 110.25 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 1.6 t -102.94 -140.56 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -98.2 143.59 16.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -43.2 134.29 3.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -1.127 . . . . 0.0 110.49 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -106.49 -59.25 1.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.856 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.3 p90 -178.11 142.75 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.491 -0.756 . . . . 0.0 110.129 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -86.57 117.17 25.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.985 . . . . 0.0 110.02 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -131.28 136.86 48.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.86 -156.35 24.0 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.12 49.77 4.16 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 39' ' ' TYR . . . 175.72 133.77 1.81 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.535 ' CE ' ' HB2' ' A' ' 30' ' ' TYR . 10.0 ttt -86.27 176.41 7.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -1.227 . . . . 0.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.862 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 76.6 m-85 -140.71 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.588 ' CB ' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.25 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.743 HG21 ' HG3' ' A' ' 27' ' ' ARG . 36.0 m . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.207 0.527 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.8 tpt180 -146.13 121.14 10.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.903 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -101.42 150.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.627 -0.671 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.25 -68.95 1.49 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.83 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.728 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.41 22.46 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.656 1.345 . . . . 0.0 112.757 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.54 -24.39 17.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.64 -1.287 . . . . 0.0 107.77 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -88.87 -24.51 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 15.3 mt-30 -85.03 -43.02 14.31 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.35 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -64.81 -42.23 61.86 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.608 -0.683 . . . . 0.0 111.308 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -75.74 4.47 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.36 1.19 . . . . 0.0 110.825 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 3.1 mmp_? -83.31 177.06 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.854 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.3 pt -53.54 -168.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.938 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.634 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 t -78.28 -45.06 2.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 111.303 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.7 Cg_endo -70.21 -7.21 20.64 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.384 1.202 . . . . 0.0 110.301 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -91.85 -13.7 30.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 2.2 mtm180 -103.41 -44.79 5.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 109.813 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.531 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -60.39 -36.06 77.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -75.92 -14.35 60.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -0.837 . . . . 0.0 110.376 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.903 ' SG ' HG21 ' A' ' 4' ' ' ILE . 26.9 t -70.7 -48.01 56.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 86.7 m -75.13 -22.98 57.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -90.1 -19.77 23.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.181 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.17 24.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -99.3 43.12 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 110.354 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 47.41 39.6 14.69 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.743 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -120.75 -179.32 3.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -1.109 . . . . 0.0 110.186 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -140.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.002 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . -92.87 -178.69 40.57 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 1.2 p90 -76.99 137.33 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.206 -1.173 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -106.99 -65.21 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 110.612 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.665 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.9 p90 -178.11 153.13 0.76 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.313 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -95.8 112.51 24.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.898 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.82 139.49 47.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.37 -149.89 0.87 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.04 45.09 3.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -162.94 151.93 21.87 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -115.09 163.16 16.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.366 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 51.8 m-85 -135.08 154.19 51.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.063 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.531 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 86.0 m . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.876 . . . . 0.0 110.598 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 40' ' ' CYS . 6.0 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.178 0.513 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.3 tpt180 -147.16 119.11 8.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 0.0 110.201 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.738 HG21 ' SG ' ' A' ' 7' ' ' CYS . 11.1 mm -101.35 160.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 109.723 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.57 -66.01 1.67 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.565 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.776 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.6 Cg_endo -76.54 20.01 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.633 1.333 . . . . 0.0 112.594 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.738 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.28 -28.16 15.74 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.547 ' HB2' ' N ' ' A' ' 38' ' ' MET . 2.4 t70 -87.75 -31.1 19.83 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -46.0 51.6 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.29 11.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.336 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 t -64.79 -44.05 71.49 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.71 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.6 Cg_endo -75.25 3.83 5.4 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.523 1.275 . . . . 0.0 110.923 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.545 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -83.2 177.35 8.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.072 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 12.9 pt -52.92 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 0.0 110.939 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.625 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.9 t -76.52 -47.22 3.23 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 111.451 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.5 Cg_endo -67.97 -9.63 26.29 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.304 1.16 . . . . 0.0 110.151 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.0 mm-40 -94.69 -16.39 23.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.849 . . . . 0.0 109.195 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -93.93 -49.89 5.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.807 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -65.05 -20.68 66.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 109.954 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -89.07 -10.03 48.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.521 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . 5.5 p -72.16 -37.87 69.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.056 -1.028 . . . . 0.0 110.067 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -82.41 -35.4 27.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 110.237 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -74.12 -30.68 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.424 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.95 66.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.567 ' CE1' ' HG3' ' A' ' 6' ' ' PRO . 29.1 m80 -112.27 9.45 19.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 110.299 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.4 82.65 0.22 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.74 -143.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -1.182 . . . . 0.0 110.178 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 p -112.79 -74.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.191 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -167.6 138.47 5.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 4.5 t80 -42.94 121.97 2.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -1.118 . . . . 0.0 110.178 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.948 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -101.97 -61.12 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.802 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 14.0 p90 -178.42 134.17 0.14 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.184 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -79.78 112.27 16.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 109.523 179.316 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 9.7 p -88.29 31.75 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.35 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.59 126.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.97 -32.51 4.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.39 144.71 9.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.547 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 5.9 ttt -93.27 154.47 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -1.131 . . . . 0.0 110.021 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.948 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 13.6 m-85 -123.71 137.56 54.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.915 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 110.656 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 40' ' ' CYS . 4.6 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.047 0.451 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.7 tpt180 -147.29 123.03 10.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 25' ' ' HIS . 39.6 mm -99.57 156.95 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.657 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.67 -64.54 1.68 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.817 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.0 Cg_endo -75.53 14.23 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.729 1.384 . . . . 0.0 112.624 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 1.8 t -94.62 -21.4 18.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.565 -1.334 . . . . 0.0 107.959 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.459 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 3.4 t70 -87.04 -23.32 25.0 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -90.12 -44.87 9.5 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.96 13.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.215 -0.928 . . . . 0.0 109.674 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.26 -43.71 73.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.0 111.231 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.0 Cg_endo -76.29 5.03 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.454 1.239 . . . . 0.0 110.797 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -85.9 -176.82 6.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 110.196 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.7 pt -53.15 -167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.181 -0.949 . . . . 0.0 110.995 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.0 t -80.6 -42.26 1.27 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 0.0 111.739 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.66 -12.41 31.15 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.27 1.142 . . . . 0.0 110.289 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.543 ' OE1' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -81.51 -24.27 36.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 9.2 mtm180 -94.57 -46.07 7.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.447 -0.783 . . . . 0.0 109.987 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -18.95 49.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.0 110.076 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.8 OUTLIER -88.96 -22.26 23.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 4.9 p -59.16 -37.26 76.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 57.8 m -77.88 -42.26 33.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 0.0 110.289 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -22.61 67.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB2' ' OE2' ' A' ' 20' ' ' GLU . . . -81.88 -22.53 36.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.606 ' HB2' HD12 ' A' ' 4' ' ' ILE . 21.5 m-70 -110.4 22.28 15.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.323 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.46 71.91 0.66 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -125.3 -154.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -1.133 . . . . 0.0 110.197 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.05 -45.9 2.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.338 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.421 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -179.5 135.15 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -45.02 148.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 110.382 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -120.33 -60.98 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.803 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 10.3 p90 -178.11 145.41 0.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.5 OUTLIER -88.18 115.95 26.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 110.111 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -110.26 128.07 55.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 110.566 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 43.82 -146.31 1.34 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.2 3.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 3' ' ' ARG . . . -165.07 119.47 0.87 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 39' ' ' TYR . 1.5 tmt? -84.39 161.08 20.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 58.1 m-85 -131.13 143.45 50.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.8 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.757 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.4 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.281 0.563 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.2 tpt180 -146.94 117.63 7.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.921 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.859 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -100.68 144.43 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 0.0 109.764 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.27 -69.43 1.28 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.086 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.65 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -73.9 19.7 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.6 1.316 . . . . 0.0 112.749 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.554 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -94.15 -21.92 18.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.715 -1.241 . . . . 0.0 107.731 178.495 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.518 ' HB2' ' N ' ' A' ' 38' ' ' MET . 11.8 t70 -92.58 -29.58 16.09 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.478 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 tt0 -78.91 -40.12 33.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.41 9.55 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.38 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.4 t -65.08 -40.34 44.8 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.582 -0.699 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.7 Cg_endo -76.34 3.64 6.11 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.185 1.097 . . . . 0.0 110.526 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 9.6 mmt180 -86.94 -177.0 5.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.984 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.0 pt -53.79 -167.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 87.9 t -81.49 -41.69 1.08 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.567 -0.708 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.4 Cg_endo -69.94 -13.59 34.42 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 122.963 0.98 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -82.86 -12.16 57.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.266 -0.896 . . . . 0.0 109.187 178.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -102.38 -58.1 1.94 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.535 -0.728 . . . . 0.0 110.069 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.417 ' NE2' ' CD1' ' A' ' 30' ' ' TYR . 24.8 m80 -58.4 -36.64 73.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -73.42 -23.27 60.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.859 ' SG ' HG21 ' A' ' 4' ' ' ILE . 6.9 t -67.8 -29.77 69.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 92.7 m -74.97 -34.25 62.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.017 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.22 -11.8 39.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.64 -14.51 56.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.661 ' CG ' HD12 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -107.27 -79.1 0.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.64 28.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HE ' HD11 ' A' ' 4' ' ' ILE . 10.2 mmt180 -102.04 -158.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.25 -54.77 2.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 22' ' ' CYS . . . -149.16 -159.86 8.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CD1' ' NE2' ' A' ' 19' ' ' HIS . 15.8 p90 -98.29 161.68 13.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -132.53 -67.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.971 . . . . 0.0 110.633 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.761 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.3 p90 -178.42 156.25 0.93 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.266 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -99.89 101.1 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 109.903 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.594 ' HG ' ' HE1' ' A' ' 39' ' ' TYR . 1.3 p -90.56 149.6 22.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.94 112.38 1.91 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.23 -44.0 1.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' CA ' ' OD2' ' A' ' 8' ' ' ASP . . . -167.29 -176.04 37.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.554 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 7.8 tpt -110.06 167.44 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -1.076 . . . . 0.0 109.523 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 42.5 m-85 -133.68 139.91 46.73 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.011 -1.056 . . . . 0.0 110.377 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.757 ' HB2' HG23 ' A' ' 2' ' ' VAL . 55.7 m . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.452 -0.78 . . . . 0.0 110.124 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.08 0.467 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.559 ' NH2' ' CA ' ' A' ' 37' ' ' GLY . 2.7 tpt180 -148.25 116.2 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 110.124 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.819 HG21 ' SG ' ' A' ' 21' ' ' CYS . 15.5 mm -99.93 152.6 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.782 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.18 -64.88 2.12 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.934 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.756 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -74.88 17.5 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.625 1.329 . . . . 0.0 112.642 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -93.86 -29.92 15.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.524 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 21.2 t70 -84.2 -31.48 25.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mt-30 -73.47 -47.01 44.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.68 13.54 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.088 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 t -64.37 -43.51 72.51 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.679 -0.638 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.7 Cg_endo -76.29 5.08 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.536 1.282 . . . . 0.0 110.865 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 1.6 mmt180 -84.71 177.68 7.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 110.18 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.573 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.2 pt -53.68 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.895 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.4 t -81.54 -43.19 1.11 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.452 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -71.85 -4.19 14.63 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.288 1.152 . . . . 0.0 110.195 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 4.1 mm-40 -98.54 -8.56 26.36 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.383 -0.823 . . . . 0.0 109.43 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 11' ' ' CYS . 3.1 ttp180 -108.46 -46.38 3.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.077 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -62.41 -30.22 71.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -80.35 -13.47 59.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.819 ' SG ' HG21 ' A' ' 4' ' ' ILE . 6.7 t -68.92 -45.15 71.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 110.148 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.26 -39.36 59.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 110.238 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -20.72 66.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.97 -30.09 21.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 110.186 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLY . 32.0 m80 -101.4 46.32 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.53 64.34 1.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -131.61 -178.23 4.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.249 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -93.74 -91.31 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -143.99 141.68 10.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD1' ' HE3' ' A' ' 38' ' ' MET . 7.0 t80 -46.69 136.54 7.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -112.39 -54.75 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.824 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.4 p90 -177.86 144.64 0.36 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.538 -0.726 . . . . 0.0 109.946 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -85.67 113.4 21.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.103 -0.998 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -146.61 176.26 9.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.751 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 47.52 57.49 7.37 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 40.96 38.79 1.77 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.559 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -173.97 -170.24 37.11 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -115.13 157.66 23.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.064 -1.257 . . . . 0.0 110.413 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.722 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 19.0 m-85 -128.6 134.54 48.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.495 ' HB3' HG11 ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.396 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.543 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 5.6 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.331 0.586 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 3.5 tpt180 -147.91 120.17 8.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.226 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.889 HG21 ' SG ' ' A' ' 21' ' ' CYS . 11.8 mm -99.71 146.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.924 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.55 -67.24 2.05 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.014 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.763 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -74.91 20.27 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.634 1.334 . . . . 0.0 112.617 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.665 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.36 -27.47 16.05 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.614 -1.304 . . . . 0.0 108.034 178.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 -22.41 25.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -86.91 -44.22 11.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.0 11.92 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.412 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.53 -42.46 65.76 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.589 -0.694 . . . . 0.0 111.306 -179.719 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.26 6.31 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.45 1.237 . . . . 0.0 111.001 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -85.18 -177.71 6.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 0.0 110.12 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.5 pt -54.29 -165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.611 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.1 t -80.81 -44.04 1.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 111.7 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -70.8 -10.71 28.28 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.372 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -81.31 -22.91 38.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.239 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.561 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 2.3 ttm180 -97.74 -47.26 5.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 109.684 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -34.08 66.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.989 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -82.41 -19.14 39.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.889 ' SG ' HG21 ' A' ' 4' ' ' ILE . 30.5 t -61.2 -43.59 98.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.49 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.06 -24.94 58.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 110.307 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -83.58 -19.91 34.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -13.14 43.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.095 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.672 ' CB ' HD12 ' A' ' 4' ' ' ILE . 7.5 m80 -117.55 39.18 3.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 0.0 110.134 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 44.35 63.79 2.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.596 ' CD ' HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -132.52 -152.05 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -1.136 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 47.0 m -119.99 -130.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.151 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -98.81 135.76 12.32 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.459 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 24.7 p90 -41.65 130.32 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.104 . . . . 0.0 110.249 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.83 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -98.64 -60.75 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.643 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.83 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 11.7 p90 -178.16 148.56 0.5 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.144 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -93.16 113.26 25.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 109.855 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.7 165.48 11.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.66 120.85 23.24 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.1 -21.59 15.3 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 160.2 177.03 32.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 11.6 ttt -100.45 167.2 10.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -1.114 . . . . 0.0 109.922 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.782 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 65.0 m-85 -139.09 148.23 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.669 HG21 ' HG3' ' A' ' 27' ' ' ARG . 18.6 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.236 0.541 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.2 tpt180 -147.94 120.11 8.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 110.259 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.9 HG21 ' SG ' ' A' ' 21' ' ' CYS . 13.0 mm -100.1 151.06 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.97 -66.61 2.0 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.795 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.06 18.42 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.661 1.348 . . . . 0.0 112.679 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.705 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.1 m -94.08 -30.01 14.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.629 -1.294 . . . . 0.0 107.912 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.472 ' N ' ' HB2' ' A' ' 38' ' ' MET . 23.8 t0 -84.16 -22.92 30.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.73 -46.45 10.69 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.2 p -91.1 12.91 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -64.33 -42.61 68.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 111.289 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.9 Cg_endo -75.49 4.2 5.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.333 1.175 . . . . 0.0 110.909 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.516 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.2 mmt-85 -84.42 -179.82 7.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.087 -1.008 . . . . 0.0 109.84 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.506 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 6.1 pt -53.63 -168.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.9 t -81.38 -43.05 1.13 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.776 . . . . 0.0 111.379 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -71.9 -3.73 13.75 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.306 1.161 . . . . 0.0 110.256 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -91.21 -13.51 32.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -0.807 . . . . 0.0 109.32 179.085 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 6.1 ttm180 -109.7 -41.55 4.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 110.036 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -31.38 64.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.067 -1.02 . . . . 0.0 109.835 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.83 -19.64 30.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.9 ' SG ' HG21 ' A' ' 4' ' ' ILE . 13.0 t -59.14 -42.65 91.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.3 m -77.59 -38.62 47.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.995 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -20.92 66.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 -18.03 34.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CB ' HD12 ' A' ' 4' ' ' ILE . 19.1 m80 -111.0 34.93 3.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.09 58.36 7.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.669 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -118.86 -151.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -1.115 . . . . 0.0 110.243 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -86.99 0.63 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -0.832 . . . . 0.0 110.257 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.53 136.4 6.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.553 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 16.1 p90 -43.54 122.73 2.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -1.159 . . . . 0.0 110.253 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.41 -59.56 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.761 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.4 p90 -178.25 151.29 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 110.226 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -93.12 114.0 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.721 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.25 161.82 13.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.389 -0.819 . . . . 0.0 110.31 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 122.62 30.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -27.1 9.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 166.47 176.37 37.56 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.542 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -93.65 165.01 12.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.163 . . . . 0.0 110.023 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.624 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.8 m-85 -138.02 142.81 40.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 110.052 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.833 HG21 ' HG3' ' A' ' 27' ' ' ARG . 31.3 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.253 0.549 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.1 tpt180 -148.23 118.87 7.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.891 HG21 ' SG ' ' A' ' 21' ' ' CYS . 11.1 mm -102.77 153.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.988 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.73 -68.1 1.65 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.823 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.735 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.15 20.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.671 1.353 . . . . 0.0 112.663 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.702 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.14 -29.01 15.36 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 107.78 178.398 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.523 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.5 p30 -85.83 -25.5 26.24 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 tt0 -82.96 -44.32 15.44 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 11.24 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.43 -44.01 73.86 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 111.057 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -76.78 5.58 4.76 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.544 1.286 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 14' ' ' ILE . 26.4 mmt180 -85.93 -175.48 5.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.093 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.803 HD11 ' OE2' ' A' ' 17' ' ' GLU . 6.8 pt -53.83 -167.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.8 t -81.55 -43.16 1.11 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 111.485 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.18 -5.22 16.53 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.286 1.15 . . . . 0.0 110.264 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.803 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -87.44 -14.39 40.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.278 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 ttm180 -106.26 -49.57 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.474 -0.766 . . . . 0.0 110.021 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.7 m-70 -55.01 -38.92 68.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.018 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -79.0 -19.98 50.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.913 . . . . 0.0 110.32 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.891 ' SG ' HG21 ' A' ' 4' ' ' ILE . 18.4 t -59.85 -40.3 88.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 110.502 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.14 -32.11 61.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -78.61 -16.97 56.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 110.233 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.44 -19.58 29.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.585 ' HB2' HD12 ' A' ' 4' ' ' ILE . 5.8 m80 -115.35 33.5 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 110.292 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . 53.36 71.13 0.74 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.833 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -140.27 -153.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -1.178 . . . . 0.0 110.298 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 84.6 p -120.06 -134.52 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.34 135.2 12.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.619 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -46.62 131.76 11.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -1.163 . . . . 0.0 110.332 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.799 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -97.54 -56.22 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.799 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.9 p90 -177.0 -177.49 0.76 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.61 -0.681 . . . . 0.0 109.988 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -125.06 115.25 20.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.507 ' HG ' ' HE1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -107.23 147.62 29.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.212 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.87 127.03 19.12 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.02 -44.9 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.87 169.67 42.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.523 ' N ' ' HB3' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -95.64 163.87 13.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -1.168 . . . . 0.0 110.029 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 82.3 m-85 -134.94 149.2 50.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.316 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.703 ' HB3' HG22 ' A' ' 2' ' ' VAL . 1.1 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 40' ' ' CYS . 2.6 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.274 0.559 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.52 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 3.1 tpt180 -147.51 122.33 9.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.868 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.2 mm -99.26 150.26 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.687 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.54 -67.33 1.89 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.087 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.771 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.25 17.81 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.638 1.336 . . . . 0.0 112.804 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.715 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.24 -27.13 16.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.642 -1.286 . . . . 0.0 108.031 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.464 ' HB2' ' N ' ' A' ' 38' ' ' MET . 30.0 t0 -86.1 -23.2 26.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.412 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 tm0? -88.03 -44.67 10.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -91.12 11.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.98 . . . . 0.0 109.598 179.328 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.592 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.57 -42.29 64.18 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.777 . . . . 0.0 111.242 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.2 Cg_endo -76.58 5.46 4.75 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.456 1.24 . . . . 0.0 110.858 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -85.36 -177.75 6.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 110.18 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.563 HD11 ' CD ' ' A' ' 17' ' ' GLU . 13.7 pt -55.5 -164.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.668 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 46.3 t -81.3 -45.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.528 -0.733 . . . . 0.0 111.497 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.37 -4.14 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.272 1.143 . . . . 0.0 110.436 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -89.89 -14.78 33.53 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.241 -0.912 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.55 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -108.12 -42.46 4.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.739 . . . . 0.0 110.034 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -32.26 69.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.188 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 37.7 tt0 -86.68 -12.28 48.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.868 ' SG ' HG21 ' A' ' 4' ' ' ILE . 12.8 t -70.67 -36.61 73.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.23 -49.6 13.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.205 -0.935 . . . . 0.0 110.463 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -64.52 -34.5 78.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.21 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -68.13 -18.6 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.206 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -97.87 -74.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.167 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.84 34.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.546 ' CG ' HD11 ' A' ' 4' ' ' ILE . 2.7 mmt180 -104.4 -153.07 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -1.232 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -119.57 -43.65 2.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.132 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -169.0 130.63 2.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 1.7 p90 -43.9 126.14 4.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -1.137 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.05 -56.63 2.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.809 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.6 p90 -177.7 -175.25 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.13 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -126.52 114.49 18.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.884 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.32 162.97 12.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 110.278 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.35 116.63 9.31 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.34 -28.87 6.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 171.88 175.26 39.98 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.531 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -99.88 164.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.126 179.919 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.613 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 46.0 m-85 -134.52 149.73 50.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 110.352 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.514 ' O ' HG22 ' A' ' 2' ' ' VAL . 1.7 t . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.413 -0.804 . . . . 0.0 110.206 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.756 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.8 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.309 0.575 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.504 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 1.5 tpt180 -147.36 121.02 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.922 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -102.7 148.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.0 -70.85 0.94 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.814 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.742 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -75.72 24.38 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.724 1.381 . . . . 0.0 112.832 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.51 -23.16 17.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.63 -1.294 . . . . 0.0 107.881 178.419 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 14.5 t70 -88.56 -28.33 20.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.129 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.418 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.4 tt0 -79.64 -43.92 21.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.15 11.35 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.453 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 t -65.11 -43.96 68.55 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -76.45 4.71 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.582 1.306 . . . . 0.0 110.697 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 29.3 mmt180 -83.06 -178.65 7.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.944 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' A' ' 17' ' ' GLU . 13.7 pt -54.2 -165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 54.7 t -81.62 -43.03 1.09 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 111.704 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.8 Cg_endo -70.91 -11.4 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.191 1.101 . . . . 0.0 110.345 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -82.42 -20.19 37.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.357 -0.839 . . . . 0.0 109.46 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.511 ' CZ ' ' O ' ' A' ' 11' ' ' CYS . 4.2 mtm180 -99.02 -49.32 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.463 -0.773 . . . . 0.0 109.888 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.685 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 7.5 m-70 -57.14 -37.36 71.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.864 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 53.6 tt0 -77.02 -20.33 56.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.084 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.922 ' SG ' HG21 ' A' ' 4' ' ' ILE . 24.3 t -64.34 -45.84 86.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 58.8 m -75.87 -40.43 54.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -73.25 -16.22 61.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.175 -0.953 . . . . 0.0 110.366 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.6 -32.55 19.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.584 ' CB ' HD12 ' A' ' 4' ' ' ILE . 9.2 m80 -94.87 54.48 1.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.296 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.52 26.35 0.65 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -106.11 172.67 6.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -1.196 . . . . 0.0 110.051 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -84.07 -143.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.907 . . . . 0.0 110.167 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -71.17 -151.58 0.9 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.685 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 13.5 p90 -113.94 151.76 31.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -1.169 . . . . 0.0 110.189 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.798 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -110.48 -63.83 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.496 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.798 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.2 p90 -178.15 -161.42 0.05 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.276 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -138.5 109.3 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -85.82 41.87 0.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.46 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . 77.96 -108.16 2.57 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.83 49.46 4.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.15 102.45 0.16 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.523 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.6 169.74 11.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 110.183 -179.853 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.581 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 70.8 m-85 -142.02 146.68 35.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 110.295 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.756 ' HB2' HG23 ' A' ' 2' ' ' VAL . 98.0 m . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 0.0 110.298 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 40' ' ' CYS . 4.0 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.21 0.529 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -148.33 131.52 16.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.318 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.766 HG21 ' SG ' ' A' ' 7' ' ' CYS . 16.9 mm -110.99 160.84 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.461 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -85.86 -63.37 1.54 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.519 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.779 ' O ' HG12 ' A' ' 10' ' ' VAL . 40.6 Cg_endo -74.6 15.74 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.645 1.339 . . . . 0.0 112.372 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.766 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.3 m -93.25 -22.74 18.83 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.545 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 p30 -88.23 -29.61 20.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.016 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.451 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -79.09 -45.24 20.48 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.302 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -91.11 13.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.393 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 t -64.43 -44.99 77.21 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.474 -0.766 . . . . 0.0 110.701 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 48.4 Cg_endo -77.13 5.77 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.592 1.312 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 10' ' ' VAL . 4.2 mmp_? -83.29 179.28 7.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 110.064 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.61 HD11 ' CD ' ' A' ' 17' ' ' GLU . 7.6 pt -54.09 -166.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -78.76 -45.71 1.87 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 111.6 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -69.62 -6.82 19.45 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.282 1.148 . . . . 0.0 110.53 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.61 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -89.18 -19.57 25.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.102 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 7.0 ttm180 -99.31 -52.32 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.875 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.547 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 17.3 m80 -57.51 -33.64 68.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.896 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.23 -21.21 46.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 110.179 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.758 ' SG ' HG21 ' A' ' 4' ' ' ILE . 10.0 t -65.42 -45.29 84.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.902 . . . . 0.0 110.205 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.91 -43.99 33.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.53 -21.78 66.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.867 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -21.27 25.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.495 ' CB ' HD12 ' A' ' 4' ' ' ILE . 19.7 m80 -102.45 14.91 30.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.266 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 27' ' ' ARG . . . 71.46 64.49 2.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HD3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -134.66 -158.3 0.87 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -1.175 . . . . 0.0 110.159 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 -89.71 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -145.61 144.87 13.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.564 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 1.4 p90 -42.58 119.86 1.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -1.158 . . . . 0.0 110.2 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.787 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -99.65 -56.18 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.488 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.787 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 13.4 p90 -178.03 129.29 0.14 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.373 -178.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -74.25 115.86 14.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 179.374 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.31 167.4 10.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.254 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.98 143.29 11.65 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.77 -50.73 2.0 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 8' ' ' ASP . . . -173.09 -139.34 2.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.541 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 9.5 ttt -126.81 162.58 25.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -1.17 . . . . 0.0 109.913 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.2 m-85 -135.24 148.07 49.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 111.015 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.549 ' HB2' HG23 ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.497 -0.752 . . . . 0.0 110.171 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.834 HG21 ' HG3' ' A' ' 27' ' ' ARG . 34.5 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.07 0.462 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.5 tpt180 -146.85 121.16 9.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.924 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.3 mm -101.17 149.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.557 -0.714 . . . . 0.0 109.545 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.32 -70.51 1.05 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.163 -1.017 . . . . 0.0 110.788 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.18 25.66 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.757 1.398 . . . . 0.0 112.746 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.78 -26.92 16.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.62 -1.3 . . . . 0.0 107.915 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 37' ' ' GLY . 1.8 t70 -87.32 -24.32 24.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 28.7 mt-30 -84.57 -41.66 16.22 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.66 12.1 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 22.8 t -64.96 -41.37 54.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.0 Cg_endo -76.83 5.28 5.0 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.344 1.181 . . . . 0.0 110.74 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.547 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 2.1 mmt180 -83.25 179.42 7.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.127 -0.983 . . . . 0.0 110.182 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.0 pt -54.23 -165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.652 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.6 t -79.3 -45.19 1.68 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 111.448 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.3 Cg_endo -70.99 -4.51 14.99 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.287 1.151 . . . . 0.0 110.361 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 3.1 mm-40 -93.18 -15.74 25.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.558 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtm180 -104.85 -50.31 3.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.08 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.473 ' NE2' ' CE1' ' A' ' 30' ' ' TYR . 20.3 m80 -61.49 -37.07 82.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.24 -0.913 . . . . 0.0 110.117 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.6 tt0 -74.53 -20.0 60.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.924 ' SG ' HG21 ' A' ' 4' ' ' ILE . 15.5 t -62.0 -40.93 97.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 83.9 m -76.18 -50.18 15.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -14.09 62.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.49 -33.27 19.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.928 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.607 ' CB ' HD12 ' A' ' 4' ' ' ILE . 4.0 m80 -96.51 50.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.146 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.83 43.24 6.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.834 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -119.53 -167.37 1.4 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -1.117 . . . . 0.0 110.216 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 4.8 t -102.14 -144.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.19 169.27 53.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' CE1' ' NE2' ' A' ' 19' ' ' HIS . 17.8 p90 -71.01 147.26 48.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -1.117 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -113.27 -69.6 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.741 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 12.1 p90 -178.6 152.19 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.425 -178.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 91.2 m -97.96 113.09 24.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' GLY . 5.2 p -93.88 30.16 1.91 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.934 . . . . 0.0 110.525 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.89 127.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.47 -19.75 30.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 177.78 139.41 3.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.534 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 8.4 ttt -103.18 169.9 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -1.13 . . . . 0.0 110.014 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.761 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 25.5 m-85 -134.45 154.2 51.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 70.8 m . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.7 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.177 0.513 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.494 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 3.7 tpt180 -147.08 118.26 7.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 110.117 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.907 HG21 ' SG ' ' A' ' 21' ' ' CYS . 7.9 mm -99.85 147.91 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -0.771 . . . . 0.0 109.862 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.467 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -64.2 -69.66 1.27 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.391 -0.909 . . . . 0.0 110.953 -179.059 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.694 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.4 Cg_endo -75.26 22.79 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.553 1.291 . . . . 0.0 112.658 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.6 -26.14 16.49 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.737 -1.227 . . . . 0.0 107.931 178.532 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.4 p30 -88.6 -30.19 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 34.6 tt0 -75.92 -43.83 43.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.408 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 9.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.417 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.07 -41.97 57.79 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 111.075 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 50.0 Cg_endo -79.42 21.02 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.441 1.232 . . . . 0.0 111.522 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -104.87 -169.59 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.795 -1.191 . . . . 0.0 110.031 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 8.7 pt -52.92 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.279 -0.888 . . . . 0.0 110.641 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.6 t -82.55 -42.87 0.94 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.8 Cg_endo -72.06 -7.83 21.76 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.214 1.113 . . . . 0.0 110.278 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -85.95 -15.2 42.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.035 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtp180 -104.16 -54.02 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.097 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 30' ' ' TYR . 24.5 m-70 -59.43 -35.59 74.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.1 -20.61 57.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 110.095 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.907 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.7 t -67.1 -39.28 86.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 73.0 m -75.1 -29.31 60.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.319 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -87.65 -16.23 35.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.368 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.32 -29.68 21.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.704 ' CB ' HD12 ' A' ' 4' ' ' ILE . 39.0 m80 -95.13 45.81 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.84 41.36 5.81 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.753 ' HD3' HD11 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -116.56 -163.34 0.9 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 0.0 110.376 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.8 p -95.18 -140.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -90.2 -146.11 14.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.554 ' CD2' ' HE1' ' A' ' 38' ' ' MET . 1.9 t80 -114.37 124.82 52.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.337 -1.096 . . . . 0.0 110.151 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.822 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -98.86 -57.91 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.146 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.822 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.3 p90 -178.19 -172.65 0.32 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.323 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.485 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -127.22 114.84 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.607 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -94.65 147.92 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 110.336 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.07 104.55 0.83 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -30.19 4.32 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.64 152.02 17.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.558 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -93.0 160.53 14.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.157 . . . . 0.0 110.095 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 27.2 m-85 -131.04 140.74 50.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.346 -0.846 . . . . 0.0 110.388 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.801 ' HB2' HG23 ' A' ' 2' ' ' VAL . 95.7 m . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.119 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.296 0.57 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG21 ' HG3' ' A' ' 27' ' ' ARG . 7.0 m -123.41 -161.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.181 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.51 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.9 tpt180 -146.02 121.44 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.917 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.1 mm -100.18 148.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.597 -0.689 . . . . 0.0 109.933 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.29 -68.66 1.58 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.928 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.779 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.6 Cg_endo -75.2 22.6 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.748 1.394 . . . . 0.0 112.66 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.554 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.29 -28.45 15.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.638 -1.288 . . . . 0.0 107.84 178.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.8 t70 -84.15 -23.58 30.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -84.9 -45.74 11.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.92 13.49 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.17 -0.956 . . . . 0.0 109.395 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.3 -45.4 78.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 110.854 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -77.19 6.89 3.99 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.697 1.367 . . . . 0.0 110.804 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.643 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.8 mmp_? -83.14 178.4 8.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -0.99 . . . . 0.0 109.985 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.48 HG12 ' HB2' ' A' ' 17' ' ' GLU . 5.9 pt -53.34 -168.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 110.64 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -80.61 -44.1 1.31 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 111.623 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.06 -5.26 16.6 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.22 1.116 . . . . 0.0 110.213 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -92.86 -19.45 21.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.164 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 8.8 ttp180 -97.16 -45.68 6.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.537 -0.727 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -36.51 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 109.777 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -75.01 -16.73 60.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 110.146 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.917 ' SG ' HG21 ' A' ' 4' ' ' ILE . 44.6 t -67.81 -50.35 57.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 74.1 m -74.81 -21.45 59.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 109.985 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.14 -16.82 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.62 -31.8 19.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.575 ' HB2' HD12 ' A' ' 4' ' ' ILE . 36.4 m80 -95.61 49.62 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.67 42.71 6.18 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.612 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -124.99 -179.88 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -1.172 . . . . 0.0 110.196 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 1.9 m -83.49 -141.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.42 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 18.1 p90 -92.16 132.14 36.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.667 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.38 -62.73 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.667 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.3 p90 -178.29 156.24 0.96 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -98.6 112.93 24.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -117.11 134.13 55.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.366 -0.833 . . . . 0.0 110.299 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.5 -153.04 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.83 43.92 3.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -165.71 138.96 5.51 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.491 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 2.3 ttt -101.4 167.25 10.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -1.17 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.656 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 75.1 m-85 -136.1 147.25 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.567 ' HB2' HG23 ' A' ' 2' ' ' VAL . 79.6 m -108.66 166.16 11.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.154 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.3 0.571 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.763 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.4 m -133.54 -168.7 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 110.512 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.528 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 1.4 tpt180 -147.03 122.46 10.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.318 -0.864 . . . . 0.0 110.063 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.7 mm -102.53 147.61 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 109.959 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -70.24 1.11 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.6 Cg_endo -74.99 23.15 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.649 1.342 . . . . 0.0 112.792 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.527 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.49 -29.52 14.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.631 -1.293 . . . . 0.0 107.669 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' CG ' ' CA ' ' A' ' 37' ' ' GLY . 1.1 t0 -84.89 -26.87 27.04 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 3.6 mt-30 -79.43 -44.28 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.77 12.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.586 ' SG ' ' HE3' ' A' ' 38' ' ' MET . 1.7 t -64.45 -44.17 74.21 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.479 -0.763 . . . . 0.0 110.841 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -77.81 6.16 4.75 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.572 1.301 . . . . 0.0 110.746 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.566 ' HG3' HG23 ' A' ' 10' ' ' VAL . 3.0 mmt180 -83.59 -175.93 6.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.55 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.6 pt -54.28 -165.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.55 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.626 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.3 t -82.1 -42.4 1.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 111.607 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.97 -9.27 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.267 1.141 . . . . 0.0 110.559 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.25 -12.3 52.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.398 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.578 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 5.8 ttp180 -109.42 -55.07 2.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 4.2 m-70 -53.83 -31.9 50.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -84.57 -23.72 29.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.375 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.0 t -60.39 -32.53 71.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.426 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' SER . 86.1 m -76.18 -33.4 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -89.94 -8.24 52.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.327 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.39 -16.09 38.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.562 ' HB2' HD12 ' A' ' 4' ' ' ILE . 38.7 m-70 -115.89 38.97 3.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 50.67 31.76 23.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -106.31 -168.82 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -1.152 . . . . 0.0 110.273 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.511 ' CB ' ' OXT' ' A' ' 41' ' ' ASN . 16.2 m -83.34 -134.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.46 -176.33 21.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -68.83 127.9 34.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -1.096 . . . . 0.0 110.196 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.872 ' HB2' ' N ' ' A' ' 41' ' ' ASN . . . -110.31 -68.88 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.452 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.3 p90 -178.61 150.37 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.514 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -90.32 118.95 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.424 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 37' ' ' GLY . 1.1 t -135.62 139.82 44.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.62 -157.05 34.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.91 43.64 3.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.586 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 1.9 ttt -98.83 168.99 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.027 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 25.7 m-85 -131.45 145.81 51.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.899 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.763 ' HB2' HG23 ' A' ' 2' ' ' VAL . 59.9 m -109.43 123.01 48.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.287 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.872 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 1.2 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.348 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.196 0.522 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 m -125.48 -178.45 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.577 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -147.98 131.15 16.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.791 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.4 mm -106.41 155.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.771 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.441 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -74.24 -67.15 1.82 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.744 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.9 Cg_endo -74.66 17.95 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.629 1.331 . . . . 0.0 112.486 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.1 m -93.79 -26.55 16.91 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.536 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.0 p30 -88.76 -29.33 19.87 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 tm0? -76.84 -44.27 32.97 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.5 p -90.51 12.55 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.354 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.7 t -64.75 -43.78 70.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.723 -0.611 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.35 4.32 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.521 1.274 . . . . 0.0 110.852 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 mtt180 -85.09 -179.17 6.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 109.998 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 7.4 pt -53.72 -167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.629 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.63 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.4 t -82.4 -42.65 0.96 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 111.564 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.6 Cg_endo -72.09 -2.15 11.14 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.281 1.148 . . . . 0.0 110.378 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -96.42 -10.56 27.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 109.454 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.596 ' HD2' ' CD2' ' A' ' 30' ' ' TYR . 10.7 ttm180 -109.57 -47.96 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -58.26 -28.92 65.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -84.13 -20.43 32.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.923 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.4 t -61.95 -45.87 91.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.36 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.4 -40.12 58.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -68.88 -19.09 64.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 110.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -29.48 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.365 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -97.82 4.3 49.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.242 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . 77.22 74.48 0.98 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -135.66 -156.66 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.184 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.461 ' HB3' ' OXT' ' A' ' 41' ' ' ASN . 28.3 t -102.07 -89.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -153.9 151.19 22.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.672 ' CD2' ' HE2' ' A' ' 38' ' ' MET . 14.5 t80 -44.08 119.57 1.81 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.245 . . . . 0.0 110.091 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -105.5 -58.34 1.91 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.368 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.779 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 13.6 p90 -177.34 138.07 0.23 Allowed 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.025 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -87.01 102.37 14.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.095 -1.003 . . . . 0.0 110.118 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 35' ' ' GLY . 1.4 p -81.19 161.64 23.93 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.5 -0.75 . . . . 0.0 110.25 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -43.16 -56.0 4.78 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.06 -72.85 0.41 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA3' ' NH2' ' A' ' 3' ' ' ARG . . . -149.19 -135.28 2.47 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.672 ' HE2' ' CD2' ' A' ' 30' ' ' TYR . 15.4 tpt -121.69 146.97 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.898 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.0 m-85 -128.21 141.99 51.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.993 -1.067 . . . . 0.0 111.083 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -107.14 149.18 27.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.48 -0.763 . . . . 0.0 110.127 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.462 ' OXT' ' O ' ' A' ' 40' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.276 0.56 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 40' ' ' CYS . 1.8 m -126.08 -172.69 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 110.292 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.2 tpt180 -146.53 122.94 11.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 110.152 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -104.14 151.47 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.766 . . . . 0.0 110.02 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.53 -68.97 1.49 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.725 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.773 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.7 Cg_endo -74.95 22.23 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.778 1.41 . . . . 0.0 112.789 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.638 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.18 -29.77 14.95 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.7 t70 -82.79 -25.02 33.16 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.64 -46.26 13.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.0 p -90.7 14.72 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.23 -0.919 . . . . 0.0 109.348 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 t -64.1 -44.1 76.45 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.658 -0.651 . . . . 0.0 111.111 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.1 Cg_endo -77.8 8.74 3.27 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.568 1.299 . . . . 0.0 111.113 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.629 ' HG3' HG23 ' A' ' 10' ' ' VAL . 1.1 mmm180 -85.22 179.14 7.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 0.0 110.22 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.3 pt -53.98 -166.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.61 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -79.07 -44.7 1.74 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.49 -0.756 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.2 Cg_endo -71.02 -5.71 17.58 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.384 1.202 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.56 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 1.8 mm-40 -88.08 -21.73 24.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.36 -0.838 . . . . 0.0 109.33 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 4.9 ttp180 -100.11 -44.99 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -0.767 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -59.2 -31.7 69.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -82.66 -17.97 42.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.342 -0.849 . . . . 0.0 110.018 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 4' ' ' ILE . 31.9 t -68.05 -49.69 59.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 84.3 m -75.12 -29.53 60.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -78.73 -21.82 47.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.11 24.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.299 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.687 ' CB ' HD12 ' A' ' 4' ' ' ILE . 1.9 m80 -102.28 51.07 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 110.403 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.06 23.2 2.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -112.29 175.51 5.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -1.231 . . . . 0.0 110.063 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 2.3 t -88.29 -143.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -72.26 -154.49 2.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.48 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 22.4 p90 -105.88 144.65 32.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -1.105 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -105.07 -65.42 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.501 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.74 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.6 p90 -178.3 148.79 0.49 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.521 -0.737 . . . . 0.0 110.297 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -87.87 119.78 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -129.25 135.27 48.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.942 . . . . 0.0 110.473 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.99 -149.7 46.9 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.42 25.4 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -151.77 157.99 27.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.521 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 10.6 ttt -106.8 167.01 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -1.203 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 35.5 m-85 -129.19 142.11 50.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.683 ' HB2' HG23 ' A' ' 2' ' ' VAL . 73.5 m -109.41 159.19 17.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.276 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.29 0.567 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 40' ' ' CYS . 30.0 m -139.71 -161.17 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 110.146 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 2.9 tpt180 -147.92 117.78 7.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.74 HG21 ' SG ' ' A' ' 7' ' ' CYS . 13.3 mm -100.46 157.52 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 0.0 109.851 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.72 -63.8 1.88 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.636 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.792 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.9 Cg_endo -74.98 16.36 0.66 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.681 1.358 . . . . 0.0 112.476 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.74 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.3 m -93.81 -27.99 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.4 t70 -89.42 -25.38 21.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -79.83 -45.1 19.33 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.2 p -91.1 14.22 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.316 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 t -64.51 -44.33 74.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 110.995 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.7 Cg_endo -76.71 5.65 4.68 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.559 1.294 . . . . 0.0 110.996 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.563 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -85.64 -179.73 6.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -0.998 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.59 HD11 ' OE1' ' A' ' 17' ' ' GLU . 14.9 pt -54.55 -165.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.278 -0.889 . . . . 0.0 110.737 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.606 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.0 t -78.71 -46.57 1.87 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.3 Cg_endo -68.77 -10.76 30.02 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.294 1.155 . . . . 0.0 110.256 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.59 ' OE1' HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -84.42 -21.91 30.6 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.348 -0.845 . . . . 0.0 109.219 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.7 mtm180 -95.89 -49.58 5.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -56.53 -19.23 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.871 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -96.78 -22.5 16.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' HB3' HG11 ' A' ' 10' ' ' VAL . 2.9 p -59.32 -36.76 76.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.9 OUTLIER -81.21 -44.1 18.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.172 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -67.82 -13.86 62.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 110.294 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.33 -15.28 55.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 110.239 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.712 ' CB ' HD12 ' A' ' 4' ' ' ILE . 2.0 m-70 -111.09 -8.21 14.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 99.15 47.71 1.83 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.652 ' HG3' HG21 ' A' ' 2' ' ' VAL . 6.8 mpt_? -114.1 -164.44 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -1.14 . . . . 0.0 110.158 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 -75.34 0.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.65 138.84 7.4 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.4 p90 -46.31 127.76 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.153 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -96.21 -59.08 1.91 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.858 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.5 p90 -178.17 160.47 1.38 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.537 -0.727 . . . . 0.0 109.933 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.6 OUTLIER -100.43 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 t -135.84 174.05 11.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 0.0 110.461 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.89 -147.79 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.21 39.34 2.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . -174.75 -164.9 30.32 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.537 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -112.35 177.42 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -1.131 . . . . 0.0 110.163 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.906 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 61.4 m-85 -143.4 135.98 27.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.973 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -121.9 117.67 27.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.576 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.562 ' H ' ' HB2' ' A' ' 31' ' ' ALA . 1.8 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.23 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.279 0.562 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.964 HG21 ' HD2' ' A' ' 27' ' ' ARG . 23.3 m -127.72 -158.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.508 ' CD ' ' O ' ' A' ' 38' ' ' MET . 4.5 tpt180 -147.05 121.27 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.208 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.903 HG21 ' SG ' ' A' ' 21' ' ' CYS . 12.5 mm -101.07 148.71 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.493 -0.754 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.66 -66.95 2.07 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.806 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.75 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.8 Cg_endo -74.57 20.25 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.688 1.362 . . . . 0.0 112.667 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.03 -24.34 17.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 107.701 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.458 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 36.0 t70 -88.57 -27.21 21.53 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 14.5 mm-40 -80.16 -44.4 19.92 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.03 13.81 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.31 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.71 -47.07 76.38 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.518 -0.739 . . . . 0.0 110.925 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -75.17 4.05 5.17 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.755 1.397 . . . . 0.0 111.133 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 22.4 mmt180 -83.42 -175.51 5.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.022 -1.048 . . . . 0.0 110.262 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.664 HD11 ' OE2' ' A' ' 17' ' ' GLU . 13.7 pt -54.09 -165.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.335 -0.853 . . . . 0.0 110.668 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -82.34 -42.17 0.96 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.11 -10.37 25.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.213 1.112 . . . . 0.0 110.472 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.664 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -83.75 -14.74 50.8 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.26 -47.82 3.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.488 ' NE2' ' CE1' ' A' ' 30' ' ' TYR . 22.4 m80 -58.87 -37.78 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.6 tm-20 -79.48 -21.91 44.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.903 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.1 t -61.04 -40.32 93.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.316 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.468 ' HA ' HG13 ' A' ' 4' ' ' ILE . 93.5 m -75.01 -52.48 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.0 110.275 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -12.64 59.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.313 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.55 -16.88 33.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -102.54 -17.2 15.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.92 34.06 1.74 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.964 ' HD2' HG21 ' A' ' 2' ' ' VAL . 16.2 mmt180 -103.42 -161.71 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -1.118 . . . . 0.0 110.282 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.66 -38.35 5.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.351 -0.843 . . . . 0.0 110.18 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.77 167.19 37.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CE1' ' NE2' ' A' ' 19' ' ' HIS . 29.8 p90 -69.78 146.32 51.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -1.162 . . . . 0.0 110.239 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -119.97 -66.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.826 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.8 p90 -178.48 163.38 1.55 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.429 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -103.99 114.87 29.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -144.86 158.41 43.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 57.69 54.26 38.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 43.35 26.96 0.67 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -146.68 -153.9 6.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.526 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -150.98 170.59 18.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 110.319 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.819 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 89.2 m-85 -143.52 144.82 32.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.808 ' O ' HG22 ' A' ' 2' ' ' VAL . 86.1 m -118.09 119.26 34.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.388 -0.82 . . . . 0.0 110.159 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' CYS . 3.9 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.26 0.553 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 40' ' ' CYS . 3.6 m -141.76 -164.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.295 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 38' ' ' MET . 4.8 tpt180 -146.77 119.43 8.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.331 -0.855 . . . . 0.0 110.04 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.882 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.6 mm -101.82 151.77 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.505 -0.747 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.15 -68.46 1.63 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.208 -0.996 . . . . 0.0 110.834 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -75.22 21.24 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.704 1.371 . . . . 0.0 112.627 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.661 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.29 -26.19 16.7 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.667 -1.271 . . . . 0.0 107.746 178.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.527 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.0 t0 -86.57 -24.35 25.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.42 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 mt-30 -85.13 -43.43 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.61 12.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.63 -45.24 76.1 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 110.792 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.3 Cg_endo -77.58 6.02 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.687 1.362 . . . . 0.0 110.737 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -85.84 -178.15 6.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 110.176 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.545 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.5 pt -53.66 -167.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.839 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.652 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.3 t -82.39 -41.04 0.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 111.815 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.9 Cg_endo -70.52 -13.19 32.54 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.085 1.045 . . . . 0.0 110.285 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.1 OUTLIER -84.89 -11.76 54.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 0.0 109.247 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 15.0 mtp180 -100.38 -54.06 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.969 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.7 m80 -57.62 -40.42 79.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.9 tt0 -73.34 -17.32 61.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.42 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.882 ' SG ' HG21 ' A' ' 4' ' ' ILE . 22.2 t -70.24 -45.9 65.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 0.0 110.446 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HA ' HG13 ' A' ' 4' ' ' ILE . 85.7 m -74.77 -28.69 60.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.067 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.92 -17.58 35.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.072 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.78 -4.21 58.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.612 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.41 -54.95 2.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.86 39.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.497 ' NE ' HD11 ' A' ' 4' ' ' ILE . 5.0 mmt180 -109.17 -164.49 0.94 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.351 -1.087 . . . . 0.0 110.129 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.3 m -120.11 -3.99 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 41' ' ' ASN . . . 162.79 174.13 32.32 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.718 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 12.0 p90 -95.44 146.85 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 110.193 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -112.63 -61.05 1.79 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.65 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.781 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.3 p90 -178.01 -161.99 0.06 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.189 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -134.74 120.85 19.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.63 162.72 19.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.329 -0.857 . . . . 0.0 110.389 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.03 129.94 44.24 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.08 -32.37 6.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 167.11 170.3 31.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.527 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -95.29 165.92 12.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.141 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 69.2 m-85 -131.61 143.34 50.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.758 ' O ' HG22 ' A' ' 2' ' ' VAL . 85.0 m -114.61 138.28 50.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 29' ' ' GLY . 2.2 t-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.19 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.529 ' CB ' ' OH ' ' A' ' 32' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.268 0.556 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.628 HG21 ' HG3' ' A' ' 27' ' ' ARG . 18.0 m -120.58 -158.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.246 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.544 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 2.8 tpt180 -146.8 120.66 9.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.892 . . . . 0.0 110.339 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.651 HG21 ' SG ' ' A' ' 7' ' ' CYS . 7.6 mm -102.24 152.99 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.505 -0.747 . . . . 0.0 109.663 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.15 -66.12 2.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.529 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.715 ' O ' HG12 ' A' ' 10' ' ' VAL . 43.1 Cg_endo -76.03 21.32 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.721 1.379 . . . . 0.0 112.582 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.16 -30.76 14.46 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 12.5 t70 -87.9 -31.04 19.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 81.9 mt-30 -70.99 -44.55 65.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.3 p -90.72 11.74 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 t -64.96 -43.66 68.85 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 110.826 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.1 Cg_endo -77.29 4.87 5.51 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.568 1.299 . . . . 0.0 110.65 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.4 mmt180 -83.31 -175.84 6.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.558 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.0 pt -54.13 -167.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.45 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 50.1 t -82.43 -42.35 0.95 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 111.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -71.78 -8.26 22.74 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.237 1.125 . . . . 0.0 110.168 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -94.23 -15.52 24.48 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.41 -0.806 . . . . 0.0 109.205 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 8.2 mtm180 -95.33 -54.47 3.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 24.4 m-70 -62.85 -24.41 67.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.739 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -86.82 -12.58 47.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.699 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HE2' ' A' ' 38' ' ' MET . 3.5 p -69.7 -38.08 76.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 0.0 110.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 m -75.16 -47.76 26.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.423 -0.798 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -73.03 -12.46 60.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -78.77 -26.44 44.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.614 ' HB2' HD12 ' A' ' 4' ' ' ILE . 2.1 m80 -105.18 50.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.41 37.22 3.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.628 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -111.02 -149.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.378 -1.072 . . . . 0.0 110.391 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.431 ' CB ' ' C ' ' A' ' 41' ' ' ASN . 1.2 m -106.35 -141.43 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.19 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.16 155.78 18.6 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CE1' ' SD ' ' A' ' 38' ' ' MET . 2.9 t80 -48.12 121.53 4.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -1.151 . . . . 0.0 110.252 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.87 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.64 -61.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 110.402 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.87 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.1 p90 -178.29 140.54 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -85.66 112.16 20.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.131 -0.981 . . . . 0.0 109.713 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.73 135.57 54.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.63 -152.59 30.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.46 41.72 3.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -164.7 165.0 37.25 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.584 ' HE2' ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -120.34 153.84 35.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.919 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.8 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.3 m-85 -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 35.1 m -113.08 176.6 4.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 0.0 110.343 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.431 ' C ' ' CB ' ' A' ' 28' ' ' SER . 14.7 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.219 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.27 0.557 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.977 HG22 ' O ' ' A' ' 40' ' ' CYS . 9.2 m -144.42 -160.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.538 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 1.3 tpt180 -147.87 118.34 7.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.261 -0.899 . . . . 0.0 110.077 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.741 HG21 ' SG ' ' A' ' 7' ' ' CYS . 11.9 mm -100.54 157.11 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 -66.81 1.68 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.097 -1.049 . . . . 0.0 110.599 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.765 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.8 Cg_endo -75.99 20.7 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.727 1.383 . . . . 0.0 112.706 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.741 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.17 -28.74 15.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.609 -1.307 . . . . 0.0 107.509 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.0 t70 -88.25 -30.31 19.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -73.26 -45.3 56.59 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.765 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.31 12.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.34 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 t -64.88 -43.37 68.35 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.611 -0.681 . . . . 0.0 111.358 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.5 Cg_endo -75.96 5.42 4.47 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.428 1.225 . . . . 0.0 111.023 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mmt180 -84.69 179.37 7.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.1 pt -54.39 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.158 -0.964 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -78.47 -45.64 2.04 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.801 . . . . 0.0 111.721 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.7 Cg_endo -68.91 -9.84 27.46 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.239 1.126 . . . . 0.0 110.297 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -87.81 -24.35 23.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.256 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -90.14 -49.18 6.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.62 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -60.47 -16.78 39.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 tt0 -96.49 -18.64 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.57 ' HB3' HG11 ' A' ' 10' ' ' VAL . 4.0 p -64.75 -37.22 86.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 1.2 m -78.95 -50.24 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 110.164 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.7 mtt-85 -64.76 -19.28 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.304 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -73.95 -22.52 59.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.466 ' HB2' HD12 ' A' ' 4' ' ' ILE . 2.4 m-70 -112.33 27.08 9.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 110.029 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 59.07 69.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.06 -151.26 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.282 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -111.07 -88.83 0.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.32 140.02 9.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.62 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.9 p90 -46.72 125.23 6.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.168 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.86 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -97.83 -60.91 1.47 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.106 -0.996 . . . . 0.0 110.338 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.86 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.2 p90 -178.28 142.65 0.26 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.013 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.8 OUTLIER -85.36 111.91 20.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.821 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -124.22 159.57 29.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.315 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.21 -150.74 0.46 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.33 42.7 2.7 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.95 145.07 8.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.538 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 8.2 ttt -87.23 159.72 18.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 110.043 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.761 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.1 m-85 -125.49 143.21 51.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.977 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -122.12 123.77 42.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.388 -0.82 . . . . 0.0 110.387 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.532 ' H ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.22 0.533 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.1 m -123.97 -163.19 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.4 tpt180 -147.04 121.36 9.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 110.285 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.889 HG21 ' SG ' ' A' ' 21' ' ' CYS . 5.7 mm -100.17 145.05 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.422 -0.799 . . . . 0.0 109.66 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . -57.55 -71.9 0.67 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.132 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.9 Cg_endo -76.76 25.73 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.632 1.332 . . . . 0.0 112.724 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -94.79 -21.83 18.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.73 -1.231 . . . . 0.0 108.164 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 3.7 p-10 -87.32 -24.51 24.28 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mt-30 -87.97 -42.53 12.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 109.482 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.88 -45.0 74.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 110.877 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 48.6 Cg_endo -77.44 8.53 3.26 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.639 1.336 . . . . 0.0 111.136 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.541 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 12.2 mmt180 -83.17 -179.17 7.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.039 -1.038 . . . . 0.0 110.049 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.543 HD12 ' HG2' ' A' ' 16' ' ' PRO . 13.6 pt -53.78 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.2 t -79.49 -44.07 1.62 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 111.22 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -72.6 -4.45 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.359 1.189 . . . . 0.0 110.285 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 3.0 mm-40 -96.31 -15.86 21.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -102.85 -50.94 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.481 ' NE2' ' CD1' ' A' ' 30' ' ' TYR . 47.3 m80 -61.54 -35.18 77.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.111 -0.993 . . . . 0.0 109.906 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.62 -19.31 59.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.145 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.889 ' SG ' HG21 ' A' ' 4' ' ' ILE . 15.2 t -62.76 -41.53 99.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.007 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 81.7 m -78.65 -25.01 44.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -86.14 -15.36 41.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.458 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.23 21.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.327 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.595 ' CB ' HD12 ' A' ' 4' ' ' ILE . 32.3 m80 -98.34 43.34 1.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.76 19.45 10.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -100.81 173.93 6.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -1.21 . . . . 0.0 110.181 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 3.1 t -82.2 -141.96 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.16 -158.49 27.78 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -96.67 141.62 29.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -1.153 . . . . 0.0 110.385 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -106.16 -60.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.74 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 17.8 p90 -178.43 146.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.253 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -94.73 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.465 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 35' ' ' GLY . 16.0 p -80.59 -143.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 110.44 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -56.17 -110.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.63 41.9 2.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.64 139.02 5.81 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.534 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 1.7 tpt -104.97 153.21 21.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.861 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 13.6 m-85 -127.29 149.25 50.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.721 ' HB2' HG23 ' A' ' 2' ' ' VAL . 74.4 m -108.49 167.14 10.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.455 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' SER . 1.1 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.259 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.253 0.549 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.749 HG21 ' HG3' ' A' ' 27' ' ' ARG . 23.7 m -145.12 -166.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' NH2' ' OD2' ' A' ' 8' ' ' ASP . 2.0 tpt180 -147.78 121.61 9.32 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.328 -0.858 . . . . 0.0 110.077 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.922 HG21 ' SG ' ' A' ' 21' ' ' CYS . 12.2 mm -99.94 152.51 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.989 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -72.76 -68.32 1.62 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.733 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.76 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.06 23.16 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.597 1.314 . . . . 0.0 112.596 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.63 -29.84 14.64 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.673 -1.267 . . . . 0.0 107.939 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 3.0 p30 -86.47 -24.89 25.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -81.25 -45.1 16.79 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -91.16 12.26 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.43 -44.75 76.35 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.54 -0.725 . . . . 0.0 110.893 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.8 Cg_endo -75.98 4.12 5.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.688 1.362 . . . . 0.0 110.647 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.589 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.5 mmp_? -83.62 -175.66 5.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 110.034 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.57 HD12 ' HG2' ' A' ' 16' ' ' PRO . 15.4 pt -55.72 -167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 110.724 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.629 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -82.55 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 111.642 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -72.29 -3.56 13.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.274 1.144 . . . . 0.0 110.393 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HB3' HG22 ' A' ' 10' ' ' VAL . 3.7 mt-10 -96.06 -12.78 24.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.377 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 mtm-85 -105.02 -49.39 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.47 ' NE2' ' CE1' ' A' ' 30' ' ' TYR . 49.9 m80 -60.63 -33.93 73.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.89 -14.53 58.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.922 ' SG ' HG21 ' A' ' 4' ' ' ILE . 13.5 t -64.31 -41.89 96.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 110.33 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.2 m -76.52 -46.24 27.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -64.84 -22.23 66.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.9 -22.5 29.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' CB ' HD12 ' A' ' 4' ' ' ILE . 6.8 m80 -105.97 7.91 32.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.484 ' O ' ' CD ' ' A' ' 27' ' ' ARG . . . 80.38 64.48 1.83 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.749 ' HG3' HG21 ' A' ' 2' ' ' VAL . 3.9 mpt_? -135.17 -178.23 5.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.422 ' HB2' ' OXT' ' A' ' 41' ' ' ASN . 12.1 m -87.92 -88.06 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -141.81 144.86 14.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 10.8 p90 -44.54 124.75 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.209 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.835 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.27 -60.57 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.835 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 11.0 p90 -178.18 158.39 1.18 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.066 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -106.56 106.62 17.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.796 179.567 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -106.59 137.92 43.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.84 -150.74 0.86 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.78 48.35 3.96 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -167.35 137.09 4.44 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.534 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 6.3 ttt -104.4 170.56 7.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.828 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 67.6 m-85 -143.71 153.05 42.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -115.24 151.42 34.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.422 ' OXT' ' HB2' ' A' ' 28' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.274 0.559 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.618 HG21 ' HG3' ' A' ' 27' ' ' ARG . 30.2 m -144.27 -165.52 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 110.276 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.0 tpt180 -147.7 121.32 9.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 110.18 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 25' ' ' HIS . 26.6 mm -101.71 156.31 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.27 -66.61 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.88 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.764 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -76.21 20.98 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.713 1.375 . . . . 0.0 112.736 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 8.5 t -94.49 -28.6 15.37 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.687 -1.258 . . . . 0.0 108.012 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 5.1 t0 -85.8 -24.21 26.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.99 -45.28 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.87 13.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.0 109.442 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.5 t -64.49 -41.94 62.28 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.539 -0.726 . . . . 0.0 111.501 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 44.3 Cg_endo -74.77 3.64 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.393 1.207 . . . . 0.0 110.999 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.56 177.83 7.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.041 -1.037 . . . . 0.0 109.794 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 9.5 pt -53.75 -166.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 110.731 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.8 t -77.69 -45.32 2.48 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 0.0 111.526 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.0 Cg_endo -68.53 -9.94 27.56 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.268 1.141 . . . . 0.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 9.2 mm-40 -91.69 -19.4 22.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.372 -0.83 . . . . 0.0 109.066 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 47.3 mtp180 -91.34 -45.39 8.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.506 -0.746 . . . . 0.0 109.766 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -18.84 65.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 110.242 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 2.3 tp10 -80.12 -13.54 59.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.709 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 9.2 p -69.8 -38.02 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.282 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 4.7 m -84.16 -46.67 11.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.368 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.477 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -70.92 -39.44 72.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.12 -0.987 . . . . 0.0 110.317 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.601 ' HB2' HD12 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -98.88 33.64 2.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 110.231 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 50.36 76.82 0.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG3' HG21 ' A' ' 2' ' ' VAL . 1.1 tpt180 -141.29 -157.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -1.156 . . . . 0.0 110.25 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 1.6 t -102.94 -140.56 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -98.2 143.59 16.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -43.2 134.29 3.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -1.127 . . . . 0.0 110.49 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -106.49 -59.25 1.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.856 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.3 p90 -178.11 142.75 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.491 -0.756 . . . . 0.0 110.129 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -86.57 117.17 25.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.985 . . . . 0.0 110.02 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -131.28 136.86 48.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.86 -156.35 24.0 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.12 49.77 4.16 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 39' ' ' TYR . . . 175.72 133.77 1.81 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.535 ' CE ' ' HB2' ' A' ' 30' ' ' TYR . 10.0 ttt -86.27 176.41 7.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -1.227 . . . . 0.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.862 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 76.6 m-85 -140.71 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.588 ' CB ' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -109.57 156.31 20.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.25 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.463 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 14.5 m-20 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.281 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.743 HG21 ' HG3' ' A' ' 27' ' ' ARG . 36.0 m -128.08 -155.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 0.0 110.185 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.8 tpt180 -146.13 121.14 10.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.903 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -101.42 150.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.627 -0.671 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.25 -68.95 1.49 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.83 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.728 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.41 22.46 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.656 1.345 . . . . 0.0 112.757 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.54 -24.39 17.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.64 -1.287 . . . . 0.0 107.77 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -88.87 -24.51 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 15.3 mt-30 -85.03 -43.02 14.31 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.35 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -64.81 -42.23 61.86 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.608 -0.683 . . . . 0.0 111.308 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -75.74 4.47 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.36 1.19 . . . . 0.0 110.825 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 3.1 mmp_? -83.31 177.06 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.854 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.3 pt -53.54 -168.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.938 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.634 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 t -78.28 -45.06 2.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 111.303 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.7 Cg_endo -70.21 -7.21 20.64 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.384 1.202 . . . . 0.0 110.301 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -91.85 -13.7 30.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 2.2 mtm180 -103.41 -44.79 5.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 109.813 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.531 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -60.39 -36.06 77.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -75.92 -14.35 60.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -0.837 . . . . 0.0 110.376 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.903 ' SG ' HG21 ' A' ' 4' ' ' ILE . 26.9 t -70.7 -48.01 56.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 86.7 m -75.13 -22.98 57.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -90.1 -19.77 23.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.181 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.17 24.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -99.3 43.12 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 110.354 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 47.41 39.6 14.69 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.743 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -120.75 -179.32 3.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -1.109 . . . . 0.0 110.186 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.459 ' HB2' ' OXT' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -80.52 -140.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.002 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . -92.87 -178.69 40.57 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 1.2 p90 -76.99 137.33 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.206 -1.173 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -106.99 -65.21 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 110.612 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.665 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.9 p90 -178.11 153.13 0.76 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.313 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -95.8 112.51 24.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.898 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.82 139.49 47.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.37 -149.89 0.87 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.04 45.09 3.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -162.94 151.93 21.87 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -115.09 163.16 16.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.366 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 51.8 m-85 -135.08 154.19 51.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.063 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.531 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 86.0 m -114.24 141.87 47.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.876 . . . . 0.0 110.598 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.626 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 1.2 t-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.313 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.236 0.541 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 40' ' ' CYS . 6.0 m -141.62 -165.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 110.056 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.3 tpt180 -147.16 119.11 8.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 0.0 110.201 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.738 HG21 ' SG ' ' A' ' 7' ' ' CYS . 11.1 mm -101.35 160.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 109.723 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.57 -66.01 1.67 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.565 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.776 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.6 Cg_endo -76.54 20.01 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.633 1.333 . . . . 0.0 112.594 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.738 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.28 -28.16 15.74 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.547 ' HB2' ' N ' ' A' ' 38' ' ' MET . 2.4 t70 -87.75 -31.1 19.83 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -46.0 51.6 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.29 11.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.336 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 t -64.79 -44.05 71.49 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.71 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.6 Cg_endo -75.25 3.83 5.4 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.523 1.275 . . . . 0.0 110.923 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.545 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -83.2 177.35 8.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.072 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 12.9 pt -52.92 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 0.0 110.939 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.625 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.9 t -76.52 -47.22 3.23 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 111.451 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.5 Cg_endo -67.97 -9.63 26.29 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.304 1.16 . . . . 0.0 110.151 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.0 mm-40 -94.69 -16.39 23.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.849 . . . . 0.0 109.195 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -93.93 -49.89 5.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.807 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -65.05 -20.68 66.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 109.954 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -89.07 -10.03 48.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.521 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . 5.5 p -72.16 -37.87 69.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.056 -1.028 . . . . 0.0 110.067 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -82.41 -35.4 27.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 110.237 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -74.12 -30.68 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.424 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.95 66.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.567 ' CE1' ' HG3' ' A' ' 6' ' ' PRO . 29.1 m80 -112.27 9.45 19.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 110.299 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.4 82.65 0.22 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.74 -143.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -1.182 . . . . 0.0 110.178 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 p -112.79 -74.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.191 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -167.6 138.47 5.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 4.5 t80 -42.94 121.97 2.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -1.118 . . . . 0.0 110.178 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.948 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -101.97 -61.12 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.802 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 14.0 p90 -178.42 134.17 0.14 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.184 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -79.78 112.27 16.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 109.523 179.316 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 9.7 p -88.29 31.75 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.35 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.59 126.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.97 -32.51 4.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.39 144.71 9.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.547 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 5.9 ttt -93.27 154.47 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -1.131 . . . . 0.0 110.021 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.948 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 13.6 m-85 -123.71 137.56 54.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.915 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -110.84 127.14 55.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 110.656 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.57 ' H ' ' HB2' ' A' ' 31' ' ' ALA . 3.2 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.091 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.279 0.561 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 40' ' ' CYS . 4.6 m -141.71 -159.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.148 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.7 tpt180 -147.29 123.03 10.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 25' ' ' HIS . 39.6 mm -99.57 156.95 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.657 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.67 -64.54 1.68 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.817 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.0 Cg_endo -75.53 14.23 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.729 1.384 . . . . 0.0 112.624 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 1.8 t -94.62 -21.4 18.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.565 -1.334 . . . . 0.0 107.959 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 3.4 t70 -87.04 -23.32 25.0 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -90.12 -44.87 9.5 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.96 13.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.215 -0.928 . . . . 0.0 109.674 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.26 -43.71 73.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.0 111.231 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.0 Cg_endo -76.29 5.03 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.454 1.239 . . . . 0.0 110.797 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -85.9 -176.82 6.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 110.196 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.7 pt -53.15 -167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.181 -0.949 . . . . 0.0 110.995 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.0 t -80.6 -42.26 1.27 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 0.0 111.739 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.66 -12.41 31.15 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.27 1.142 . . . . 0.0 110.289 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.543 ' OE1' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -81.51 -24.27 36.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 9.2 mtm180 -94.57 -46.07 7.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.447 -0.783 . . . . 0.0 109.987 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -18.95 49.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.0 110.076 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.8 OUTLIER -88.96 -22.26 23.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 4.9 p -59.16 -37.26 76.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 57.8 m -77.88 -42.26 33.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 0.0 110.289 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -22.61 67.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB2' ' OE2' ' A' ' 20' ' ' GLU . . . -81.88 -22.53 36.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.606 ' HB2' HD12 ' A' ' 4' ' ' ILE . 21.5 m-70 -110.4 22.28 15.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.323 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.46 71.91 0.66 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -125.3 -154.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -1.133 . . . . 0.0 110.197 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.05 -45.9 2.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.338 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -179.5 135.15 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -45.02 148.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 110.382 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -120.33 -60.98 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.803 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 10.3 p90 -178.11 145.41 0.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.5 OUTLIER -88.18 115.95 26.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 110.111 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -110.26 128.07 55.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 110.566 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 43.82 -146.31 1.34 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.2 3.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 3' ' ' ARG . . . -165.07 119.47 0.87 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 39' ' ' TYR . 1.5 tmt? -84.39 161.08 20.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 58.1 m-85 -131.13 143.45 50.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.8 t -121.2 132.13 54.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.472 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.242 0.544 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.757 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.4 m -134.08 -169.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.313 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.2 tpt180 -146.94 117.63 7.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.921 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.859 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -100.68 144.43 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 0.0 109.764 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.27 -69.43 1.28 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.086 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.65 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -73.9 19.7 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.6 1.316 . . . . 0.0 112.749 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.554 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -94.15 -21.92 18.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.715 -1.241 . . . . 0.0 107.731 178.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.518 ' HB2' ' N ' ' A' ' 38' ' ' MET . 11.8 t70 -92.58 -29.58 16.09 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.478 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 tt0 -78.91 -40.12 33.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.41 9.55 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.38 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.4 t -65.08 -40.34 44.8 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.582 -0.699 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.7 Cg_endo -76.34 3.64 6.11 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.185 1.097 . . . . 0.0 110.526 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 9.6 mmt180 -86.94 -177.0 5.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.984 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.0 pt -53.79 -167.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 87.9 t -81.49 -41.69 1.08 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.567 -0.708 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.4 Cg_endo -69.94 -13.59 34.42 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 122.963 0.98 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -82.86 -12.16 57.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.266 -0.896 . . . . 0.0 109.187 178.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -102.38 -58.1 1.94 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.535 -0.728 . . . . 0.0 110.069 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.417 ' NE2' ' CD1' ' A' ' 30' ' ' TYR . 24.8 m80 -58.4 -36.64 73.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -73.42 -23.27 60.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.859 ' SG ' HG21 ' A' ' 4' ' ' ILE . 6.9 t -67.8 -29.77 69.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 92.7 m -74.97 -34.25 62.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.017 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.22 -11.8 39.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.64 -14.51 56.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.661 ' CG ' HD12 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -107.27 -79.1 0.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.64 28.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HE ' HD11 ' A' ' 4' ' ' ILE . 10.2 mmt180 -102.04 -158.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -114.25 -54.77 2.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 22' ' ' CYS . . . -149.16 -159.86 8.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CD1' ' NE2' ' A' ' 19' ' ' HIS . 15.8 p90 -98.29 161.68 13.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -132.53 -67.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.971 . . . . 0.0 110.633 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.761 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.3 p90 -178.42 156.25 0.93 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.266 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -99.89 101.1 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 109.903 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.594 ' HG ' ' HE1' ' A' ' 39' ' ' TYR . 1.3 p -90.56 149.6 22.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.94 112.38 1.91 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.23 -44.0 1.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' CA ' ' OD2' ' A' ' 8' ' ' ASP . . . -167.29 -176.04 37.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.554 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 7.8 tpt -110.06 167.44 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -1.076 . . . . 0.0 109.523 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 42.5 m-85 -133.68 139.91 46.73 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.011 -1.056 . . . . 0.0 110.377 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.757 ' HB2' HG23 ' A' ' 2' ' ' VAL . 55.7 m -110.67 141.53 43.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.452 -0.78 . . . . 0.0 110.124 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' SER . 26.4 t-20 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.308 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.311 0.576 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 t -118.91 157.42 20.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.218 -0.926 . . . . 0.0 109.884 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.559 ' NH2' ' CA ' ' A' ' 37' ' ' GLY . 2.7 tpt180 -148.25 116.2 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 110.124 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.819 HG21 ' SG ' ' A' ' 21' ' ' CYS . 15.5 mm -99.93 152.6 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.782 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.18 -64.88 2.12 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.934 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.756 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -74.88 17.5 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.625 1.329 . . . . 0.0 112.642 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -93.86 -29.92 15.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.524 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 21.2 t70 -84.2 -31.48 25.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mt-30 -73.47 -47.01 44.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.68 13.54 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.088 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 t -64.37 -43.51 72.51 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.679 -0.638 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.7 Cg_endo -76.29 5.08 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.536 1.282 . . . . 0.0 110.865 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 1.6 mmt180 -84.71 177.68 7.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 110.18 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.573 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.2 pt -53.68 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.895 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.4 t -81.54 -43.19 1.11 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.452 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -71.85 -4.19 14.63 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.288 1.152 . . . . 0.0 110.195 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 4.1 mm-40 -98.54 -8.56 26.36 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.383 -0.823 . . . . 0.0 109.43 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 11' ' ' CYS . 3.1 ttp180 -108.46 -46.38 3.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.077 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -62.41 -30.22 71.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -80.35 -13.47 59.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.819 ' SG ' HG21 ' A' ' 4' ' ' ILE . 6.7 t -68.92 -45.15 71.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 110.148 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.26 -39.36 59.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 110.238 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -20.72 66.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.97 -30.09 21.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 110.186 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLY . 32.0 m80 -101.4 46.32 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.53 64.34 1.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -131.61 -178.23 4.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.249 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -93.74 -91.31 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -143.99 141.68 10.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD1' ' HE3' ' A' ' 38' ' ' MET . 7.0 t80 -46.69 136.54 7.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -112.39 -54.75 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.824 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.4 p90 -177.86 144.64 0.36 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.538 -0.726 . . . . 0.0 109.946 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -85.67 113.4 21.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.103 -0.998 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -146.61 176.26 9.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.751 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 47.52 57.49 7.37 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 40.96 38.79 1.77 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.559 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -173.97 -170.24 37.11 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -115.13 157.66 23.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.064 -1.257 . . . . 0.0 110.413 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.722 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 19.0 m-85 -128.6 134.54 48.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.495 ' HB3' HG11 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -111.58 171.5 7.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.396 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.223 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.171 0.51 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.543 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 5.6 m -141.04 -167.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.38 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 3.5 tpt180 -147.91 120.17 8.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.226 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.889 HG21 ' SG ' ' A' ' 21' ' ' CYS . 11.8 mm -99.71 146.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.924 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.55 -67.24 2.05 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.014 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.763 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -74.91 20.27 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.634 1.334 . . . . 0.0 112.617 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.665 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.36 -27.47 16.05 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.614 -1.304 . . . . 0.0 108.034 178.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 -22.41 25.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -86.91 -44.22 11.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.0 11.92 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.412 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.53 -42.46 65.76 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.589 -0.694 . . . . 0.0 111.306 -179.719 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.26 6.31 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.45 1.237 . . . . 0.0 111.001 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -85.18 -177.71 6.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 0.0 110.12 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.5 pt -54.29 -165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.611 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.1 t -80.81 -44.04 1.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 111.7 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -70.8 -10.71 28.28 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.372 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -81.31 -22.91 38.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.239 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.561 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 2.3 ttm180 -97.74 -47.26 5.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 109.684 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -34.08 66.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.989 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -82.41 -19.14 39.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.889 ' SG ' HG21 ' A' ' 4' ' ' ILE . 30.5 t -61.2 -43.59 98.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.49 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.06 -24.94 58.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 110.307 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -83.58 -19.91 34.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -13.14 43.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.095 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.672 ' CB ' HD12 ' A' ' 4' ' ' ILE . 7.5 m80 -117.55 39.18 3.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 0.0 110.134 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 44.35 63.79 2.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.596 ' CD ' HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -132.52 -152.05 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -1.136 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 47.0 m -119.99 -130.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.151 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -98.81 135.76 12.32 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.459 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 24.7 p90 -41.65 130.32 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.104 . . . . 0.0 110.249 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.83 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -98.64 -60.75 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.643 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.83 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 11.7 p90 -178.16 148.56 0.5 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.144 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -93.16 113.26 25.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 109.855 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.7 165.48 11.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.66 120.85 23.24 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.1 -21.59 15.3 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 160.2 177.03 32.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 11.6 ttt -100.45 167.2 10.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -1.114 . . . . 0.0 109.922 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.782 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 65.0 m-85 -139.09 148.23 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -119.13 176.05 5.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 41' ' ' ASN . 3.4 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.208 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.217 0.532 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.669 HG21 ' HG3' ' A' ' 27' ' ' ARG . 18.6 m -122.92 -161.23 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.956 . . . . 0.0 110.366 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.2 tpt180 -147.94 120.11 8.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 110.259 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.9 HG21 ' SG ' ' A' ' 21' ' ' CYS . 13.0 mm -100.1 151.06 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.97 -66.61 2.0 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.795 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.06 18.42 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.661 1.348 . . . . 0.0 112.679 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.705 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.1 m -94.08 -30.01 14.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.629 -1.294 . . . . 0.0 107.912 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' N ' ' HB2' ' A' ' 38' ' ' MET . 23.8 t0 -84.16 -22.92 30.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.73 -46.45 10.69 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.2 p -91.1 12.91 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -64.33 -42.61 68.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 111.289 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.9 Cg_endo -75.49 4.2 5.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.333 1.175 . . . . 0.0 110.909 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.516 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.2 mmt-85 -84.42 -179.82 7.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.087 -1.008 . . . . 0.0 109.84 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.506 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 6.1 pt -53.63 -168.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.9 t -81.38 -43.05 1.13 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.776 . . . . 0.0 111.379 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -71.9 -3.73 13.75 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.306 1.161 . . . . 0.0 110.256 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -91.21 -13.51 32.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -0.807 . . . . 0.0 109.32 179.085 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 6.1 ttm180 -109.7 -41.55 4.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 110.036 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -31.38 64.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.067 -1.02 . . . . 0.0 109.835 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.83 -19.64 30.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.9 ' SG ' HG21 ' A' ' 4' ' ' ILE . 13.0 t -59.14 -42.65 91.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.3 m -77.59 -38.62 47.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.995 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -20.92 66.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 -18.03 34.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CB ' HD12 ' A' ' 4' ' ' ILE . 19.1 m80 -111.0 34.93 3.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.09 58.36 7.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.669 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -118.86 -151.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -1.115 . . . . 0.0 110.243 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.461 ' OG ' ' OXT' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -117.69 -86.99 0.63 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -0.832 . . . . 0.0 110.257 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.53 136.4 6.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.553 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 16.1 p90 -43.54 122.73 2.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -1.159 . . . . 0.0 110.253 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.41 -59.56 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.761 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.4 p90 -178.25 151.29 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 110.226 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -93.12 114.0 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.721 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.25 161.82 13.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.389 -0.819 . . . . 0.0 110.31 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 122.62 30.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -27.1 9.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 166.47 176.37 37.56 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.542 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -93.65 165.01 12.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.163 . . . . 0.0 110.023 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.624 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.8 m-85 -138.02 142.81 40.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.3 OUTLIER -115.55 -175.62 2.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 110.052 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.461 ' OXT' ' OG ' ' A' ' 28' ' ' SER . 4.6 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.207 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.303 0.573 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.833 HG21 ' HG3' ' A' ' 27' ' ' ARG . 31.3 m -131.12 -152.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.1 tpt180 -148.23 118.87 7.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.891 HG21 ' SG ' ' A' ' 21' ' ' CYS . 11.1 mm -102.77 153.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.988 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.73 -68.1 1.65 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.823 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.735 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.15 20.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.671 1.353 . . . . 0.0 112.663 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.702 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.14 -29.01 15.36 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 107.78 178.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.5 p30 -85.83 -25.5 26.24 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 tt0 -82.96 -44.32 15.44 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 11.24 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.43 -44.01 73.86 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 111.057 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -76.78 5.58 4.76 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.544 1.286 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 14' ' ' ILE . 26.4 mmt180 -85.93 -175.48 5.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.093 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.803 HD11 ' OE2' ' A' ' 17' ' ' GLU . 6.8 pt -53.83 -167.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.8 t -81.55 -43.16 1.11 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 111.485 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.18 -5.22 16.53 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.286 1.15 . . . . 0.0 110.264 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.803 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -87.44 -14.39 40.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.278 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 ttm180 -106.26 -49.57 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.474 -0.766 . . . . 0.0 110.021 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.7 m-70 -55.01 -38.92 68.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.018 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -79.0 -19.98 50.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.913 . . . . 0.0 110.32 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.891 ' SG ' HG21 ' A' ' 4' ' ' ILE . 18.4 t -59.85 -40.3 88.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 110.502 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.14 -32.11 61.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -78.61 -16.97 56.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 110.233 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.44 -19.58 29.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.585 ' HB2' HD12 ' A' ' 4' ' ' ILE . 5.8 m80 -115.35 33.5 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 110.292 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . 53.36 71.13 0.74 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.833 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -140.27 -153.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -1.178 . . . . 0.0 110.298 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 84.6 p -120.06 -134.52 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.34 135.2 12.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.619 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -46.62 131.76 11.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -1.163 . . . . 0.0 110.332 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.799 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -97.54 -56.22 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.799 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.9 p90 -177.0 -177.49 0.76 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.61 -0.681 . . . . 0.0 109.988 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -125.06 115.25 20.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.507 ' HG ' ' HE1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -107.23 147.62 29.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.212 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.87 127.03 19.12 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.02 -44.9 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.87 169.67 42.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.523 ' N ' ' HB3' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -95.64 163.87 13.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -1.168 . . . . 0.0 110.029 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 82.3 m-85 -134.94 149.2 50.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.316 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.703 ' HB3' HG22 ' A' ' 2' ' ' VAL . 1.1 t -114.84 -175.12 2.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.308 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.352 0.596 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 40' ' ' CYS . 2.6 m -131.93 -168.61 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.156 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.52 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 3.1 tpt180 -147.51 122.33 9.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.868 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.2 mm -99.26 150.26 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.687 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.54 -67.33 1.89 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.087 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.771 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.25 17.81 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.638 1.336 . . . . 0.0 112.804 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.715 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.24 -27.13 16.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.642 -1.286 . . . . 0.0 108.031 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.464 ' HB2' ' N ' ' A' ' 38' ' ' MET . 30.0 t0 -86.1 -23.2 26.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.412 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 tm0? -88.03 -44.67 10.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -91.12 11.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.98 . . . . 0.0 109.598 179.328 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.592 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.57 -42.29 64.18 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.777 . . . . 0.0 111.242 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.2 Cg_endo -76.58 5.46 4.75 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.456 1.24 . . . . 0.0 110.858 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -85.36 -177.75 6.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 110.18 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.563 HD11 ' CD ' ' A' ' 17' ' ' GLU . 13.7 pt -55.5 -164.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.668 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 46.3 t -81.3 -45.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.528 -0.733 . . . . 0.0 111.497 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.37 -4.14 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.272 1.143 . . . . 0.0 110.436 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -89.89 -14.78 33.53 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.241 -0.912 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.55 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -108.12 -42.46 4.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.739 . . . . 0.0 110.034 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -32.26 69.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.188 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 37.7 tt0 -86.68 -12.28 48.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.868 ' SG ' HG21 ' A' ' 4' ' ' ILE . 12.8 t -70.67 -36.61 73.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.23 -49.6 13.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.205 -0.935 . . . . 0.0 110.463 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -64.52 -34.5 78.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.21 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -68.13 -18.6 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.206 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -97.87 -74.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.167 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.84 34.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.546 ' CG ' HD11 ' A' ' 4' ' ' ILE . 2.7 mmt180 -104.4 -153.07 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -1.232 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -119.57 -43.65 2.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.132 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -169.0 130.63 2.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 1.7 p90 -43.9 126.14 4.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -1.137 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.05 -56.63 2.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.809 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.6 p90 -177.7 -175.25 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.13 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -126.52 114.49 18.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.884 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.32 162.97 12.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 110.278 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.35 116.63 9.31 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.34 -28.87 6.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 171.88 175.26 39.98 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.531 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -99.88 164.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.126 179.919 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.613 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 46.0 m-85 -134.52 149.73 50.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 110.352 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.514 ' O ' HG22 ' A' ' 2' ' ' VAL . 1.7 t -127.83 171.3 11.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.413 -0.804 . . . . 0.0 110.206 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.242 179.998 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.238 0.542 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.756 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.8 m -144.89 -162.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 110.34 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.504 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 1.5 tpt180 -147.36 121.02 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.922 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -102.7 148.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.0 -70.85 0.94 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.814 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.742 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -75.72 24.38 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.724 1.381 . . . . 0.0 112.832 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.51 -23.16 17.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.63 -1.294 . . . . 0.0 107.881 178.419 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 14.5 t70 -88.56 -28.33 20.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.129 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.418 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.4 tt0 -79.64 -43.92 21.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.15 11.35 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.453 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 t -65.11 -43.96 68.55 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -76.45 4.71 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.582 1.306 . . . . 0.0 110.697 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 29.3 mmt180 -83.06 -178.65 7.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.944 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' A' ' 17' ' ' GLU . 13.7 pt -54.2 -165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 54.7 t -81.62 -43.03 1.09 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 111.704 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.8 Cg_endo -70.91 -11.4 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.191 1.101 . . . . 0.0 110.345 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -82.42 -20.19 37.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.357 -0.839 . . . . 0.0 109.46 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' CZ ' ' O ' ' A' ' 11' ' ' CYS . 4.2 mtm180 -99.02 -49.32 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.463 -0.773 . . . . 0.0 109.888 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.685 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 7.5 m-70 -57.14 -37.36 71.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.864 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 53.6 tt0 -77.02 -20.33 56.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.084 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.922 ' SG ' HG21 ' A' ' 4' ' ' ILE . 24.3 t -64.34 -45.84 86.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 58.8 m -75.87 -40.43 54.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -73.25 -16.22 61.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.175 -0.953 . . . . 0.0 110.366 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.6 -32.55 19.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.584 ' CB ' HD12 ' A' ' 4' ' ' ILE . 9.2 m80 -94.87 54.48 1.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.296 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.52 26.35 0.65 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -106.11 172.67 6.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -1.196 . . . . 0.0 110.051 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -84.07 -143.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.907 . . . . 0.0 110.167 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -71.17 -151.58 0.9 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.685 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 13.5 p90 -113.94 151.76 31.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -1.169 . . . . 0.0 110.189 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.798 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -110.48 -63.83 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.496 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.798 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.2 p90 -178.15 -161.42 0.05 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.276 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -138.5 109.3 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -85.82 41.87 0.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.46 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . 77.96 -108.16 2.57 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.83 49.46 4.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.15 102.45 0.16 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.523 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.6 169.74 11.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 110.183 -179.853 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.581 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 70.8 m-85 -142.02 146.68 35.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 110.295 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.756 ' HB2' HG23 ' A' ' 2' ' ' VAL . 98.0 m -116.28 149.25 39.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 0.0 110.298 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.248 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.274 0.559 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 40' ' ' CYS . 4.0 m -141.45 -175.23 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -148.33 131.52 16.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.318 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.766 HG21 ' SG ' ' A' ' 7' ' ' CYS . 16.9 mm -110.99 160.84 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.461 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -85.86 -63.37 1.54 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.519 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.779 ' O ' HG12 ' A' ' 10' ' ' VAL . 40.6 Cg_endo -74.6 15.74 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.645 1.339 . . . . 0.0 112.372 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.766 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.3 m -93.25 -22.74 18.83 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.545 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 p30 -88.23 -29.61 20.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.016 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -79.09 -45.24 20.48 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.302 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -91.11 13.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.393 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 t -64.43 -44.99 77.21 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.474 -0.766 . . . . 0.0 110.701 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 48.4 Cg_endo -77.13 5.77 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.592 1.312 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 10' ' ' VAL . 4.2 mmp_? -83.29 179.28 7.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 110.064 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.61 HD11 ' CD ' ' A' ' 17' ' ' GLU . 7.6 pt -54.09 -166.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -78.76 -45.71 1.87 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 111.6 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -69.62 -6.82 19.45 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.282 1.148 . . . . 0.0 110.53 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.61 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -89.18 -19.57 25.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.102 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 7.0 ttm180 -99.31 -52.32 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.875 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.547 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 17.3 m80 -57.51 -33.64 68.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.896 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.23 -21.21 46.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 110.179 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.758 ' SG ' HG21 ' A' ' 4' ' ' ILE . 10.0 t -65.42 -45.29 84.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.902 . . . . 0.0 110.205 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.91 -43.99 33.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.53 -21.78 66.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.867 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -21.27 25.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.495 ' CB ' HD12 ' A' ' 4' ' ' ILE . 19.7 m80 -102.45 14.91 30.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.266 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 27' ' ' ARG . . . 71.46 64.49 2.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HD3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -134.66 -158.3 0.87 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -1.175 . . . . 0.0 110.159 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 -89.71 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -145.61 144.87 13.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.564 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 1.4 p90 -42.58 119.86 1.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -1.158 . . . . 0.0 110.2 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.787 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -99.65 -56.18 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.488 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.787 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 13.4 p90 -178.03 129.29 0.14 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.373 -178.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -74.25 115.86 14.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 179.374 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.31 167.4 10.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.254 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.98 143.29 11.65 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.77 -50.73 2.0 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 8' ' ' ASP . . . -173.09 -139.34 2.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.541 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 9.5 ttt -126.81 162.58 25.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -1.17 . . . . 0.0 109.913 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.2 m-85 -135.24 148.07 49.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 111.015 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.549 ' HB2' HG23 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -115.97 161.54 18.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.497 -0.752 . . . . 0.0 110.171 -179.842 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.449 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 17.1 t-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.204 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.268 0.556 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.834 HG21 ' HG3' ' A' ' 27' ' ' ARG . 34.5 m -136.6 -155.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.059 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.5 tpt180 -146.85 121.16 9.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.924 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.3 mm -101.17 149.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.557 -0.714 . . . . 0.0 109.545 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.32 -70.51 1.05 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.163 -1.017 . . . . 0.0 110.788 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.18 25.66 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.757 1.398 . . . . 0.0 112.746 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.78 -26.92 16.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.62 -1.3 . . . . 0.0 107.915 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 37' ' ' GLY . 1.8 t70 -87.32 -24.32 24.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 28.7 mt-30 -84.57 -41.66 16.22 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.66 12.1 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 22.8 t -64.96 -41.37 54.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.0 Cg_endo -76.83 5.28 5.0 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.344 1.181 . . . . 0.0 110.74 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.547 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 2.1 mmt180 -83.25 179.42 7.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.127 -0.983 . . . . 0.0 110.182 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.0 pt -54.23 -165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.652 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.6 t -79.3 -45.19 1.68 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 111.448 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.3 Cg_endo -70.99 -4.51 14.99 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.287 1.151 . . . . 0.0 110.361 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 3.1 mm-40 -93.18 -15.74 25.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.558 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtm180 -104.85 -50.31 3.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.08 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.473 ' NE2' ' CE1' ' A' ' 30' ' ' TYR . 20.3 m80 -61.49 -37.07 82.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.24 -0.913 . . . . 0.0 110.117 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.6 tt0 -74.53 -20.0 60.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.924 ' SG ' HG21 ' A' ' 4' ' ' ILE . 15.5 t -62.0 -40.93 97.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 83.9 m -76.18 -50.18 15.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -14.09 62.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.49 -33.27 19.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.928 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.607 ' CB ' HD12 ' A' ' 4' ' ' ILE . 4.0 m80 -96.51 50.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.146 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.83 43.24 6.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.834 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -119.53 -167.37 1.4 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -1.117 . . . . 0.0 110.216 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.463 ' HB3' ' OXT' ' A' ' 41' ' ' ASN . 4.8 t -102.14 -144.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.19 169.27 53.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' CE1' ' NE2' ' A' ' 19' ' ' HIS . 17.8 p90 -71.01 147.26 48.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -1.117 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -113.27 -69.6 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.741 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 12.1 p90 -178.6 152.19 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.425 -178.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 91.2 m -97.96 113.09 24.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' GLY . 5.2 p -93.88 30.16 1.91 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.934 . . . . 0.0 110.525 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.89 127.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.47 -19.75 30.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 177.78 139.41 3.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.534 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 8.4 ttt -103.18 169.9 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -1.13 . . . . 0.0 110.014 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.761 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 25.5 m-85 -134.45 154.2 51.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 70.8 m -113.82 130.22 56.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.584 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 12.9 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.219 0.533 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.7 m -145.06 -160.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.927 . . . . 0.0 110.256 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.494 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 3.7 tpt180 -147.08 118.26 7.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 110.117 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.907 HG21 ' SG ' ' A' ' 21' ' ' CYS . 7.9 mm -99.85 147.91 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -0.771 . . . . 0.0 109.862 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.467 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -64.2 -69.66 1.27 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.391 -0.909 . . . . 0.0 110.953 -179.059 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.694 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.4 Cg_endo -75.26 22.79 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.553 1.291 . . . . 0.0 112.658 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.6 -26.14 16.49 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.737 -1.227 . . . . 0.0 107.931 178.532 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.4 p30 -88.6 -30.19 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 34.6 tt0 -75.92 -43.83 43.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.408 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 9.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.417 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.07 -41.97 57.79 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 111.075 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 50.0 Cg_endo -79.42 21.02 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.441 1.232 . . . . 0.0 111.522 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -104.87 -169.59 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.795 -1.191 . . . . 0.0 110.031 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 8.7 pt -52.92 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.279 -0.888 . . . . 0.0 110.641 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.6 t -82.55 -42.87 0.94 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.8 Cg_endo -72.06 -7.83 21.76 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.214 1.113 . . . . 0.0 110.278 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -85.95 -15.2 42.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.035 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtp180 -104.16 -54.02 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.097 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 30' ' ' TYR . 24.5 m-70 -59.43 -35.59 74.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.1 -20.61 57.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 110.095 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.907 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.7 t -67.1 -39.28 86.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 73.0 m -75.1 -29.31 60.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.319 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -87.65 -16.23 35.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.368 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.32 -29.68 21.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.704 ' CB ' HD12 ' A' ' 4' ' ' ILE . 39.0 m80 -95.13 45.81 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.84 41.36 5.81 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.753 ' HD3' HD11 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -116.56 -163.34 0.9 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 0.0 110.376 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.487 ' CB ' ' OXT' ' A' ' 41' ' ' ASN . 91.8 p -95.18 -140.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.179 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -90.2 -146.11 14.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.554 ' CD2' ' HE1' ' A' ' 38' ' ' MET . 1.9 t80 -114.37 124.82 52.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.337 -1.096 . . . . 0.0 110.151 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.822 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -98.86 -57.91 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.146 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.822 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.3 p90 -178.19 -172.65 0.32 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.323 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.485 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -127.22 114.84 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.607 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -94.65 147.92 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 110.336 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.07 104.55 0.83 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -30.19 4.32 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.64 152.02 17.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.558 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -93.0 160.53 14.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.157 . . . . 0.0 110.095 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 27.2 m-85 -131.04 140.74 50.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.346 -0.846 . . . . 0.0 110.388 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.801 ' HB2' HG23 ' A' ' 2' ' ' VAL . 95.7 m -106.47 138.83 41.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.119 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.487 ' OXT' ' CB ' ' A' ' 28' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.341 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.612 HG21 ' HG3' ' A' ' 27' ' ' ARG . 7.0 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.298 0.571 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.51 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.9 tpt180 -146.02 121.44 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.917 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.1 mm -100.18 148.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.597 -0.689 . . . . 0.0 109.933 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.29 -68.66 1.58 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.928 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.779 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.6 Cg_endo -75.2 22.6 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.748 1.394 . . . . 0.0 112.66 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.554 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.29 -28.45 15.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.638 -1.288 . . . . 0.0 107.84 178.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.8 t70 -84.15 -23.58 30.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -84.9 -45.74 11.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.92 13.49 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.17 -0.956 . . . . 0.0 109.395 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.3 -45.4 78.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 110.854 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -77.19 6.89 3.99 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.697 1.367 . . . . 0.0 110.804 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.643 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.8 mmp_? -83.14 178.4 8.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -0.99 . . . . 0.0 109.985 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.48 HG12 ' HB2' ' A' ' 17' ' ' GLU . 5.9 pt -53.34 -168.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 110.64 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -80.61 -44.1 1.31 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 111.623 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.06 -5.26 16.6 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.22 1.116 . . . . 0.0 110.213 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -92.86 -19.45 21.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.164 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 8.8 ttp180 -97.16 -45.68 6.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.537 -0.727 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -36.51 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 109.777 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -75.01 -16.73 60.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 110.146 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.917 ' SG ' HG21 ' A' ' 4' ' ' ILE . 44.6 t -67.81 -50.35 57.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 74.1 m -74.81 -21.45 59.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 109.985 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.14 -16.82 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.62 -31.8 19.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.575 ' HB2' HD12 ' A' ' 4' ' ' ILE . 36.4 m80 -95.61 49.62 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.67 42.71 6.18 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.612 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -124.99 -179.88 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -1.172 . . . . 0.0 110.196 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 1.9 m -83.49 -141.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.42 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 18.1 p90 -92.16 132.14 36.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.667 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.38 -62.73 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.667 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.3 p90 -178.29 156.24 0.96 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -98.6 112.93 24.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -117.11 134.13 55.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.366 -0.833 . . . . 0.0 110.299 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.5 -153.04 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.83 43.92 3.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -165.71 138.96 5.51 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.491 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 2.3 ttt -101.4 167.25 10.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -1.17 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.656 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 75.1 m-85 -136.1 147.25 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.567 ' HB2' HG23 ' A' ' 2' ' ' VAL . 79.6 m . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.763 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.4 m . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.361 0.601 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.528 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 1.4 tpt180 -147.03 122.46 10.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.318 -0.864 . . . . 0.0 110.063 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.7 mm -102.53 147.61 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 109.959 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -70.24 1.11 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.6 Cg_endo -74.99 23.15 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.649 1.342 . . . . 0.0 112.792 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.527 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.49 -29.52 14.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.631 -1.293 . . . . 0.0 107.669 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.435 ' CG ' ' CA ' ' A' ' 37' ' ' GLY . 1.1 t0 -84.89 -26.87 27.04 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 3.6 mt-30 -79.43 -44.28 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.77 12.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.586 ' SG ' ' HE3' ' A' ' 38' ' ' MET . 1.7 t -64.45 -44.17 74.21 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.479 -0.763 . . . . 0.0 110.841 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -77.81 6.16 4.75 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.572 1.301 . . . . 0.0 110.746 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.566 ' HG3' HG23 ' A' ' 10' ' ' VAL . 3.0 mmt180 -83.59 -175.93 6.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.55 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.6 pt -54.28 -165.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.55 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.626 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.3 t -82.1 -42.4 1.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 111.607 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.97 -9.27 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.267 1.141 . . . . 0.0 110.559 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.25 -12.3 52.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.398 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.578 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 5.8 ttp180 -109.42 -55.07 2.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 4.2 m-70 -53.83 -31.9 50.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -84.57 -23.72 29.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.375 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.0 t -60.39 -32.53 71.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.426 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' SER . 86.1 m -76.18 -33.4 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -89.94 -8.24 52.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.327 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.39 -16.09 38.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.562 ' HB2' HD12 ' A' ' 4' ' ' ILE . 29.2 m80 -115.89 38.97 3.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 50.67 31.76 23.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -106.31 -168.82 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -1.152 . . . . 0.0 110.273 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 16.2 m -83.34 -134.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.46 -176.33 21.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -68.83 127.9 34.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -1.096 . . . . 0.0 110.196 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -110.31 -68.88 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.452 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.3 p90 -178.61 150.37 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.514 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -90.32 118.95 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.424 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 37' ' ' GLY . 1.1 t -135.62 139.82 44.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.62 -157.05 34.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.91 43.64 3.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.586 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 1.9 ttt -98.83 168.99 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.027 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 25.7 m-85 -131.45 145.81 51.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.899 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.763 ' HB2' HG23 ' A' ' 2' ' ' VAL . 59.9 m . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.287 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.136 0.493 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.577 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -147.98 131.15 16.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.791 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.4 mm -106.41 155.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.771 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.441 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -74.24 -67.15 1.82 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.744 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.9 Cg_endo -74.66 17.95 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.629 1.331 . . . . 0.0 112.486 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.1 m -93.79 -26.55 16.91 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.536 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.0 p30 -88.76 -29.33 19.87 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 tm0? -76.84 -44.27 32.97 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.5 p -90.51 12.55 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.354 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.7 t -64.75 -43.78 70.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.723 -0.611 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.35 4.32 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.521 1.274 . . . . 0.0 110.852 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 mtt180 -85.09 -179.17 6.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 109.998 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 7.4 pt -53.72 -167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.629 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.63 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.4 t -82.4 -42.65 0.96 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 111.564 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.6 Cg_endo -72.09 -2.15 11.14 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.281 1.148 . . . . 0.0 110.378 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -96.42 -10.56 27.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 109.454 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.596 ' HD2' ' CD2' ' A' ' 30' ' ' TYR . 10.7 ttm180 -109.57 -47.96 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -58.26 -28.92 65.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -84.13 -20.43 32.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.923 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.4 t -61.95 -45.87 91.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.36 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.4 -40.12 58.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -68.88 -19.09 64.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 110.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -29.48 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.365 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -97.82 4.3 49.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.242 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . 77.22 74.48 0.98 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -135.66 -156.66 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.184 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.3 t -102.07 -89.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -153.9 151.19 22.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.672 ' CD2' ' HE2' ' A' ' 38' ' ' MET . 14.5 t80 -44.08 119.57 1.81 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.245 . . . . 0.0 110.091 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -105.5 -58.34 1.91 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.368 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.779 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 13.6 p90 -177.34 138.07 0.23 Allowed 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.025 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -87.01 102.37 14.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.095 -1.003 . . . . 0.0 110.118 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 35' ' ' GLY . 1.4 p -81.19 161.64 23.93 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.5 -0.75 . . . . 0.0 110.25 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -43.16 -56.0 4.78 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.06 -72.85 0.41 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA3' ' NH2' ' A' ' 3' ' ' ARG . . . -149.19 -135.28 2.47 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.672 ' HE2' ' CD2' ' A' ' 30' ' ' TYR . 15.4 tpt -121.69 146.97 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.898 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.0 m-85 -128.21 141.99 51.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.993 -1.067 . . . . 0.0 111.083 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.48 -0.763 . . . . 0.0 110.127 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 40' ' ' CYS . 1.8 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.319 0.58 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.2 tpt180 -146.53 122.94 11.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 110.152 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -104.14 151.47 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.766 . . . . 0.0 110.02 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.53 -68.97 1.49 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.725 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.773 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.7 Cg_endo -74.95 22.23 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.778 1.41 . . . . 0.0 112.789 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.638 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.18 -29.77 14.95 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.7 t70 -82.79 -25.02 33.16 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.64 -46.26 13.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.0 p -90.7 14.72 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.23 -0.919 . . . . 0.0 109.348 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 t -64.1 -44.1 76.45 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.658 -0.651 . . . . 0.0 111.111 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.1 Cg_endo -77.8 8.74 3.27 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.568 1.299 . . . . 0.0 111.113 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.629 ' HG3' HG23 ' A' ' 10' ' ' VAL . 1.1 mmm180 -85.22 179.14 7.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 0.0 110.22 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.3 pt -53.98 -166.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.61 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -79.07 -44.7 1.74 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.49 -0.756 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.2 Cg_endo -71.02 -5.71 17.58 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.384 1.202 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.56 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 1.8 mm-40 -88.08 -21.73 24.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.36 -0.838 . . . . 0.0 109.33 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 4.9 ttp180 -100.11 -44.99 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -0.767 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -59.2 -31.7 69.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -82.66 -17.97 42.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.342 -0.849 . . . . 0.0 110.018 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 4' ' ' ILE . 31.9 t -68.05 -49.69 59.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 84.3 m -75.12 -29.53 60.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -78.73 -21.82 47.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.11 24.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.299 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.687 ' CB ' HD12 ' A' ' 4' ' ' ILE . 10.7 m170 -102.28 51.07 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 110.403 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.06 23.2 2.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -112.29 175.51 5.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -1.231 . . . . 0.0 110.063 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 2.3 t -88.29 -143.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -72.26 -154.49 2.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.48 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 22.4 p90 -105.88 144.65 32.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -1.105 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -105.07 -65.42 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.501 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.74 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.6 p90 -178.3 148.79 0.49 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.521 -0.737 . . . . 0.0 110.297 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -87.87 119.78 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -129.25 135.27 48.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.942 . . . . 0.0 110.473 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.99 -149.7 46.9 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.42 25.4 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -151.77 157.99 27.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.521 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 10.6 ttt -106.8 167.01 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -1.203 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 35.5 m-85 -129.19 142.11 50.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.683 ' HB2' HG23 ' A' ' 2' ' ' VAL . 73.5 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 40' ' ' CYS . 30.0 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 2.9 tpt180 -147.92 117.78 7.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.74 HG21 ' SG ' ' A' ' 7' ' ' CYS . 13.3 mm -100.46 157.52 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 0.0 109.851 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.72 -63.8 1.88 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.636 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.792 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.9 Cg_endo -74.98 16.36 0.66 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.681 1.358 . . . . 0.0 112.476 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.74 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.3 m -93.81 -27.99 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.516 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.4 t70 -89.42 -25.38 21.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -79.83 -45.1 19.33 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.2 p -91.1 14.22 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.316 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 t -64.51 -44.33 74.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 110.995 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.7 Cg_endo -76.71 5.65 4.68 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.559 1.294 . . . . 0.0 110.996 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.563 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -85.64 -179.73 6.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -0.998 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.59 HD11 ' OE1' ' A' ' 17' ' ' GLU . 14.9 pt -54.55 -165.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.278 -0.889 . . . . 0.0 110.737 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.606 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.0 t -78.71 -46.57 1.87 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.3 Cg_endo -68.77 -10.76 30.02 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.294 1.155 . . . . 0.0 110.256 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.59 ' OE1' HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -84.42 -21.91 30.6 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.348 -0.845 . . . . 0.0 109.219 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.7 mtm180 -95.89 -49.58 5.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -56.53 -19.23 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.871 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -96.78 -22.5 16.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' HB3' HG11 ' A' ' 10' ' ' VAL . 2.9 p -59.32 -36.76 76.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.9 OUTLIER -81.21 -44.1 18.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.172 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -67.82 -13.86 62.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 110.294 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.33 -15.28 55.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 110.239 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.712 ' CB ' HD12 ' A' ' 4' ' ' ILE . 3.6 m80 -111.09 -8.21 14.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 99.15 47.71 1.83 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.652 ' HG3' HG21 ' A' ' 2' ' ' VAL . 6.8 mpt_? -114.1 -164.44 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -1.14 . . . . 0.0 110.158 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 -75.34 0.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.65 138.84 7.4 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.4 p90 -46.31 127.76 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.153 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -96.21 -59.08 1.91 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.858 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.5 p90 -178.17 160.47 1.38 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.537 -0.727 . . . . 0.0 109.933 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.6 OUTLIER -100.43 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 t -135.84 174.05 11.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 0.0 110.461 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.89 -147.79 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.21 39.34 2.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . -174.75 -164.9 30.32 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.537 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -112.35 177.42 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -1.131 . . . . 0.0 110.163 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.906 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 61.4 m-85 -143.4 135.98 27.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.973 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.576 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.964 HG21 ' HD2' ' A' ' 27' ' ' ARG . 23.3 m . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.154 0.502 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.508 ' CD ' ' O ' ' A' ' 38' ' ' MET . 4.5 tpt180 -147.05 121.27 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.208 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.903 HG21 ' SG ' ' A' ' 21' ' ' CYS . 12.5 mm -101.07 148.71 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.493 -0.754 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.66 -66.95 2.07 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.806 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.75 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.8 Cg_endo -74.57 20.25 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.688 1.362 . . . . 0.0 112.667 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.03 -24.34 17.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 107.701 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.458 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 36.0 t70 -88.57 -27.21 21.53 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 14.5 mm-40 -80.16 -44.4 19.92 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.03 13.81 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.31 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.71 -47.07 76.38 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.518 -0.739 . . . . 0.0 110.925 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -75.17 4.05 5.17 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.755 1.397 . . . . 0.0 111.133 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 22.4 mmt180 -83.42 -175.51 5.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.022 -1.048 . . . . 0.0 110.262 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.664 HD11 ' OE2' ' A' ' 17' ' ' GLU . 13.7 pt -54.09 -165.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.335 -0.853 . . . . 0.0 110.668 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -82.34 -42.17 0.96 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.11 -10.37 25.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.213 1.112 . . . . 0.0 110.472 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.664 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -83.75 -14.74 50.8 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.26 -47.82 3.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 12.8 m-70 -58.87 -37.78 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.6 tm-20 -79.48 -21.91 44.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.903 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.1 t -61.04 -40.32 93.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.316 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.468 ' HA ' HG13 ' A' ' 4' ' ' ILE . 93.5 m -75.01 -52.48 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.0 110.275 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -12.64 59.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.313 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.55 -16.88 33.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -102.54 -17.2 15.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.92 34.06 1.74 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.964 ' HD2' HG21 ' A' ' 2' ' ' VAL . 16.2 mmt180 -103.42 -161.71 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -1.118 . . . . 0.0 110.282 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.66 -38.35 5.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.351 -0.843 . . . . 0.0 110.18 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.77 167.19 37.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 29.8 p90 -69.78 146.32 51.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -1.162 . . . . 0.0 110.239 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -119.97 -66.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.826 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.8 p90 -178.48 163.38 1.55 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.429 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -103.99 114.87 29.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -144.86 158.41 43.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 57.69 54.26 38.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 43.35 26.96 0.67 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -146.68 -153.9 6.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.526 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -150.98 170.59 18.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 110.319 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.819 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 89.2 m-85 -143.52 144.82 32.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.808 ' O ' HG22 ' A' ' 2' ' ' VAL . 86.1 m . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.388 -0.82 . . . . 0.0 110.159 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 40' ' ' CYS . 3.6 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.324 0.583 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 38' ' ' MET . 4.8 tpt180 -146.77 119.43 8.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.331 -0.855 . . . . 0.0 110.04 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.882 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.6 mm -101.82 151.77 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.505 -0.747 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.15 -68.46 1.63 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.208 -0.996 . . . . 0.0 110.834 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -75.22 21.24 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.704 1.371 . . . . 0.0 112.627 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.661 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.29 -26.19 16.7 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.667 -1.271 . . . . 0.0 107.746 178.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.527 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.0 t0 -86.57 -24.35 25.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.42 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 mt-30 -85.13 -43.43 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.61 12.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.63 -45.24 76.1 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 110.792 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.3 Cg_endo -77.58 6.02 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.687 1.362 . . . . 0.0 110.737 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -85.84 -178.15 6.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 110.176 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.545 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.5 pt -53.66 -167.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.839 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.652 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.3 t -82.39 -41.04 0.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 111.815 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.9 Cg_endo -70.52 -13.19 32.54 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.085 1.045 . . . . 0.0 110.285 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.1 OUTLIER -84.89 -11.76 54.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 0.0 109.247 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 15.0 mtp180 -100.38 -54.06 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.969 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.681 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 6.8 m-70 -57.62 -40.42 79.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.9 tt0 -73.34 -17.32 61.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.42 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.882 ' SG ' HG21 ' A' ' 4' ' ' ILE . 22.2 t -70.24 -45.9 65.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 0.0 110.446 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HA ' HG13 ' A' ' 4' ' ' ILE . 85.7 m -74.77 -28.69 60.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.067 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.92 -17.58 35.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.072 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.78 -4.21 58.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.612 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.41 -54.95 2.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.86 39.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.497 ' NE ' HD11 ' A' ' 4' ' ' ILE . 5.0 mmt180 -109.17 -164.49 0.94 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.351 -1.087 . . . . 0.0 110.129 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.3 m -120.11 -3.99 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . 162.79 174.13 32.32 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 12.0 p90 -95.44 146.85 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 110.193 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -112.63 -61.05 1.79 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.65 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.781 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.3 p90 -178.01 -161.99 0.06 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.189 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -134.74 120.85 19.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.63 162.72 19.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.329 -0.857 . . . . 0.0 110.389 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.03 129.94 44.24 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.08 -32.37 6.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 167.11 170.3 31.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.527 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -95.29 165.92 12.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.141 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 69.2 m-85 -131.61 143.34 50.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.758 ' O ' HG22 ' A' ' 2' ' ' VAL . 85.0 m . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.628 HG21 ' HG3' ' A' ' 27' ' ' ARG . 18.0 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.229 0.538 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.544 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 2.8 tpt180 -146.8 120.66 9.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.892 . . . . 0.0 110.339 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.651 HG21 ' SG ' ' A' ' 7' ' ' CYS . 7.6 mm -102.24 152.99 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.505 -0.747 . . . . 0.0 109.663 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.15 -66.12 2.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.529 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.715 ' O ' HG12 ' A' ' 10' ' ' VAL . 43.1 Cg_endo -76.03 21.32 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.721 1.379 . . . . 0.0 112.582 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.16 -30.76 14.46 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 12.5 t70 -87.9 -31.04 19.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 81.9 mt-30 -70.99 -44.55 65.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.3 p -90.72 11.74 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 t -64.96 -43.66 68.85 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 110.826 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.1 Cg_endo -77.29 4.87 5.51 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.568 1.299 . . . . 0.0 110.65 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.4 mmt180 -83.31 -175.84 6.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.558 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.0 pt -54.13 -167.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.45 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 50.1 t -82.43 -42.35 0.95 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 111.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -71.78 -8.26 22.74 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.237 1.125 . . . . 0.0 110.168 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -94.23 -15.52 24.48 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.41 -0.806 . . . . 0.0 109.205 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 8.2 mtm180 -95.33 -54.47 3.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 24.4 m-70 -62.85 -24.41 67.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.739 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -86.82 -12.58 47.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.699 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HE2' ' A' ' 38' ' ' MET . 3.5 p -69.7 -38.08 76.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 0.0 110.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 m -75.16 -47.76 26.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.423 -0.798 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -73.03 -12.46 60.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -78.77 -26.44 44.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.629 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 10.6 m170 -105.18 50.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.41 37.22 3.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.628 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -111.02 -149.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.378 -1.072 . . . . 0.0 110.391 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 m -106.35 -141.43 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.19 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.16 155.78 18.6 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CE1' ' SD ' ' A' ' 38' ' ' MET . 2.9 t80 -48.12 121.53 4.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -1.151 . . . . 0.0 110.252 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.87 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.64 -61.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 110.402 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.87 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.1 p90 -178.29 140.54 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -85.66 112.16 20.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.131 -0.981 . . . . 0.0 109.713 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.73 135.57 54.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.63 -152.59 30.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.46 41.72 3.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -164.7 165.0 37.25 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.584 ' HE2' ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -120.34 153.84 35.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.919 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.8 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.3 m-85 -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 35.1 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 0.0 110.343 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.977 HG22 ' O ' ' A' ' 40' ' ' CYS . 9.2 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.538 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 1.3 tpt180 -147.87 118.34 7.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.261 -0.899 . . . . 0.0 110.077 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.741 HG21 ' SG ' ' A' ' 7' ' ' CYS . 11.9 mm -100.54 157.11 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 -66.81 1.68 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.097 -1.049 . . . . 0.0 110.599 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.765 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.8 Cg_endo -75.99 20.7 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.727 1.383 . . . . 0.0 112.706 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.741 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.17 -28.74 15.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.609 -1.307 . . . . 0.0 107.509 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.0 t70 -88.25 -30.31 19.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -73.26 -45.3 56.59 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.765 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.31 12.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.34 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 t -64.88 -43.37 68.35 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.611 -0.681 . . . . 0.0 111.358 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.5 Cg_endo -75.96 5.42 4.47 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.428 1.225 . . . . 0.0 111.023 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mmt180 -84.69 179.37 7.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.1 pt -54.39 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.158 -0.964 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -78.47 -45.64 2.04 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.801 . . . . 0.0 111.721 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.7 Cg_endo -68.91 -9.84 27.46 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.239 1.126 . . . . 0.0 110.297 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -87.81 -24.35 23.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.256 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -90.14 -49.18 6.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.4 m-70 -60.47 -16.78 39.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 tt0 -96.49 -18.64 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.57 ' HB3' HG11 ' A' ' 10' ' ' VAL . 4.0 p -64.75 -37.22 86.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.497 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 1.2 m -78.95 -50.24 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 110.164 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.7 mtt-85 -64.76 -19.28 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.304 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -73.95 -22.52 59.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.466 ' HB2' HD12 ' A' ' 4' ' ' ILE . 4.7 m80 -112.33 27.08 9.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 110.029 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 59.07 69.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.06 -151.26 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.282 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -111.07 -88.83 0.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.32 140.02 9.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.675 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.9 p90 -46.72 125.23 6.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.168 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.86 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -97.83 -60.91 1.47 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.106 -0.996 . . . . 0.0 110.338 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.86 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.2 p90 -178.28 142.65 0.26 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.013 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.8 OUTLIER -85.36 111.91 20.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.821 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -124.22 159.57 29.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.315 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.21 -150.74 0.46 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.33 42.7 2.7 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.95 145.07 8.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.538 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 8.2 ttt -87.23 159.72 18.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 110.043 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.761 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.1 m-85 -125.49 143.21 51.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.977 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.388 -0.82 . . . . 0.0 110.387 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.1 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.25 0.548 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.4 tpt180 -147.04 121.36 9.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 110.285 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.889 HG21 ' SG ' ' A' ' 21' ' ' CYS . 5.7 mm -100.17 145.05 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.422 -0.799 . . . . 0.0 109.66 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . -57.55 -71.9 0.67 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.132 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.9 Cg_endo -76.76 25.73 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.632 1.332 . . . . 0.0 112.724 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -94.79 -21.83 18.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.73 -1.231 . . . . 0.0 108.164 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 3.7 p-10 -87.32 -24.51 24.28 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mt-30 -87.97 -42.53 12.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 109.482 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.88 -45.0 74.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 110.877 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 48.6 Cg_endo -77.44 8.53 3.26 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.639 1.336 . . . . 0.0 111.136 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.541 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 12.2 mmt180 -83.17 -179.17 7.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.039 -1.038 . . . . 0.0 110.049 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.543 HD12 ' HG2' ' A' ' 16' ' ' PRO . 13.6 pt -53.78 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.2 t -79.49 -44.07 1.62 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 111.22 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -72.6 -4.45 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.359 1.189 . . . . 0.0 110.285 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 3.0 mm-40 -96.31 -15.86 21.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -102.85 -50.94 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.682 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 44.5 m-70 -61.54 -35.18 77.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.111 -0.993 . . . . 0.0 109.906 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.62 -19.31 59.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.145 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.889 ' SG ' HG21 ' A' ' 4' ' ' ILE . 15.2 t -62.76 -41.53 99.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.007 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 81.7 m -78.65 -25.01 44.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -86.14 -15.36 41.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.458 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.23 21.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.327 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.595 ' CB ' HD12 ' A' ' 4' ' ' ILE . 32.3 m80 -98.34 43.34 1.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.76 19.45 10.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -100.81 173.93 6.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -1.21 . . . . 0.0 110.181 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 3.1 t -82.2 -141.96 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.16 -158.49 27.78 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.682 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -96.67 141.62 29.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -1.153 . . . . 0.0 110.385 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -106.16 -60.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.74 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 17.8 p90 -178.43 146.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.253 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -94.73 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.465 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 35' ' ' GLY . 16.0 p -80.59 -143.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 110.44 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -56.17 -110.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.63 41.9 2.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.64 139.02 5.81 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.534 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 1.7 tpt -104.97 153.21 21.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.861 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 13.6 m-85 -127.29 149.25 50.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.721 ' HB2' HG23 ' A' ' 2' ' ' VAL . 74.4 m . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.455 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.749 HG21 ' HG3' ' A' ' 27' ' ' ARG . 23.7 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.26 0.552 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.513 ' NH2' ' OD2' ' A' ' 8' ' ' ASP . 2.0 tpt180 -147.78 121.61 9.32 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.328 -0.858 . . . . 0.0 110.077 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.922 HG21 ' SG ' ' A' ' 21' ' ' CYS . 12.2 mm -99.94 152.51 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.989 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -72.76 -68.32 1.62 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.733 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.76 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.06 23.16 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.597 1.314 . . . . 0.0 112.596 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.63 -29.84 14.64 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.673 -1.267 . . . . 0.0 107.939 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 3.0 p30 -86.47 -24.89 25.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -81.25 -45.1 16.79 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -91.16 12.26 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.43 -44.75 76.35 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.54 -0.725 . . . . 0.0 110.893 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.8 Cg_endo -75.98 4.12 5.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.688 1.362 . . . . 0.0 110.647 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.589 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.5 mmp_? -83.62 -175.66 5.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 110.034 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.57 HD12 ' HG2' ' A' ' 16' ' ' PRO . 15.4 pt -55.72 -167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 110.724 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.629 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -82.55 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 111.642 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -72.29 -3.56 13.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.274 1.144 . . . . 0.0 110.393 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HB3' HG22 ' A' ' 10' ' ' VAL . 3.7 mt-10 -96.06 -12.78 24.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.377 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 mtm-85 -105.02 -49.39 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.659 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 33.4 m-70 -60.63 -33.93 73.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.89 -14.53 58.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.922 ' SG ' HG21 ' A' ' 4' ' ' ILE . 13.5 t -64.31 -41.89 96.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 110.33 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.2 m -76.52 -46.24 27.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -64.84 -22.23 66.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.9 -22.5 29.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.545 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 12.2 m-70 -105.97 7.91 32.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.484 ' O ' ' CD ' ' A' ' 27' ' ' ARG . . . 80.38 64.48 1.83 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.749 ' HG3' HG21 ' A' ' 2' ' ' VAL . 3.9 mpt_? -135.17 -178.23 5.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.1 m -87.92 -88.06 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -141.81 144.86 14.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.659 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 10.8 p90 -44.54 124.75 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.209 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.835 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.27 -60.57 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.835 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 11.0 p90 -178.18 158.39 1.18 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.066 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -106.56 106.62 17.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.796 179.567 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -106.59 137.92 43.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.84 -150.74 0.86 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.78 48.35 3.96 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -167.35 137.09 4.44 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.534 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 6.3 ttt -104.4 170.56 7.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.828 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 67.6 m-85 -143.71 153.05 42.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.618 HG21 ' HG3' ' A' ' 27' ' ' ARG . 30.2 m . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.202 0.525 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.0 tpt180 -147.7 121.32 9.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 110.18 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 25' ' ' HIS . 26.6 mm -101.71 156.31 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.27 -66.61 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.88 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.764 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -76.21 20.98 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.713 1.375 . . . . 0.0 112.736 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 8.5 t -94.49 -28.6 15.37 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.687 -1.258 . . . . 0.0 108.012 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.506 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 5.1 t0 -85.8 -24.21 26.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.99 -45.28 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.87 13.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.0 109.442 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.5 t -64.49 -41.94 62.28 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.539 -0.726 . . . . 0.0 111.501 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 44.3 Cg_endo -74.77 3.64 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.393 1.207 . . . . 0.0 110.999 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.56 177.83 7.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.041 -1.037 . . . . 0.0 109.794 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 9.5 pt -53.75 -166.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 110.731 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.8 t -77.69 -45.32 2.48 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 0.0 111.526 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.0 Cg_endo -68.53 -9.94 27.56 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.268 1.141 . . . . 0.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 9.2 mm-40 -91.69 -19.4 22.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.372 -0.83 . . . . 0.0 109.066 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 47.3 mtp180 -91.34 -45.39 8.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.506 -0.746 . . . . 0.0 109.766 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.598 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -64.56 -18.84 65.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 110.242 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 2.3 tp10 -80.12 -13.54 59.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.709 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 9.2 p -69.8 -38.02 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.282 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 4.7 m -84.16 -46.67 11.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.368 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.477 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -70.92 -39.44 72.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.12 -0.987 . . . . 0.0 110.317 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.601 ' HB2' HD12 ' A' ' 4' ' ' ILE . 9.7 m170 -98.88 33.64 2.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 110.231 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 50.36 76.82 0.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG3' HG21 ' A' ' 2' ' ' VAL . 1.1 tpt180 -141.29 -157.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -1.156 . . . . 0.0 110.25 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 1.6 t -102.94 -140.56 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -98.2 143.59 16.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.598 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -43.2 134.29 3.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -1.127 . . . . 0.0 110.49 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -106.49 -59.25 1.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.856 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.3 p90 -178.11 142.75 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.491 -0.756 . . . . 0.0 110.129 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -86.57 117.17 25.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.985 . . . . 0.0 110.02 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -131.28 136.86 48.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.86 -156.35 24.0 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.12 49.77 4.16 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 39' ' ' TYR . . . 175.72 133.77 1.81 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.535 ' CE ' ' HB2' ' A' ' 30' ' ' TYR . 10.0 ttt -86.27 176.41 7.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -1.227 . . . . 0.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.862 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 76.6 m-85 -140.71 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.588 ' CB ' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.25 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.743 HG21 ' HG3' ' A' ' 27' ' ' ARG . 36.0 m . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.207 0.527 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.8 tpt180 -146.13 121.14 10.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.903 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -101.42 150.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.627 -0.671 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.25 -68.95 1.49 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.83 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.728 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.41 22.46 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.656 1.345 . . . . 0.0 112.757 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.54 -24.39 17.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.64 -1.287 . . . . 0.0 107.77 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -88.87 -24.51 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 15.3 mt-30 -85.03 -43.02 14.31 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.35 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -64.81 -42.23 61.86 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.608 -0.683 . . . . 0.0 111.308 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -75.74 4.47 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.36 1.19 . . . . 0.0 110.825 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 3.1 mmp_? -83.31 177.06 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.854 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.3 pt -53.54 -168.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.938 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.634 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 t -78.28 -45.06 2.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 111.303 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.7 Cg_endo -70.21 -7.21 20.64 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.384 1.202 . . . . 0.0 110.301 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -91.85 -13.7 30.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 2.2 mtm180 -103.41 -44.79 5.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 109.813 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.531 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -60.39 -36.06 77.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -75.92 -14.35 60.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -0.837 . . . . 0.0 110.376 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.903 ' SG ' HG21 ' A' ' 4' ' ' ILE . 26.9 t -70.7 -48.01 56.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 86.7 m -75.13 -22.98 57.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -90.1 -19.77 23.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.181 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.17 24.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -99.3 43.12 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 110.354 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 47.41 39.6 14.69 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.743 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -120.75 -179.32 3.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -1.109 . . . . 0.0 110.186 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -140.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.002 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . -92.87 -178.69 40.57 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 1.2 p90 -76.99 137.33 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.206 -1.173 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -106.99 -65.21 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 110.612 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.665 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.9 p90 -178.11 153.13 0.76 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.313 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -95.8 112.51 24.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.898 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.82 139.49 47.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.37 -149.89 0.87 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.04 45.09 3.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -162.94 151.93 21.87 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -115.09 163.16 16.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.366 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 51.8 m-85 -135.08 154.19 51.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.063 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.531 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 86.0 m . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.876 . . . . 0.0 110.598 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 40' ' ' CYS . 6.0 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.178 0.513 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.3 tpt180 -147.16 119.11 8.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 0.0 110.201 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.738 HG21 ' SG ' ' A' ' 7' ' ' CYS . 11.1 mm -101.35 160.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 109.723 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.57 -66.01 1.67 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.565 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.776 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.6 Cg_endo -76.54 20.01 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.633 1.333 . . . . 0.0 112.594 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.738 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.28 -28.16 15.74 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.547 ' HB2' ' N ' ' A' ' 38' ' ' MET . 2.4 t70 -87.75 -31.1 19.83 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -46.0 51.6 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.29 11.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.336 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 t -64.79 -44.05 71.49 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.71 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.6 Cg_endo -75.25 3.83 5.4 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.523 1.275 . . . . 0.0 110.923 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.545 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -83.2 177.35 8.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.072 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 12.9 pt -52.92 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 0.0 110.939 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.625 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.9 t -76.52 -47.22 3.23 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 111.451 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.5 Cg_endo -67.97 -9.63 26.29 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.304 1.16 . . . . 0.0 110.151 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.0 mm-40 -94.69 -16.39 23.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.849 . . . . 0.0 109.195 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -93.93 -49.89 5.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.807 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -65.05 -20.68 66.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 109.954 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -89.07 -10.03 48.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.521 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . 5.5 p -72.16 -37.87 69.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.056 -1.028 . . . . 0.0 110.067 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -82.41 -35.4 27.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 110.237 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -74.12 -30.68 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.424 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.95 66.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.567 ' CE1' ' HG3' ' A' ' 6' ' ' PRO . 29.1 m80 -112.27 9.45 19.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 110.299 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.4 82.65 0.22 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.74 -143.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -1.182 . . . . 0.0 110.178 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 p -112.79 -74.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.191 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -167.6 138.47 5.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 4.5 t80 -42.94 121.97 2.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -1.118 . . . . 0.0 110.178 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.948 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -101.97 -61.12 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.802 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 14.0 p90 -178.42 134.17 0.14 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.184 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -79.78 112.27 16.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 109.523 179.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 9.7 p -88.29 31.75 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.35 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.59 126.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.97 -32.51 4.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.39 144.71 9.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.547 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 5.9 ttt -93.27 154.47 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -1.131 . . . . 0.0 110.021 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.948 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 13.6 m-85 -123.71 137.56 54.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.915 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 110.656 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 40' ' ' CYS . 4.6 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.047 0.451 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.7 tpt180 -147.29 123.03 10.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 25' ' ' HIS . 39.6 mm -99.57 156.95 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.657 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.67 -64.54 1.68 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.817 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.0 Cg_endo -75.53 14.23 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.729 1.384 . . . . 0.0 112.624 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 1.8 t -94.62 -21.4 18.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.565 -1.334 . . . . 0.0 107.959 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.459 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 3.4 t70 -87.04 -23.32 25.0 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -90.12 -44.87 9.5 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.96 13.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.215 -0.928 . . . . 0.0 109.674 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.26 -43.71 73.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.0 111.231 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.0 Cg_endo -76.29 5.03 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.454 1.239 . . . . 0.0 110.797 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -85.9 -176.82 6.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 110.196 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.7 pt -53.15 -167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.181 -0.949 . . . . 0.0 110.995 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.0 t -80.6 -42.26 1.27 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 0.0 111.739 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.66 -12.41 31.15 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.27 1.142 . . . . 0.0 110.289 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.543 ' OE1' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -81.51 -24.27 36.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 9.2 mtm180 -94.57 -46.07 7.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.447 -0.783 . . . . 0.0 109.987 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.571 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -59.97 -18.95 49.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.0 110.076 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.8 OUTLIER -88.96 -22.26 23.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 4.9 p -59.16 -37.26 76.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 57.8 m -77.88 -42.26 33.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 0.0 110.289 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -22.61 67.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB2' ' OE2' ' A' ' 20' ' ' GLU . . . -81.88 -22.53 36.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.606 ' HB2' HD12 ' A' ' 4' ' ' ILE . 29.0 m80 -110.4 22.28 15.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.323 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.46 71.91 0.66 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -125.3 -154.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -1.133 . . . . 0.0 110.197 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.05 -45.9 2.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.338 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.421 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -179.5 135.15 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 9.2 p90 -45.02 148.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 110.382 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -120.33 -60.98 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.803 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 10.3 p90 -178.11 145.41 0.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.5 OUTLIER -88.18 115.95 26.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 110.111 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -110.26 128.07 55.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 110.566 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 43.82 -146.31 1.34 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.2 3.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 3' ' ' ARG . . . -165.07 119.47 0.87 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 39' ' ' TYR . 1.5 tmt? -84.39 161.08 20.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 58.1 m-85 -131.13 143.45 50.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.8 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.757 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.4 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.281 0.563 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.2 tpt180 -146.94 117.63 7.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.921 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.859 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -100.68 144.43 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 0.0 109.764 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.27 -69.43 1.28 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.086 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.65 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -73.9 19.7 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.6 1.316 . . . . 0.0 112.749 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.554 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -94.15 -21.92 18.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.715 -1.241 . . . . 0.0 107.731 178.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.518 ' HB2' ' N ' ' A' ' 38' ' ' MET . 11.8 t70 -92.58 -29.58 16.09 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.478 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 tt0 -78.91 -40.12 33.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.41 9.55 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.38 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.4 t -65.08 -40.34 44.8 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.582 -0.699 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.7 Cg_endo -76.34 3.64 6.11 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.185 1.097 . . . . 0.0 110.526 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 9.6 mmt180 -86.94 -177.0 5.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.984 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.0 pt -53.79 -167.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 87.9 t -81.49 -41.69 1.08 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.567 -0.708 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.4 Cg_endo -69.94 -13.59 34.42 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 122.963 0.98 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -82.86 -12.16 57.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.266 -0.896 . . . . 0.0 109.187 178.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -102.38 -58.1 1.94 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.535 -0.728 . . . . 0.0 110.069 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.617 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 20.4 m-70 -58.4 -36.64 73.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -73.42 -23.27 60.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.859 ' SG ' HG21 ' A' ' 4' ' ' ILE . 6.9 t -67.8 -29.77 69.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 92.7 m -74.97 -34.25 62.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.017 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.22 -11.8 39.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.64 -14.51 56.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.661 ' CG ' HD12 ' A' ' 4' ' ' ILE . 1.2 m80 -107.27 -79.1 0.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.64 28.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HE ' HD11 ' A' ' 4' ' ' ILE . 10.2 mmt180 -102.04 -158.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.25 -54.77 2.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 22' ' ' CYS . . . -149.16 -159.86 8.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.617 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 15.8 p90 -98.29 161.68 13.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -132.53 -67.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.971 . . . . 0.0 110.633 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.761 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.3 p90 -178.42 156.25 0.93 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.266 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -99.89 101.1 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 109.903 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.594 ' HG ' ' HE1' ' A' ' 39' ' ' TYR . 1.3 p -90.56 149.6 22.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.94 112.38 1.91 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.23 -44.0 1.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' CA ' ' OD2' ' A' ' 8' ' ' ASP . . . -167.29 -176.04 37.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.554 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 7.8 tpt -110.06 167.44 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -1.076 . . . . 0.0 109.523 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 42.5 m-85 -133.68 139.91 46.73 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.011 -1.056 . . . . 0.0 110.377 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.757 ' HB2' HG23 ' A' ' 2' ' ' VAL . 55.7 m . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.452 -0.78 . . . . 0.0 110.124 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.08 0.467 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.559 ' NH2' ' CA ' ' A' ' 37' ' ' GLY . 2.7 tpt180 -148.25 116.2 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 110.124 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.819 HG21 ' SG ' ' A' ' 21' ' ' CYS . 15.5 mm -99.93 152.6 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.782 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.18 -64.88 2.12 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.934 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.756 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -74.88 17.5 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.625 1.329 . . . . 0.0 112.642 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -93.86 -29.92 15.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.524 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 21.2 t70 -84.2 -31.48 25.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mt-30 -73.47 -47.01 44.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.68 13.54 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.088 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 t -64.37 -43.51 72.51 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.679 -0.638 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.7 Cg_endo -76.29 5.08 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.536 1.282 . . . . 0.0 110.865 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 1.6 mmt180 -84.71 177.68 7.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 110.18 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.573 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.2 pt -53.68 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.895 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.4 t -81.54 -43.19 1.11 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.452 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -71.85 -4.19 14.63 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.288 1.152 . . . . 0.0 110.195 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 4.1 mm-40 -98.54 -8.56 26.36 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.383 -0.823 . . . . 0.0 109.43 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 11' ' ' CYS . 3.1 ttp180 -108.46 -46.38 3.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.077 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -62.41 -30.22 71.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -80.35 -13.47 59.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.819 ' SG ' HG21 ' A' ' 4' ' ' ILE . 6.7 t -68.92 -45.15 71.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 110.148 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.26 -39.36 59.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 110.238 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -20.72 66.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.97 -30.09 21.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 110.186 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLY . 32.0 m80 -101.4 46.32 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.53 64.34 1.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -131.61 -178.23 4.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.249 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -93.74 -91.31 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -143.99 141.68 10.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD1' ' HE3' ' A' ' 38' ' ' MET . 7.0 t80 -46.69 136.54 7.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -112.39 -54.75 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.824 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.4 p90 -177.86 144.64 0.36 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.538 -0.726 . . . . 0.0 109.946 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -85.67 113.4 21.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.103 -0.998 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -146.61 176.26 9.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.751 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 47.52 57.49 7.37 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 40.96 38.79 1.77 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.559 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -173.97 -170.24 37.11 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -115.13 157.66 23.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.064 -1.257 . . . . 0.0 110.413 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.722 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 19.0 m-85 -128.6 134.54 48.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.495 ' HB3' HG11 ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.396 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.543 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 5.6 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.331 0.586 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 3.5 tpt180 -147.91 120.17 8.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.226 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.889 HG21 ' SG ' ' A' ' 21' ' ' CYS . 11.8 mm -99.71 146.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.924 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.55 -67.24 2.05 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.014 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.763 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -74.91 20.27 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.634 1.334 . . . . 0.0 112.617 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.665 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.36 -27.47 16.05 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.614 -1.304 . . . . 0.0 108.034 178.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 -22.41 25.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -86.91 -44.22 11.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.0 11.92 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.412 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.53 -42.46 65.76 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.589 -0.694 . . . . 0.0 111.306 -179.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.26 6.31 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.45 1.237 . . . . 0.0 111.001 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -85.18 -177.71 6.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 0.0 110.12 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.5 pt -54.29 -165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.611 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.1 t -80.81 -44.04 1.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 111.7 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -70.8 -10.71 28.28 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.372 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -81.31 -22.91 38.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.239 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.561 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 2.3 ttm180 -97.74 -47.26 5.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 109.684 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -34.08 66.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.989 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -82.41 -19.14 39.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.889 ' SG ' HG21 ' A' ' 4' ' ' ILE . 30.5 t -61.2 -43.59 98.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.49 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.06 -24.94 58.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 110.307 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -83.58 -19.91 34.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -13.14 43.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.095 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.672 ' CB ' HD12 ' A' ' 4' ' ' ILE . 7.5 m80 -117.55 39.18 3.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 0.0 110.134 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 44.35 63.79 2.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.596 ' CD ' HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -132.52 -152.05 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -1.136 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 47.0 m -119.99 -130.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.151 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -98.81 135.76 12.32 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.459 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 24.7 p90 -41.65 130.32 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.104 . . . . 0.0 110.249 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.83 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -98.64 -60.75 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.643 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.83 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 11.7 p90 -178.16 148.56 0.5 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.144 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -93.16 113.26 25.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 109.855 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.7 165.48 11.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.66 120.85 23.24 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.1 -21.59 15.3 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 160.2 177.03 32.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 11.6 ttt -100.45 167.2 10.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -1.114 . . . . 0.0 109.922 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.782 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 65.0 m-85 -139.09 148.23 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.669 HG21 ' HG3' ' A' ' 27' ' ' ARG . 18.6 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.236 0.541 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.2 tpt180 -147.94 120.11 8.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 110.259 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.9 HG21 ' SG ' ' A' ' 21' ' ' CYS . 13.0 mm -100.1 151.06 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.97 -66.61 2.0 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.795 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.06 18.42 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.661 1.348 . . . . 0.0 112.679 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.705 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.1 m -94.08 -30.01 14.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.629 -1.294 . . . . 0.0 107.912 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.472 ' N ' ' HB2' ' A' ' 38' ' ' MET . 23.8 t0 -84.16 -22.92 30.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.73 -46.45 10.69 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.2 p -91.1 12.91 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -64.33 -42.61 68.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 111.289 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.9 Cg_endo -75.49 4.2 5.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.333 1.175 . . . . 0.0 110.909 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.516 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.2 mmt-85 -84.42 -179.82 7.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.087 -1.008 . . . . 0.0 109.84 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.506 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 6.1 pt -53.63 -168.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.9 t -81.38 -43.05 1.13 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.776 . . . . 0.0 111.379 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -71.9 -3.73 13.75 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.306 1.161 . . . . 0.0 110.256 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -91.21 -13.51 32.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -0.807 . . . . 0.0 109.32 179.085 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 6.1 ttm180 -109.7 -41.55 4.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 110.036 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -31.38 64.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.067 -1.02 . . . . 0.0 109.835 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.83 -19.64 30.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.9 ' SG ' HG21 ' A' ' 4' ' ' ILE . 13.0 t -59.14 -42.65 91.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.3 m -77.59 -38.62 47.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.995 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -20.92 66.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 -18.03 34.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CB ' HD12 ' A' ' 4' ' ' ILE . 19.1 m80 -111.0 34.93 3.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.09 58.36 7.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.669 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -118.86 -151.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -1.115 . . . . 0.0 110.243 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -86.99 0.63 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -0.832 . . . . 0.0 110.257 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.53 136.4 6.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.553 ' CG ' ' O ' ' A' ' 30' ' ' TYR . 16.1 p90 -43.54 122.73 2.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -1.159 . . . . 0.0 110.253 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.41 -59.56 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.761 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.4 p90 -178.25 151.29 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 110.226 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -93.12 114.0 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.721 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.25 161.82 13.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.389 -0.819 . . . . 0.0 110.31 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 122.62 30.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -27.1 9.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 166.47 176.37 37.56 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.542 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -93.65 165.01 12.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.163 . . . . 0.0 110.023 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.624 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.8 m-85 -138.02 142.81 40.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 110.052 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.833 HG21 ' HG3' ' A' ' 27' ' ' ARG . 31.3 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.253 0.549 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.1 tpt180 -148.23 118.87 7.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.891 HG21 ' SG ' ' A' ' 21' ' ' CYS . 11.1 mm -102.77 153.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.988 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.73 -68.1 1.65 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.823 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.735 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.15 20.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.671 1.353 . . . . 0.0 112.663 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.702 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.14 -29.01 15.36 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 107.78 178.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.523 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.5 p30 -85.83 -25.5 26.24 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 tt0 -82.96 -44.32 15.44 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 11.24 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.43 -44.01 73.86 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 111.057 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -76.78 5.58 4.76 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.544 1.286 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 14' ' ' ILE . 26.4 mmt180 -85.93 -175.48 5.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.093 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.803 HD11 ' OE2' ' A' ' 17' ' ' GLU . 6.8 pt -53.83 -167.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.8 t -81.55 -43.16 1.11 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 111.485 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.18 -5.22 16.53 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.286 1.15 . . . . 0.0 110.264 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.803 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -87.44 -14.39 40.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.278 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 ttm180 -106.26 -49.57 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.474 -0.766 . . . . 0.0 110.021 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.7 m-70 -55.01 -38.92 68.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.018 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -79.0 -19.98 50.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.913 . . . . 0.0 110.32 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.891 ' SG ' HG21 ' A' ' 4' ' ' ILE . 18.4 t -59.85 -40.3 88.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 110.502 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.14 -32.11 61.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -78.61 -16.97 56.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 110.233 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.44 -19.58 29.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.585 ' HB2' HD12 ' A' ' 4' ' ' ILE . 5.8 m80 -115.35 33.5 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 110.292 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . 53.36 71.13 0.74 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.833 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -140.27 -153.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -1.178 . . . . 0.0 110.298 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 84.6 p -120.06 -134.52 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.34 135.2 12.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.619 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -46.62 131.76 11.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -1.163 . . . . 0.0 110.332 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.799 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -97.54 -56.22 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.799 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.9 p90 -177.0 -177.49 0.76 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.61 -0.681 . . . . 0.0 109.988 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -125.06 115.25 20.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.507 ' HG ' ' HE1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -107.23 147.62 29.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.212 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.87 127.03 19.12 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.02 -44.9 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.87 169.67 42.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.523 ' N ' ' HB3' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -95.64 163.87 13.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -1.168 . . . . 0.0 110.029 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 82.3 m-85 -134.94 149.2 50.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.316 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.703 ' HB3' HG22 ' A' ' 2' ' ' VAL . 1.1 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 40' ' ' CYS . 2.6 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.274 0.559 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.52 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 3.1 tpt180 -147.51 122.33 9.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.868 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.2 mm -99.26 150.26 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.687 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.54 -67.33 1.89 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.087 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.771 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.25 17.81 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.638 1.336 . . . . 0.0 112.804 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.715 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.24 -27.13 16.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.642 -1.286 . . . . 0.0 108.031 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.464 ' HB2' ' N ' ' A' ' 38' ' ' MET . 30.0 t0 -86.1 -23.2 26.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.412 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 tm0? -88.03 -44.67 10.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -91.12 11.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.98 . . . . 0.0 109.598 179.328 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.592 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.57 -42.29 64.18 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.777 . . . . 0.0 111.242 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.2 Cg_endo -76.58 5.46 4.75 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.456 1.24 . . . . 0.0 110.858 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -85.36 -177.75 6.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 110.18 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.563 HD11 ' CD ' ' A' ' 17' ' ' GLU . 13.7 pt -55.5 -164.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.668 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 46.3 t -81.3 -45.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.528 -0.733 . . . . 0.0 111.497 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.37 -4.14 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.272 1.143 . . . . 0.0 110.436 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -89.89 -14.78 33.53 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.241 -0.912 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.55 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -108.12 -42.46 4.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.739 . . . . 0.0 110.034 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.436 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -59.17 -32.26 69.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.188 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 37.7 tt0 -86.68 -12.28 48.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.868 ' SG ' HG21 ' A' ' 4' ' ' ILE . 12.8 t -70.67 -36.61 73.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.23 -49.6 13.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.205 -0.935 . . . . 0.0 110.463 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -64.52 -34.5 78.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.21 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -68.13 -18.6 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.206 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -97.87 -74.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.167 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.84 34.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.546 ' CG ' HD11 ' A' ' 4' ' ' ILE . 2.7 mmt180 -104.4 -153.07 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -1.232 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -119.57 -43.65 2.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.132 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -169.0 130.63 2.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 30' ' ' TYR . 1.7 p90 -43.9 126.14 4.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -1.137 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.05 -56.63 2.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.809 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.6 p90 -177.7 -175.25 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.13 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -126.52 114.49 18.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.884 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.32 162.97 12.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 110.278 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.35 116.63 9.31 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.34 -28.87 6.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 171.88 175.26 39.98 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.531 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -99.88 164.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.126 179.919 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.613 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 46.0 m-85 -134.52 149.73 50.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 110.352 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.514 ' O ' HG22 ' A' ' 2' ' ' VAL . 1.7 t . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.413 -0.804 . . . . 0.0 110.206 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.756 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.8 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.309 0.575 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.504 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 1.5 tpt180 -147.36 121.02 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.922 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -102.7 148.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.0 -70.85 0.94 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.814 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.742 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -75.72 24.38 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.724 1.381 . . . . 0.0 112.832 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.51 -23.16 17.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.63 -1.294 . . . . 0.0 107.881 178.419 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 14.5 t70 -88.56 -28.33 20.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.418 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.4 tt0 -79.64 -43.92 21.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.15 11.35 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.453 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 t -65.11 -43.96 68.55 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -76.45 4.71 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.582 1.306 . . . . 0.0 110.697 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 29.3 mmt180 -83.06 -178.65 7.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.944 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' A' ' 17' ' ' GLU . 13.7 pt -54.2 -165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 54.7 t -81.62 -43.03 1.09 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 111.704 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.8 Cg_endo -70.91 -11.4 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.191 1.101 . . . . 0.0 110.345 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -82.42 -20.19 37.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.357 -0.839 . . . . 0.0 109.46 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.511 ' CZ ' ' O ' ' A' ' 11' ' ' CYS . 4.2 mtm180 -99.02 -49.32 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.463 -0.773 . . . . 0.0 109.888 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.685 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 7.5 m-70 -57.14 -37.36 71.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.864 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 53.6 tt0 -77.02 -20.33 56.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.084 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.922 ' SG ' HG21 ' A' ' 4' ' ' ILE . 24.3 t -64.34 -45.84 86.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 58.8 m -75.87 -40.43 54.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -73.25 -16.22 61.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.175 -0.953 . . . . 0.0 110.366 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.6 -32.55 19.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.584 ' CB ' HD12 ' A' ' 4' ' ' ILE . 9.2 m80 -94.87 54.48 1.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.296 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.52 26.35 0.65 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -106.11 172.67 6.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -1.196 . . . . 0.0 110.051 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -84.07 -143.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.907 . . . . 0.0 110.167 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -71.17 -151.58 0.9 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.685 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 13.5 p90 -113.94 151.76 31.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -1.169 . . . . 0.0 110.189 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.798 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -110.48 -63.83 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.496 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.798 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.2 p90 -178.15 -161.42 0.05 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.276 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -138.5 109.3 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -85.82 41.87 0.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.46 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . 77.96 -108.16 2.57 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.83 49.46 4.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.15 102.45 0.16 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.523 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.6 169.74 11.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 110.183 -179.853 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.581 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 70.8 m-85 -142.02 146.68 35.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 110.295 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.756 ' HB2' HG23 ' A' ' 2' ' ' VAL . 98.0 m . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 0.0 110.298 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 40' ' ' CYS . 4.0 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.21 0.529 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -148.33 131.52 16.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.318 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.766 HG21 ' SG ' ' A' ' 7' ' ' CYS . 16.9 mm -110.99 160.84 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.461 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -85.86 -63.37 1.54 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.519 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.779 ' O ' HG12 ' A' ' 10' ' ' VAL . 40.6 Cg_endo -74.6 15.74 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.645 1.339 . . . . 0.0 112.372 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.766 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.3 m -93.25 -22.74 18.83 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.545 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 p30 -88.23 -29.61 20.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.451 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -79.09 -45.24 20.48 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.302 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -91.11 13.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.393 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 t -64.43 -44.99 77.21 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.474 -0.766 . . . . 0.0 110.701 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 48.4 Cg_endo -77.13 5.77 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.592 1.312 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 10' ' ' VAL . 4.2 mmp_? -83.29 179.28 7.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 110.064 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.61 HD11 ' CD ' ' A' ' 17' ' ' GLU . 7.6 pt -54.09 -166.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -78.76 -45.71 1.87 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 111.6 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -69.62 -6.82 19.45 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.282 1.148 . . . . 0.0 110.53 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.61 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -89.18 -19.57 25.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.102 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 7.0 ttm180 -99.31 -52.32 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.875 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 19.2 m-70 -57.51 -33.64 68.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.896 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.23 -21.21 46.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 110.179 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.758 ' SG ' HG21 ' A' ' 4' ' ' ILE . 10.0 t -65.42 -45.29 84.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.902 . . . . 0.0 110.205 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.91 -43.99 33.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.53 -21.78 66.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.867 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -21.27 25.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.495 ' CB ' HD12 ' A' ' 4' ' ' ILE . 19.7 m80 -102.45 14.91 30.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.266 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 27' ' ' ARG . . . 71.46 64.49 2.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HD3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -134.66 -158.3 0.87 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -1.175 . . . . 0.0 110.159 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 -89.71 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -145.61 144.87 13.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.686 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -42.58 119.86 1.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -1.158 . . . . 0.0 110.2 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.787 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -99.65 -56.18 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.488 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.787 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 13.4 p90 -178.03 129.29 0.14 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.373 -178.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -74.25 115.86 14.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 179.374 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.31 167.4 10.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.254 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.98 143.29 11.65 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.77 -50.73 2.0 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 8' ' ' ASP . . . -173.09 -139.34 2.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.541 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 9.5 ttt -126.81 162.58 25.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -1.17 . . . . 0.0 109.913 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.2 m-85 -135.24 148.07 49.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 111.015 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.549 ' HB2' HG23 ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.497 -0.752 . . . . 0.0 110.171 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.834 HG21 ' HG3' ' A' ' 27' ' ' ARG . 34.5 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.07 0.462 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.5 tpt180 -146.85 121.16 9.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.924 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.3 mm -101.17 149.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.557 -0.714 . . . . 0.0 109.545 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.32 -70.51 1.05 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.163 -1.017 . . . . 0.0 110.788 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.18 25.66 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.757 1.398 . . . . 0.0 112.746 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.78 -26.92 16.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.62 -1.3 . . . . 0.0 107.915 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 37' ' ' GLY . 1.8 t70 -87.32 -24.32 24.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 28.7 mt-30 -84.57 -41.66 16.22 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.66 12.1 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 22.8 t -64.96 -41.37 54.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.0 Cg_endo -76.83 5.28 5.0 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.344 1.181 . . . . 0.0 110.74 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.547 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 2.1 mmt180 -83.25 179.42 7.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.127 -0.983 . . . . 0.0 110.182 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.0 pt -54.23 -165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.652 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.6 t -79.3 -45.19 1.68 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 111.448 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.3 Cg_endo -70.99 -4.51 14.99 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.287 1.151 . . . . 0.0 110.361 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 3.1 mm-40 -93.18 -15.74 25.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.558 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtm180 -104.85 -50.31 3.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.08 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 19.1 m-70 -61.49 -37.07 82.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.24 -0.913 . . . . 0.0 110.117 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.6 tt0 -74.53 -20.0 60.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.924 ' SG ' HG21 ' A' ' 4' ' ' ILE . 15.5 t -62.0 -40.93 97.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 83.9 m -76.18 -50.18 15.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -14.09 62.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.49 -33.27 19.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.928 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.607 ' CB ' HD12 ' A' ' 4' ' ' ILE . 11.9 m-70 -96.51 50.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.146 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.83 43.24 6.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.834 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -119.53 -167.37 1.4 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -1.117 . . . . 0.0 110.216 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 4.8 t -102.14 -144.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.19 169.27 53.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.673 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 17.8 p90 -71.01 147.26 48.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -1.117 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -113.27 -69.6 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.741 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 12.1 p90 -178.6 152.19 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.425 -178.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 91.2 m -97.96 113.09 24.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' GLY . 5.2 p -93.88 30.16 1.91 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.934 . . . . 0.0 110.525 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.89 127.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.47 -19.75 30.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 177.78 139.41 3.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.534 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 8.4 ttt -103.18 169.9 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -1.13 . . . . 0.0 110.014 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.761 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 25.5 m-85 -134.45 154.2 51.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 70.8 m . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.7 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.177 0.513 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.494 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 3.7 tpt180 -147.08 118.26 7.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 110.117 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.907 HG21 ' SG ' ' A' ' 21' ' ' CYS . 7.9 mm -99.85 147.91 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -0.771 . . . . 0.0 109.862 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.467 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -64.2 -69.66 1.27 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.391 -0.909 . . . . 0.0 110.953 -179.059 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.694 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.4 Cg_endo -75.26 22.79 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.553 1.291 . . . . 0.0 112.658 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.6 -26.14 16.49 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.737 -1.227 . . . . 0.0 107.931 178.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.4 p30 -88.6 -30.19 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 34.6 tt0 -75.92 -43.83 43.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 9.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.417 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.07 -41.97 57.79 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 111.075 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 50.0 Cg_endo -79.42 21.02 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.441 1.232 . . . . 0.0 111.522 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -104.87 -169.59 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.795 -1.191 . . . . 0.0 110.031 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 8.7 pt -52.92 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.279 -0.888 . . . . 0.0 110.641 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.6 t -82.55 -42.87 0.94 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.8 Cg_endo -72.06 -7.83 21.76 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.214 1.113 . . . . 0.0 110.278 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -85.95 -15.2 42.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.035 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtp180 -104.16 -54.02 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.097 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 30' ' ' TYR . 24.5 m-70 -59.43 -35.59 74.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.1 -20.61 57.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 110.095 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.907 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.7 t -67.1 -39.28 86.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 73.0 m -75.1 -29.31 60.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.319 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -87.65 -16.23 35.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.368 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.32 -29.68 21.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.704 ' CB ' HD12 ' A' ' 4' ' ' ILE . 25.5 m-70 -95.13 45.81 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.84 41.36 5.81 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.753 ' HD3' HD11 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -116.56 -163.34 0.9 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 0.0 110.376 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.8 p -95.18 -140.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -90.2 -146.11 14.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.554 ' CD2' ' HE1' ' A' ' 38' ' ' MET . 1.9 t80 -114.37 124.82 52.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.337 -1.096 . . . . 0.0 110.151 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.822 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -98.86 -57.91 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.146 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.822 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.3 p90 -178.19 -172.65 0.32 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.323 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.485 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -127.22 114.84 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.607 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -94.65 147.92 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 110.336 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.07 104.55 0.83 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -30.19 4.32 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.64 152.02 17.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.558 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -93.0 160.53 14.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.157 . . . . 0.0 110.095 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 27.2 m-85 -131.04 140.74 50.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.346 -0.846 . . . . 0.0 110.388 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.801 ' HB2' HG23 ' A' ' 2' ' ' VAL . 95.7 m . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.119 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.296 0.57 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG21 ' HG3' ' A' ' 27' ' ' ARG . 7.0 m -123.41 -161.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.181 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.51 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.9 tpt180 -146.02 121.44 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.917 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.1 mm -100.18 148.44 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.597 -0.689 . . . . 0.0 109.933 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.29 -68.66 1.58 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.928 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.779 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.6 Cg_endo -75.2 22.6 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.748 1.394 . . . . 0.0 112.66 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.554 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.29 -28.45 15.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.638 -1.288 . . . . 0.0 107.84 178.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.8 t70 -84.15 -23.58 30.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -84.9 -45.74 11.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.92 13.49 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.17 -0.956 . . . . 0.0 109.395 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.3 -45.4 78.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 110.854 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -77.19 6.89 3.99 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.697 1.367 . . . . 0.0 110.804 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.643 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.8 mmp_? -83.14 178.4 8.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -0.99 . . . . 0.0 109.985 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.48 HG12 ' HB2' ' A' ' 17' ' ' GLU . 5.9 pt -53.34 -168.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 110.64 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -80.61 -44.1 1.31 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 111.623 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.06 -5.26 16.6 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.22 1.116 . . . . 0.0 110.213 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -92.86 -19.45 21.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.164 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 8.8 ttp180 -97.16 -45.68 6.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.537 -0.727 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -36.51 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.0 109.777 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -75.01 -16.73 60.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 110.146 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.917 ' SG ' HG21 ' A' ' 4' ' ' ILE . 44.6 t -67.81 -50.35 57.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 74.1 m -74.81 -21.45 59.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.182 -0.949 . . . . 0.0 109.985 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.14 -16.82 28.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.62 -31.8 19.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.575 ' HB2' HD12 ' A' ' 4' ' ' ILE . 36.4 m80 -95.61 49.62 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.67 42.71 6.18 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.612 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -124.99 -179.88 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -1.172 . . . . 0.0 110.196 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 1.9 m -83.49 -141.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.42 40.07 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 18.1 p90 -92.16 132.14 36.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.667 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.38 -62.73 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.667 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.3 p90 -178.29 156.24 0.96 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.208 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -98.6 112.93 24.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.894 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -117.11 134.13 55.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.366 -0.833 . . . . 0.0 110.299 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.5 -153.04 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.83 43.92 3.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -165.71 138.96 5.51 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.491 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 2.3 ttt -101.4 167.25 10.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -1.17 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.656 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 75.1 m-85 -136.1 147.25 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.567 ' HB2' HG23 ' A' ' 2' ' ' VAL . 79.6 m -108.66 166.16 11.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.154 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.3 0.571 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.763 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.4 m -133.54 -168.7 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 110.512 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.528 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 1.4 tpt180 -147.03 122.46 10.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.318 -0.864 . . . . 0.0 110.063 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.7 mm -102.53 147.61 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 109.959 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -70.24 1.11 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.6 Cg_endo -74.99 23.15 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.649 1.342 . . . . 0.0 112.792 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.527 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.49 -29.52 14.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.631 -1.293 . . . . 0.0 107.669 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' CG ' ' CA ' ' A' ' 37' ' ' GLY . 1.1 t0 -84.89 -26.87 27.04 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 3.6 mt-30 -79.43 -44.28 21.68 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.77 12.75 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.586 ' SG ' ' HE3' ' A' ' 38' ' ' MET . 1.7 t -64.45 -44.17 74.21 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.479 -0.763 . . . . 0.0 110.841 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -77.81 6.16 4.75 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.572 1.301 . . . . 0.0 110.746 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.566 ' HG3' HG23 ' A' ' 10' ' ' VAL . 3.0 mmt180 -83.59 -175.93 6.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.128 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.55 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.6 pt -54.28 -165.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.55 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.626 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.3 t -82.1 -42.4 1.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 111.607 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.97 -9.27 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.267 1.141 . . . . 0.0 110.559 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -85.25 -12.3 52.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.398 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.578 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 5.8 ttp180 -109.42 -55.07 2.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 4.2 m-70 -53.83 -31.9 50.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -84.57 -23.72 29.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.375 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.0 t -60.39 -32.53 71.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 110.426 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' SER . 86.1 m -76.18 -33.4 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -89.94 -8.24 52.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.327 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.39 -16.09 38.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.562 ' HB2' HD12 ' A' ' 4' ' ' ILE . 29.2 m80 -115.89 38.97 3.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 50.67 31.76 23.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -106.31 -168.82 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -1.152 . . . . 0.0 110.273 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.511 ' CB ' ' OXT' ' A' ' 41' ' ' ASN . 16.2 m -83.34 -134.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.46 -176.33 21.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 0.5 OUTLIER -68.83 127.9 34.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -1.096 . . . . 0.0 110.196 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.872 ' HB2' ' N ' ' A' ' 41' ' ' ASN . . . -110.31 -68.88 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.452 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.3 p90 -178.61 150.37 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.514 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -90.32 118.95 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.424 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 37' ' ' GLY . 1.1 t -135.62 139.82 44.1 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.62 -157.05 34.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.91 43.64 3.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.586 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 1.9 ttt -98.83 168.99 9.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.027 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 25.7 m-85 -131.45 145.81 51.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.899 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.763 ' HB2' HG23 ' A' ' 2' ' ' VAL . 59.9 m -109.43 123.01 48.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.92 . . . . 0.0 110.287 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.872 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 1.2 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.348 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.196 0.522 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 m -125.48 -178.45 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.577 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -147.98 131.15 16.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.322 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.791 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.4 mm -106.41 155.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.771 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.441 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -74.24 -67.15 1.82 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.744 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.9 Cg_endo -74.66 17.95 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.629 1.331 . . . . 0.0 112.486 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.1 m -93.79 -26.55 16.91 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.536 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.0 p30 -88.76 -29.33 19.87 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 tm0? -76.84 -44.27 32.97 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.5 p -90.51 12.55 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.354 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.7 t -64.75 -43.78 70.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.723 -0.611 . . . . 0.0 111.077 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.35 4.32 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.521 1.274 . . . . 0.0 110.852 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 mtt180 -85.09 -179.17 6.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 109.998 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 7.4 pt -53.72 -167.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.951 . . . . 0.0 110.629 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.63 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.4 t -82.4 -42.65 0.96 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.487 -0.758 . . . . 0.0 111.564 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.6 Cg_endo -72.09 -2.15 11.14 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.281 1.148 . . . . 0.0 110.378 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -96.42 -10.56 27.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -0.875 . . . . 0.0 109.454 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.596 ' HD2' ' CD2' ' A' ' 30' ' ' TYR . 10.7 ttm180 -109.57 -47.96 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -58.26 -28.92 65.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -84.13 -20.43 32.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.923 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.791 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.4 t -61.95 -45.87 91.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.36 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.4 -40.12 58.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -68.88 -19.09 64.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 110.232 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -29.48 21.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.365 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -97.82 4.3 49.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.242 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . 77.22 74.48 0.98 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -135.66 -156.66 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.184 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.461 ' HB3' ' OXT' ' A' ' 41' ' ' ASN . 28.3 t -102.07 -89.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -153.9 151.19 22.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.672 ' CD2' ' HE2' ' A' ' 38' ' ' MET . 14.5 t80 -44.08 119.57 1.81 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.245 . . . . 0.0 110.091 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.898 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -105.5 -58.34 1.91 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.368 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.779 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 13.6 p90 -177.34 138.07 0.23 Allowed 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.025 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -87.01 102.37 14.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.095 -1.003 . . . . 0.0 110.118 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 35' ' ' GLY . 1.4 p -81.19 161.64 23.93 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.5 -0.75 . . . . 0.0 110.25 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -43.16 -56.0 4.78 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.06 -72.85 0.41 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA3' ' NH2' ' A' ' 3' ' ' ARG . . . -149.19 -135.28 2.47 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.672 ' HE2' ' CD2' ' A' ' 30' ' ' TYR . 15.4 tpt -121.69 146.97 46.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.898 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.0 m-85 -128.21 141.99 51.3 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.993 -1.067 . . . . 0.0 111.083 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -107.14 149.18 27.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.48 -0.763 . . . . 0.0 110.127 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.462 ' OXT' ' O ' ' A' ' 40' ' ' CYS . 8.1 t-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.234 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.276 0.56 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 40' ' ' CYS . 1.8 m -126.08 -172.69 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 110.292 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.2 tpt180 -146.53 122.94 11.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 110.152 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -104.14 151.47 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.474 -0.766 . . . . 0.0 110.02 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.53 -68.97 1.49 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.725 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.773 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.7 Cg_endo -74.95 22.23 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.778 1.41 . . . . 0.0 112.789 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.638 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.18 -29.77 14.95 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 38' ' ' MET . 17.7 t70 -82.79 -25.02 33.16 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -82.64 -46.26 13.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.0 p -90.7 14.72 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.23 -0.919 . . . . 0.0 109.348 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 t -64.1 -44.1 76.45 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.658 -0.651 . . . . 0.0 111.111 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 48.1 Cg_endo -77.8 8.74 3.27 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.568 1.299 . . . . 0.0 111.113 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.629 ' HG3' HG23 ' A' ' 10' ' ' VAL . 1.1 mmm180 -85.22 179.14 7.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 0.0 110.22 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.3 pt -53.98 -166.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.61 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -79.07 -44.7 1.74 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.49 -0.756 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.2 Cg_endo -71.02 -5.71 17.58 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.384 1.202 . . . . 0.0 110.246 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.56 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 1.8 mm-40 -88.08 -21.73 24.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.36 -0.838 . . . . 0.0 109.33 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 4.9 ttp180 -100.11 -44.99 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -0.767 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -59.2 -31.7 69.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.911 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -82.66 -17.97 42.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.342 -0.849 . . . . 0.0 110.018 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 4' ' ' ILE . 31.9 t -68.05 -49.69 59.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 110.24 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 84.3 m -75.12 -29.53 60.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -78.73 -21.82 47.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.11 24.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.299 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.687 ' CB ' HD12 ' A' ' 4' ' ' ILE . 10.7 m170 -102.28 51.07 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 110.403 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.06 23.2 2.55 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -112.29 175.51 5.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -1.231 . . . . 0.0 110.063 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 2.3 t -88.29 -143.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -72.26 -154.49 2.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.48 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 22.4 p90 -105.88 144.65 32.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -1.105 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -105.07 -65.42 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.501 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.74 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.6 p90 -178.3 148.79 0.49 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.521 -0.737 . . . . 0.0 110.297 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -87.87 119.78 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -129.25 135.27 48.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.194 -0.942 . . . . 0.0 110.473 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.99 -149.7 46.9 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.42 25.4 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -151.77 157.99 27.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.521 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 10.6 ttt -106.8 167.01 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -1.203 . . . . 0.0 110.072 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 35.5 m-85 -129.19 142.11 50.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.683 ' HB2' HG23 ' A' ' 2' ' ' VAL . 73.5 m -109.41 159.19 17.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.276 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.29 0.567 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 40' ' ' CYS . 30.0 m -139.71 -161.17 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 110.146 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 2.9 tpt180 -147.92 117.78 7.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.342 -0.849 . . . . 0.0 110.196 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.74 HG21 ' SG ' ' A' ' 7' ' ' CYS . 13.3 mm -100.46 157.52 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 0.0 109.851 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.72 -63.8 1.88 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.636 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.792 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.9 Cg_endo -74.98 16.36 0.66 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.681 1.358 . . . . 0.0 112.476 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.74 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.3 m -93.81 -27.99 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.4 t70 -89.42 -25.38 21.56 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -79.83 -45.1 19.33 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.2 p -91.1 14.22 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.339 -0.944 . . . . 0.0 109.316 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 t -64.51 -44.33 74.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.628 -0.67 . . . . 0.0 110.995 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.7 Cg_endo -76.71 5.65 4.68 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.559 1.294 . . . . 0.0 110.996 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.563 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -85.64 -179.73 6.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -0.998 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.59 HD11 ' OE1' ' A' ' 17' ' ' GLU . 14.9 pt -54.55 -165.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.278 -0.889 . . . . 0.0 110.737 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.606 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.0 t -78.71 -46.57 1.87 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 111.73 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.3 Cg_endo -68.77 -10.76 30.02 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.294 1.155 . . . . 0.0 110.256 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.59 ' OE1' HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -84.42 -21.91 30.6 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.348 -0.845 . . . . 0.0 109.219 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.7 mtm180 -95.89 -49.58 5.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.6 OUTLIER -56.53 -19.23 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.871 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -96.78 -22.5 16.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' HB3' HG11 ' A' ' 10' ' ' VAL . 2.9 p -59.32 -36.76 76.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.9 OUTLIER -81.21 -44.1 18.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.172 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -67.82 -13.86 62.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 110.294 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.33 -15.28 55.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 110.239 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.712 ' CB ' HD12 ' A' ' 4' ' ' ILE . 3.6 m80 -111.09 -8.21 14.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 99.15 47.71 1.83 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.652 ' HG3' HG21 ' A' ' 2' ' ' VAL . 6.8 mpt_? -114.1 -164.44 0.93 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -1.14 . . . . 0.0 110.158 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 -75.34 0.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.245 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.65 138.84 7.4 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.4 p90 -46.31 127.76 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.153 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -96.21 -59.08 1.91 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.858 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.5 p90 -178.17 160.47 1.38 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.537 -0.727 . . . . 0.0 109.933 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.6 OUTLIER -100.43 113.82 26.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 0.0 109.83 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 t -135.84 174.05 11.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -0.892 . . . . 0.0 110.461 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.89 -147.79 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.21 39.34 2.85 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . -174.75 -164.9 30.32 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.537 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -112.35 177.42 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -1.131 . . . . 0.0 110.163 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.906 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 61.4 m-85 -143.4 135.98 27.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.144 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.973 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -121.9 117.67 27.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.576 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.562 ' H ' ' HB2' ' A' ' 31' ' ' ALA . 1.8 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.23 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.279 0.562 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.964 HG21 ' HD2' ' A' ' 27' ' ' ARG . 23.3 m -127.72 -158.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.231 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.508 ' CD ' ' O ' ' A' ' 38' ' ' MET . 4.5 tpt180 -147.05 121.27 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.208 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.903 HG21 ' SG ' ' A' ' 21' ' ' CYS . 12.5 mm -101.07 148.71 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.493 -0.754 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.66 -66.95 2.07 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.806 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.75 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.8 Cg_endo -74.57 20.25 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.688 1.362 . . . . 0.0 112.667 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.03 -24.34 17.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 107.701 178.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.458 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 36.0 t70 -88.57 -27.21 21.53 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 14.5 mm-40 -80.16 -44.4 19.92 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.03 13.81 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.31 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.71 -47.07 76.38 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.518 -0.739 . . . . 0.0 110.925 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -75.17 4.05 5.17 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.755 1.397 . . . . 0.0 111.133 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 22.4 mmt180 -83.42 -175.51 5.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.022 -1.048 . . . . 0.0 110.262 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.664 HD11 ' OE2' ' A' ' 17' ' ' GLU . 13.7 pt -54.09 -165.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.335 -0.853 . . . . 0.0 110.668 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -82.34 -42.17 0.96 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -72.11 -10.37 25.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.213 1.112 . . . . 0.0 110.472 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.664 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -83.75 -14.74 50.8 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.26 -47.82 3.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 12.8 m-70 -58.87 -37.78 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.6 tm-20 -79.48 -21.91 44.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.903 ' SG ' HG21 ' A' ' 4' ' ' ILE . 11.1 t -61.04 -40.32 93.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.316 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.468 ' HA ' HG13 ' A' ' 4' ' ' ILE . 93.5 m -75.01 -52.48 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.0 110.275 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.88 -12.64 59.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.313 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.55 -16.88 33.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 110.3 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.61 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -102.54 -17.2 15.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.92 34.06 1.74 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.964 ' HD2' HG21 ' A' ' 2' ' ' VAL . 16.2 mmt180 -103.42 -161.71 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -1.118 . . . . 0.0 110.282 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.66 -38.35 5.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.351 -0.843 . . . . 0.0 110.18 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.77 167.19 37.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 29.8 p90 -69.78 146.32 51.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -1.162 . . . . 0.0 110.239 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -119.97 -66.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.923 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.826 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.8 p90 -178.48 163.38 1.55 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.429 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -103.99 114.87 29.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 t -144.86 158.41 43.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.776 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 57.69 54.26 38.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 43.35 26.96 0.67 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -146.68 -153.9 6.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.526 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -150.98 170.59 18.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 110.319 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.819 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 89.2 m-85 -143.52 144.82 32.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.808 ' O ' HG22 ' A' ' 2' ' ' VAL . 86.1 m -118.09 119.26 34.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.388 -0.82 . . . . 0.0 110.159 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' CYS . 3.9 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.26 0.553 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 40' ' ' CYS . 3.6 m -141.76 -164.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.295 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 38' ' ' MET . 4.8 tpt180 -146.77 119.43 8.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.331 -0.855 . . . . 0.0 110.04 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.882 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.6 mm -101.82 151.77 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.505 -0.747 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.15 -68.46 1.63 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.208 -0.996 . . . . 0.0 110.834 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -75.22 21.24 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.704 1.371 . . . . 0.0 112.627 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.661 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.29 -26.19 16.7 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.667 -1.271 . . . . 0.0 107.746 178.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.527 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.0 t0 -86.57 -24.35 25.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.42 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 mt-30 -85.13 -43.43 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.61 12.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.63 -45.24 76.1 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 110.792 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.3 Cg_endo -77.58 6.02 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.687 1.362 . . . . 0.0 110.737 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -85.84 -178.15 6.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 110.176 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.545 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.5 pt -53.66 -167.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.839 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.652 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.3 t -82.39 -41.04 0.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.451 -0.781 . . . . 0.0 111.815 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.9 Cg_endo -70.52 -13.19 32.54 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.085 1.045 . . . . 0.0 110.285 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.1 OUTLIER -84.89 -11.76 54.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 0.0 109.247 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 15.0 mtp180 -100.38 -54.06 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.969 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.681 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 6.8 m-70 -57.62 -40.42 79.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.9 tt0 -73.34 -17.32 61.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.42 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.882 ' SG ' HG21 ' A' ' 4' ' ' ILE . 22.2 t -70.24 -45.9 65.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 0.0 110.446 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HA ' HG13 ' A' ' 4' ' ' ILE . 85.7 m -74.77 -28.69 60.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.067 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.92 -17.58 35.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.072 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.78 -4.21 58.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.612 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.41 -54.95 2.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.86 39.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.497 ' NE ' HD11 ' A' ' 4' ' ' ILE . 5.0 mmt180 -109.17 -164.49 0.94 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.351 -1.087 . . . . 0.0 110.129 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.3 m -120.11 -3.99 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 41' ' ' ASN . . . 162.79 174.13 32.32 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 12.0 p90 -95.44 146.85 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -1.187 . . . . 0.0 110.193 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -112.63 -61.05 1.79 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.65 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.781 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 5.3 p90 -178.01 -161.99 0.06 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.189 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -134.74 120.85 19.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.823 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.63 162.72 19.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.329 -0.857 . . . . 0.0 110.389 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.03 129.94 44.24 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.08 -32.37 6.56 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.454 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 167.11 170.3 31.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.527 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -95.29 165.92 12.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.141 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 69.2 m-85 -131.61 143.34 50.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.758 ' O ' HG22 ' A' ' 2' ' ' VAL . 85.0 m -114.61 138.28 50.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.0 110.187 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 29' ' ' GLY . 2.2 t-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.19 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.529 ' CB ' ' OH ' ' A' ' 32' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.268 0.556 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.628 HG21 ' HG3' ' A' ' 27' ' ' ARG . 18.0 m -120.58 -158.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.246 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.544 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 2.8 tpt180 -146.8 120.66 9.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.892 . . . . 0.0 110.339 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.651 HG21 ' SG ' ' A' ' 7' ' ' CYS . 7.6 mm -102.24 152.99 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.505 -0.747 . . . . 0.0 109.663 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.15 -66.12 2.18 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.529 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.715 ' O ' HG12 ' A' ' 10' ' ' VAL . 43.1 Cg_endo -76.03 21.32 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.721 1.379 . . . . 0.0 112.582 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.16 -30.76 14.46 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 12.5 t70 -87.9 -31.04 19.67 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 81.9 mt-30 -70.99 -44.55 65.68 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 6' ' ' PRO . 2.3 p -90.72 11.74 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 t -64.96 -43.66 68.85 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 110.826 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.1 Cg_endo -77.29 4.87 5.51 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.568 1.299 . . . . 0.0 110.65 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.4 mmt180 -83.31 -175.84 6.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.558 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.0 pt -54.13 -167.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.45 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 50.1 t -82.43 -42.35 0.95 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 111.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -71.78 -8.26 22.74 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.237 1.125 . . . . 0.0 110.168 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -94.23 -15.52 24.48 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.41 -0.806 . . . . 0.0 109.205 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.551 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 8.2 mtm180 -95.33 -54.47 3.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' ND1' ' HB3' ' A' ' 30' ' ' TYR . 24.4 m-70 -62.85 -24.41 67.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.739 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.5 OUTLIER -86.82 -12.58 47.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 110.699 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HE2' ' A' ' 38' ' ' MET . 3.5 p -69.7 -38.08 76.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 0.0 110.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 m -75.16 -47.76 26.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.423 -0.798 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -73.03 -12.46 60.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -78.77 -26.44 44.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.338 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.629 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 10.6 m170 -105.18 50.57 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.41 37.22 3.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.628 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -111.02 -149.18 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.378 -1.072 . . . . 0.0 110.391 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.431 ' CB ' ' C ' ' A' ' 41' ' ' ASN . 1.2 m -106.35 -141.43 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.19 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.16 155.78 18.6 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CE1' ' SD ' ' A' ' 38' ' ' MET . 2.9 t80 -48.12 121.53 4.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -1.151 . . . . 0.0 110.252 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.87 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.64 -61.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 110.402 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.87 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.1 p90 -178.29 140.54 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -85.66 112.16 20.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.131 -0.981 . . . . 0.0 109.713 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.73 135.57 54.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.63 -152.59 30.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.46 41.72 3.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . -164.7 165.0 37.25 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.584 ' HE2' ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -120.34 153.84 35.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.919 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.8 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.3 m-85 -123.24 152.01 41.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 35.1 m -113.08 176.6 4.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.192 -0.943 . . . . 0.0 110.343 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.431 ' C ' ' CB ' ' A' ' 28' ' ' SER . 14.7 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.219 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.27 0.557 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.977 HG22 ' O ' ' A' ' 40' ' ' CYS . 9.2 m -144.42 -160.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.538 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 1.3 tpt180 -147.87 118.34 7.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.261 -0.899 . . . . 0.0 110.077 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.741 HG21 ' SG ' ' A' ' 7' ' ' CYS . 11.9 mm -100.54 157.11 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 110.011 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 -66.81 1.68 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.097 -1.049 . . . . 0.0 110.599 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.765 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.8 Cg_endo -75.99 20.7 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.727 1.383 . . . . 0.0 112.706 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.741 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.17 -28.74 15.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.609 -1.307 . . . . 0.0 107.509 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 38' ' ' MET . 33.0 t70 -88.25 -30.31 19.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -73.26 -45.3 56.59 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.765 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.9 p -91.31 12.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.34 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.9 t -64.88 -43.37 68.35 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.611 -0.681 . . . . 0.0 111.358 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.5 Cg_endo -75.96 5.42 4.47 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.428 1.225 . . . . 0.0 111.023 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 20.1 mmt180 -84.69 179.37 7.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.119 -0.988 . . . . 0.0 109.965 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.1 pt -54.39 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.158 -0.964 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.8 t -78.47 -45.64 2.04 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.801 . . . . 0.0 111.721 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.7 Cg_endo -68.91 -9.84 27.46 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.239 1.126 . . . . 0.0 110.297 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -87.81 -24.35 23.76 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.256 178.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -90.14 -49.18 6.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.4 m-70 -60.47 -16.78 39.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 tt0 -96.49 -18.64 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.57 ' HB3' HG11 ' A' ' 10' ' ' VAL . 4.0 p -64.75 -37.22 86.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.984 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 1.2 m -78.95 -50.24 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 110.164 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.7 mtt-85 -64.76 -19.28 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.304 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -73.95 -22.52 59.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.466 ' HB2' HD12 ' A' ' 4' ' ' ILE . 4.7 m80 -112.33 27.08 9.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 110.029 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 59.07 69.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.06 -151.26 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.282 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -111.07 -88.83 0.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.32 140.02 9.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.675 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 2.9 p90 -46.72 125.23 6.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.168 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.86 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -97.83 -60.91 1.47 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.106 -0.996 . . . . 0.0 110.338 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.86 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.2 p90 -178.28 142.65 0.26 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.013 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.8 OUTLIER -85.36 111.91 20.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.821 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -124.22 159.57 29.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.315 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.21 -150.74 0.46 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.33 42.7 2.7 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.95 145.07 8.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.538 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 8.2 ttt -87.23 159.72 18.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 110.043 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.761 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.1 m-85 -125.49 143.21 51.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.977 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -122.12 123.77 42.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.388 -0.82 . . . . 0.0 110.387 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.532 ' H ' ' HB2' ' A' ' 31' ' ' ALA . 12.7 t-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.208 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.22 0.533 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.1 m -123.97 -163.19 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.4 tpt180 -147.04 121.36 9.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 110.285 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.889 HG21 ' SG ' ' A' ' 21' ' ' CYS . 5.7 mm -100.17 145.05 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.422 -0.799 . . . . 0.0 109.66 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . -57.55 -71.9 0.67 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.132 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.9 Cg_endo -76.76 25.73 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.632 1.332 . . . . 0.0 112.724 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -94.79 -21.83 18.46 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.73 -1.231 . . . . 0.0 108.164 178.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 3.7 p-10 -87.32 -24.51 24.28 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mt-30 -87.97 -42.53 12.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 109.482 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.88 -45.0 74.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 110.877 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 48.6 Cg_endo -77.44 8.53 3.26 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.639 1.336 . . . . 0.0 111.136 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.541 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 12.2 mmt180 -83.17 -179.17 7.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.039 -1.038 . . . . 0.0 110.049 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.543 HD12 ' HG2' ' A' ' 16' ' ' PRO . 13.6 pt -53.78 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.2 t -79.49 -44.07 1.62 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 111.22 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.7 Cg_endo -72.6 -4.45 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.359 1.189 . . . . 0.0 110.285 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 3.0 mm-40 -96.31 -15.86 21.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -102.85 -50.94 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.439 -0.788 . . . . 0.0 109.881 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.682 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 44.5 m-70 -61.54 -35.18 77.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.111 -0.993 . . . . 0.0 109.906 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.62 -19.31 59.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.145 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.889 ' SG ' HG21 ' A' ' 4' ' ' ILE . 15.2 t -62.76 -41.53 99.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.007 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 81.7 m -78.65 -25.01 44.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -86.14 -15.36 41.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.125 -0.984 . . . . 0.0 110.458 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.23 21.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.327 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.595 ' CB ' HD12 ' A' ' 4' ' ' ILE . 32.3 m80 -98.34 43.34 1.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 53.76 19.45 10.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -100.81 173.93 6.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -1.21 . . . . 0.0 110.181 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . 3.1 t -82.2 -141.96 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.16 -158.49 27.78 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.682 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -96.67 141.62 29.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -1.153 . . . . 0.0 110.385 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -106.16 -60.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.946 . . . . 0.0 110.248 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.74 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 17.8 p90 -178.43 146.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.253 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -94.73 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.465 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 35' ' ' GLY . 16.0 p -80.59 -143.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 110.44 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -56.17 -110.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.63 41.9 2.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.64 139.02 5.81 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.534 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 1.7 tpt -104.97 153.21 21.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -1.168 . . . . 0.0 109.861 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 13.6 m-85 -127.29 149.25 50.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.721 ' HB2' HG23 ' A' ' 2' ' ' VAL . 74.4 m -108.49 167.14 10.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.455 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' SER . 1.1 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.259 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.253 0.549 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.749 HG21 ' HG3' ' A' ' 27' ' ' ARG . 23.7 m -145.12 -166.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' NH2' ' OD2' ' A' ' 8' ' ' ASP . 2.0 tpt180 -147.78 121.61 9.32 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.328 -0.858 . . . . 0.0 110.077 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.922 HG21 ' SG ' ' A' ' 21' ' ' CYS . 12.2 mm -99.94 152.51 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.989 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -72.76 -68.32 1.62 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.733 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.76 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.06 23.16 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.597 1.314 . . . . 0.0 112.596 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.63 -29.84 14.64 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.673 -1.267 . . . . 0.0 107.939 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 3.0 p30 -86.47 -24.89 25.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -81.25 -45.1 16.79 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -91.16 12.26 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.207 -0.933 . . . . 0.0 109.453 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -64.43 -44.75 76.35 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.54 -0.725 . . . . 0.0 110.893 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.8 Cg_endo -75.98 4.12 5.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.688 1.362 . . . . 0.0 110.647 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.589 ' HG3' HG23 ' A' ' 10' ' ' VAL . 2.5 mmp_? -83.62 -175.66 5.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 110.034 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.57 HD12 ' HG2' ' A' ' 16' ' ' PRO . 15.4 pt -55.72 -167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 110.724 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.629 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 53.3 t -82.55 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 111.642 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -72.29 -3.56 13.58 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.274 1.144 . . . . 0.0 110.393 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HB3' HG22 ' A' ' 10' ' ' VAL . 3.7 mt-10 -96.06 -12.78 24.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.377 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 mtm-85 -105.02 -49.39 3.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.659 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 33.4 m-70 -60.63 -33.93 73.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.226 -0.921 . . . . 0.0 110.11 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.89 -14.53 58.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.922 ' SG ' HG21 ' A' ' 4' ' ' ILE . 13.5 t -64.31 -41.89 96.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 110.33 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.2 m -76.52 -46.24 27.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -64.84 -22.23 66.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.9 -22.5 29.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.24 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.545 ' CE1' ' CG ' ' A' ' 6' ' ' PRO . 12.2 m-70 -105.97 7.91 32.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.484 ' O ' ' CD ' ' A' ' 27' ' ' ARG . . . 80.38 64.48 1.83 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.749 ' HG3' HG21 ' A' ' 2' ' ' VAL . 3.9 mpt_? -135.17 -178.23 5.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.422 ' HB2' ' OXT' ' A' ' 41' ' ' ASN . 12.1 m -87.92 -88.06 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -141.81 144.86 14.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.659 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 10.8 p90 -44.54 124.75 4.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.209 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.835 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.27 -60.57 1.59 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -0.961 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.835 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 11.0 p90 -178.18 158.39 1.18 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.066 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -106.56 106.62 17.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.796 179.567 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -106.59 137.92 43.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.84 -150.74 0.86 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.78 48.35 3.96 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -167.35 137.09 4.44 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.534 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 6.3 ttt -104.4 170.56 7.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.828 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 67.6 m-85 -143.71 153.05 42.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 110.342 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -115.24 151.42 34.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.422 ' OXT' ' HB2' ' A' ' 28' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.274 0.559 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.618 HG21 ' HG3' ' A' ' 27' ' ' ARG . 30.2 m -144.27 -165.52 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 110.276 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.0 tpt180 -147.7 121.32 9.18 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 110.18 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 25' ' ' HIS . 26.6 mm -101.71 156.31 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.27 -66.61 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.88 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.764 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -76.21 20.98 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.713 1.375 . . . . 0.0 112.736 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 8.5 t -94.49 -28.6 15.37 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.687 -1.258 . . . . 0.0 108.012 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 5.1 t0 -85.8 -24.21 26.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.99 -45.28 14.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -90.87 13.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.0 109.442 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.615 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.5 t -64.49 -41.94 62.28 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.539 -0.726 . . . . 0.0 111.501 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 44.3 Cg_endo -74.77 3.64 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.393 1.207 . . . . 0.0 110.999 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.56 177.83 7.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.041 -1.037 . . . . 0.0 109.794 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 9.5 pt -53.75 -166.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.12 -0.987 . . . . 0.0 110.731 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.8 t -77.69 -45.32 2.48 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.488 -0.757 . . . . 0.0 111.526 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.0 Cg_endo -68.53 -9.94 27.56 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.268 1.141 . . . . 0.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 9.2 mm-40 -91.69 -19.4 22.69 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.372 -0.83 . . . . 0.0 109.066 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 47.3 mtp180 -91.34 -45.39 8.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.506 -0.746 . . . . 0.0 109.766 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.598 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -64.56 -18.84 65.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 110.242 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 2.3 tp10 -80.12 -13.54 59.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.709 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 9.2 p -69.8 -38.02 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.282 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 4.7 m -84.16 -46.67 11.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 110.368 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.477 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -70.92 -39.44 72.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.12 -0.987 . . . . 0.0 110.317 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.601 ' HB2' HD12 ' A' ' 4' ' ' ILE . 9.7 m170 -98.88 33.64 2.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 110.231 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . 50.36 76.82 0.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HG3' HG21 ' A' ' 2' ' ' VAL . 1.1 tpt180 -141.29 -157.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -1.156 . . . . 0.0 110.25 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 1.6 t -102.94 -140.56 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' ' 40' ' ' CYS . . . -98.2 143.59 16.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.598 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -43.2 134.29 3.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -1.127 . . . . 0.0 110.49 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -106.49 -59.25 1.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.856 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.3 p90 -178.11 142.75 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.491 -0.756 . . . . 0.0 110.129 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -86.57 117.17 25.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.985 . . . . 0.0 110.02 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -131.28 136.86 48.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.86 -156.35 24.0 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.12 49.77 4.16 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 39' ' ' TYR . . . 175.72 133.77 1.81 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.535 ' CE ' ' HB2' ' A' ' 30' ' ' TYR . 10.0 ttt -86.27 176.41 7.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -1.227 . . . . 0.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.862 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 76.6 m-85 -140.71 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.588 ' CB ' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -109.57 156.31 20.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.25 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.463 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 14.5 m-20 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.281 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.743 HG21 ' HG3' ' A' ' 27' ' ' ARG . 36.0 m -128.08 -155.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 0.0 110.185 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.8 tpt180 -146.13 121.14 10.04 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.903 HG21 ' SG ' ' A' ' 21' ' ' CYS . 9.0 mm -101.42 150.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.627 -0.671 . . . . 0.0 109.718 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.25 -68.95 1.49 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.83 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.728 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.41 22.46 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.656 1.345 . . . . 0.0 112.757 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.54 -24.39 17.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.64 -1.287 . . . . 0.0 107.77 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -88.87 -24.51 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.425 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 15.3 mt-30 -85.03 -43.02 14.31 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.88 11.35 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -64.81 -42.23 61.86 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.608 -0.683 . . . . 0.0 111.308 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -75.74 4.47 5.09 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.36 1.19 . . . . 0.0 110.825 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 3.1 mmp_? -83.31 177.06 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.113 -0.992 . . . . 0.0 109.854 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.3 pt -53.54 -168.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.938 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.634 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 t -78.28 -45.06 2.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 111.303 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.7 Cg_endo -70.21 -7.21 20.64 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.384 1.202 . . . . 0.0 110.301 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -91.85 -13.7 30.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 178.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 2.2 mtm180 -103.41 -44.79 5.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.613 -0.679 . . . . 0.0 109.813 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.531 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -60.39 -36.06 77.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -75.92 -14.35 60.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -0.837 . . . . 0.0 110.376 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.903 ' SG ' HG21 ' A' ' 4' ' ' ILE . 26.9 t -70.7 -48.01 56.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.53 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 27' ' ' ARG . 86.7 m -75.13 -22.98 57.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -90.1 -19.77 23.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.181 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.17 24.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -99.3 43.12 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 110.354 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 47.41 39.6 14.69 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.743 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -120.75 -179.32 3.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -1.109 . . . . 0.0 110.186 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.459 ' HB2' ' OXT' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -80.52 -140.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.943 . . . . 0.0 110.002 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . -92.87 -178.69 40.57 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 1.2 p90 -76.99 137.33 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.206 -1.173 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -106.99 -65.21 1.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 110.612 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.665 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.9 p90 -178.11 153.13 0.76 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.313 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -95.8 112.51 24.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.898 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.82 139.49 47.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 44.37 -149.89 0.87 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.04 45.09 3.46 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 34' ' ' SER . . . -162.94 151.93 21.87 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -115.09 163.16 16.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.366 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 51.8 m-85 -135.08 154.19 51.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.063 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.531 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 86.0 m -114.24 141.87 47.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.876 . . . . 0.0 110.598 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.626 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 1.2 t-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.313 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.236 0.541 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 40' ' ' CYS . 6.0 m -141.62 -165.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 110.056 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.3 tpt180 -147.16 119.11 8.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 0.0 110.201 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.738 HG21 ' SG ' ' A' ' 7' ' ' CYS . 11.1 mm -101.35 160.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 109.723 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.57 -66.01 1.67 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.565 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.776 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.6 Cg_endo -76.54 20.01 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.633 1.333 . . . . 0.0 112.594 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.738 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.28 -28.16 15.74 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.547 ' HB2' ' N ' ' A' ' 38' ' ' MET . 2.4 t70 -87.75 -31.1 19.83 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -46.0 51.6 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.29 11.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.336 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 t -64.79 -44.05 71.49 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.71 . . . . 0.0 111.346 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.6 Cg_endo -75.25 3.83 5.4 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.523 1.275 . . . . 0.0 110.923 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.545 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -83.2 177.35 8.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.072 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 12.9 pt -52.92 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 0.0 110.939 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.625 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.9 t -76.52 -47.22 3.23 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 111.451 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 40.5 Cg_endo -67.97 -9.63 26.29 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.304 1.16 . . . . 0.0 110.151 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.0 mm-40 -94.69 -16.39 23.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.341 -0.849 . . . . 0.0 109.195 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -93.93 -49.89 5.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.807 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -65.05 -20.68 66.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 109.954 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -89.07 -10.03 48.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.521 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . 5.5 p -72.16 -37.87 69.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.056 -1.028 . . . . 0.0 110.067 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -82.41 -35.4 27.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 110.237 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -74.12 -30.68 62.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.424 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.86 -21.95 66.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.567 ' CE1' ' HG3' ' A' ' 6' ' ' PRO . 29.1 m80 -112.27 9.45 19.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 110.299 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.4 82.65 0.22 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.74 -143.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -1.182 . . . . 0.0 110.178 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 p -112.79 -74.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.191 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -167.6 138.47 5.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 30' ' ' TYR . 4.5 t80 -42.94 121.97 2.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -1.118 . . . . 0.0 110.178 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.948 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -101.97 -61.12 1.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.802 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 14.0 p90 -178.42 134.17 0.14 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.184 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -79.78 112.27 16.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 109.523 179.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 39' ' ' TYR . 9.7 p -88.29 31.75 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.878 . . . . 0.0 110.35 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.59 126.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.97 -32.51 4.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.39 144.71 9.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.547 ' N ' ' HB2' ' A' ' 8' ' ' ASP . 5.9 ttt -93.27 154.47 17.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -1.131 . . . . 0.0 110.021 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.948 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 13.6 m-85 -123.71 137.56 54.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.915 ' O ' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -110.84 127.14 55.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 110.656 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.57 ' H ' ' HB2' ' A' ' 31' ' ' ALA . 3.2 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.091 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.279 0.561 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 40' ' ' CYS . 4.6 m -141.71 -159.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.148 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 2.7 tpt180 -147.29 123.03 10.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 25' ' ' HIS . 39.6 mm -99.57 156.95 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.657 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.67 -64.54 1.68 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.817 ' O ' HG12 ' A' ' 10' ' ' VAL . 41.0 Cg_endo -75.53 14.23 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.729 1.384 . . . . 0.0 112.624 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 1.8 t -94.62 -21.4 18.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.565 -1.334 . . . . 0.0 107.959 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 3.4 t70 -87.04 -23.32 25.0 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -90.12 -44.87 9.5 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.96 13.05 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.215 -0.928 . . . . 0.0 109.674 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.26 -43.71 73.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.0 111.231 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.0 Cg_endo -76.29 5.03 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.454 1.239 . . . . 0.0 110.797 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -85.9 -176.82 6.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.145 -0.972 . . . . 0.0 110.196 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 11.7 pt -53.15 -167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.181 -0.949 . . . . 0.0 110.995 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.0 t -80.6 -42.26 1.27 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 0.0 111.739 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.66 -12.41 31.15 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.27 1.142 . . . . 0.0 110.289 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.543 ' OE1' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -81.51 -24.27 36.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 9.2 mtm180 -94.57 -46.07 7.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.447 -0.783 . . . . 0.0 109.987 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.571 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -59.97 -18.95 49.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.106 -0.996 . . . . 0.0 110.076 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 0.8 OUTLIER -88.96 -22.26 23.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 4.9 p -59.16 -37.26 76.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 57.8 m -77.88 -42.26 33.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 0.0 110.289 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -22.61 67.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB2' ' OE2' ' A' ' 20' ' ' GLU . . . -81.88 -22.53 36.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.606 ' HB2' HD12 ' A' ' 4' ' ' ILE . 29.0 m80 -110.4 22.28 15.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.323 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.46 71.91 0.66 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -125.3 -154.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -1.133 . . . . 0.0 110.197 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.05 -45.9 2.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.338 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -179.5 135.15 2.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.571 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 9.2 p90 -45.02 148.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 110.382 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -120.33 -60.98 1.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.803 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 10.3 p90 -178.11 145.41 0.36 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.5 OUTLIER -88.18 115.95 26.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 110.111 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -110.26 128.07 55.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 110.566 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 34' ' ' SER . . . 43.82 -146.31 1.34 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.2 3.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 3' ' ' ARG . . . -165.07 119.47 0.87 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 39' ' ' TYR . 1.5 tmt? -84.39 161.08 20.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -1.226 . . . . 0.0 110.171 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 58.1 m-85 -131.13 143.45 50.65 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 110.153 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.8 t -121.2 132.13 54.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.472 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.242 0.544 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.757 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.4 m -134.08 -169.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.313 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 4.2 tpt180 -146.94 117.63 7.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.921 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.859 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -100.68 144.43 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 0.0 109.764 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.27 -69.43 1.28 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.086 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.65 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.0 Cg_endo -73.9 19.7 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.6 1.316 . . . . 0.0 112.749 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.554 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 0.7 OUTLIER -94.15 -21.92 18.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.715 -1.241 . . . . 0.0 107.731 178.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.518 ' HB2' ' N ' ' A' ' 38' ' ' MET . 11.8 t70 -92.58 -29.58 16.09 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.478 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 tt0 -78.91 -40.12 33.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -90.41 9.55 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.38 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 2.4 t -65.08 -40.34 44.8 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.582 -0.699 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 45.7 Cg_endo -76.34 3.64 6.11 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.185 1.097 . . . . 0.0 110.526 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 9.6 mmt180 -86.94 -177.0 5.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.984 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 10.0 pt -53.79 -167.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 87.9 t -81.49 -41.69 1.08 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.567 -0.708 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.4 Cg_endo -69.94 -13.59 34.42 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 122.963 0.98 . . . . 0.0 110.156 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -82.86 -12.16 57.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.266 -0.896 . . . . 0.0 109.187 178.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -102.38 -58.1 1.94 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.535 -0.728 . . . . 0.0 110.069 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.617 ' CE1' ' CD1' ' A' ' 30' ' ' TYR . 20.4 m-70 -58.4 -36.64 73.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -73.42 -23.27 60.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.859 ' SG ' HG21 ' A' ' 4' ' ' ILE . 6.9 t -67.8 -29.77 69.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 92.7 m -74.97 -34.25 62.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.017 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.22 -11.8 39.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.64 -14.51 56.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.661 ' CG ' HD12 ' A' ' 4' ' ' ILE . 1.2 m80 -107.27 -79.1 0.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.64 28.88 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HE ' HD11 ' A' ' 4' ' ' ILE . 10.2 mmt180 -102.04 -158.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -1.192 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -114.25 -54.77 2.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 22' ' ' CYS . . . -149.16 -159.86 8.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.617 ' CD1' ' CE1' ' A' ' 19' ' ' HIS . 15.8 p90 -98.29 161.68 13.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -132.53 -67.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.971 . . . . 0.0 110.633 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.761 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 4.3 p90 -178.42 156.25 0.93 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.266 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -99.89 101.1 12.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.136 -0.977 . . . . 0.0 109.903 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.594 ' HG ' ' HE1' ' A' ' 39' ' ' TYR . 1.3 p -90.56 149.6 22.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -51.94 112.38 1.91 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.23 -44.0 1.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' CA ' ' OD2' ' A' ' 8' ' ' ASP . . . -167.29 -176.04 37.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.554 ' CG ' ' HB3' ' A' ' 7' ' ' CYS . 7.8 tpt -110.06 167.44 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.371 -1.076 . . . . 0.0 109.523 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.641 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 42.5 m-85 -133.68 139.91 46.73 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.011 -1.056 . . . . 0.0 110.377 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.757 ' HB2' HG23 ' A' ' 2' ' ' VAL . 55.7 m -110.67 141.53 43.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.452 -0.78 . . . . 0.0 110.124 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 28' ' ' SER . 18.5 t30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.308 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.311 0.576 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 5.4 t -118.91 157.42 20.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.218 -0.926 . . . . 0.0 109.884 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.559 ' NH2' ' CA ' ' A' ' 37' ' ' GLY . 2.7 tpt180 -148.25 116.2 6.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 110.124 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.819 HG21 ' SG ' ' A' ' 21' ' ' CYS . 15.5 mm -99.93 152.6 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.782 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.18 -64.88 2.12 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.934 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.756 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -74.88 17.5 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.625 1.329 . . . . 0.0 112.642 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -93.86 -29.92 15.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.524 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 21.2 t70 -84.2 -31.48 25.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mt-30 -73.47 -47.01 44.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -90.68 13.54 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.088 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 t -64.37 -43.51 72.51 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.679 -0.638 . . . . 0.0 111.284 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.7 Cg_endo -76.29 5.08 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.536 1.282 . . . . 0.0 110.865 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 1.6 mmt180 -84.71 177.68 7.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 110.18 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.573 HD12 ' HG2' ' A' ' 16' ' ' PRO . 14.2 pt -53.68 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.895 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.4 t -81.54 -43.19 1.11 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 111.452 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -71.85 -4.19 14.63 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.288 1.152 . . . . 0.0 110.195 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 4.1 mm-40 -98.54 -8.56 26.36 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.383 -0.823 . . . . 0.0 109.43 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 11' ' ' CYS . 3.1 ttp180 -108.46 -46.38 3.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.077 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -62.41 -30.22 71.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -80.35 -13.47 59.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.819 ' SG ' HG21 ' A' ' 4' ' ' ILE . 6.7 t -68.92 -45.15 71.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 110.148 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -75.26 -39.36 59.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 110.238 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -20.72 66.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.97 -30.09 21.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 110.186 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLY . 32.0 m80 -101.4 46.32 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.53 64.34 1.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -131.61 -178.23 4.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.249 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -93.74 -91.31 0.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -143.99 141.68 10.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD1' ' HE3' ' A' ' 38' ' ' MET . 7.0 t80 -46.69 136.54 7.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -112.39 -54.75 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.824 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.4 p90 -177.86 144.64 0.36 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.538 -0.726 . . . . 0.0 109.946 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -85.67 113.4 21.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.103 -0.998 . . . . 0.0 110.123 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -146.61 176.26 9.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 110.751 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 36' ' ' GLY . . . 47.52 57.49 7.37 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . 40.96 38.79 1.77 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.559 ' CA ' ' NH2' ' A' ' 3' ' ' ARG . . . -173.97 -170.24 37.11 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -115.13 157.66 23.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.064 -1.257 . . . . 0.0 110.413 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.722 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 19.0 m-85 -128.6 134.54 48.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 110.438 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.495 ' HB3' HG11 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -111.58 171.5 7.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.396 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.223 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.171 0.51 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.543 ' CG2' ' HB3' ' A' ' 40' ' ' CYS . 5.6 m -141.04 -167.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.38 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 3.5 tpt180 -147.91 120.17 8.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.226 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.889 HG21 ' SG ' ' A' ' 21' ' ' CYS . 11.8 mm -99.71 146.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.924 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.55 -67.24 2.05 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.014 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.763 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -74.91 20.27 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.634 1.334 . . . . 0.0 112.617 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.665 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -94.36 -27.47 16.05 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.614 -1.304 . . . . 0.0 108.034 178.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 -22.41 25.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.413 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -86.91 -44.22 11.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.0 11.92 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.412 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.53 -42.46 65.76 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.589 -0.694 . . . . 0.0 111.306 -179.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.1 Cg_endo -76.26 6.31 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.45 1.237 . . . . 0.0 111.001 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -85.18 -177.71 6.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 0.0 110.12 179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.5 pt -54.29 -165.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.611 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.1 t -80.81 -44.04 1.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 111.7 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -70.8 -10.71 28.28 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.372 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -81.31 -22.91 38.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.239 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.561 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 2.3 ttm180 -97.74 -47.26 5.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 109.684 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -34.08 66.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.989 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -82.41 -19.14 39.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 110.125 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.889 ' SG ' HG21 ' A' ' 4' ' ' ILE . 30.5 t -61.2 -43.59 98.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.49 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.06 -24.94 58.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 110.307 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -83.58 -19.91 34.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.172 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -13.14 43.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 110.095 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.672 ' CB ' HD12 ' A' ' 4' ' ' ILE . 7.5 m80 -117.55 39.18 3.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 0.0 110.134 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 44.35 63.79 2.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.596 ' CD ' HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -132.52 -152.05 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -1.136 . . . . 0.0 110.288 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 47.0 m -119.99 -130.89 0.29 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.151 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -98.81 135.76 12.32 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.459 ' O ' ' CG ' ' A' ' 30' ' ' TYR . 24.7 p90 -41.65 130.32 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.104 . . . . 0.0 110.249 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.83 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -98.64 -60.75 1.48 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.311 -0.868 . . . . 0.0 110.643 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.83 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 11.7 p90 -178.16 148.56 0.5 Allowed 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.144 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -93.16 113.26 25.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 109.855 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.7 165.48 11.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.66 120.85 23.24 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.1 -21.59 15.3 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 160.2 177.03 32.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.539 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 11.6 ttt -100.45 167.2 10.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -1.114 . . . . 0.0 109.922 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.782 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 65.0 m-85 -139.09 148.23 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -119.13 176.05 5.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 3.4 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.208 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.217 0.532 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.669 HG21 ' HG3' ' A' ' 27' ' ' ARG . 18.6 m -122.92 -161.23 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.956 . . . . 0.0 110.366 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 37' ' ' GLY . 4.2 tpt180 -147.94 120.11 8.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 110.259 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.9 HG21 ' SG ' ' A' ' 21' ' ' CYS . 13.0 mm -100.1 151.06 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.97 -66.61 2.0 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.956 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.795 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.06 18.42 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.661 1.348 . . . . 0.0 112.679 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.705 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.1 m -94.08 -30.01 14.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.629 -1.294 . . . . 0.0 107.912 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' N ' ' HB2' ' A' ' 38' ' ' MET . 23.8 t0 -84.16 -22.92 30.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.73 -46.45 10.69 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.2 p -91.1 12.91 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 109.49 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -64.33 -42.61 68.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 111.289 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.9 Cg_endo -75.49 4.2 5.2 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.333 1.175 . . . . 0.0 110.909 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.516 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 2.2 mmt-85 -84.42 -179.82 7.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.087 -1.008 . . . . 0.0 109.84 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.506 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 6.1 pt -53.63 -168.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 43.9 t -81.38 -43.05 1.13 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.776 . . . . 0.0 111.379 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.9 Cg_endo -71.9 -3.73 13.75 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.306 1.161 . . . . 0.0 110.256 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -91.21 -13.51 32.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -0.807 . . . . 0.0 109.32 179.085 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 6.1 ttm180 -109.7 -41.55 4.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 110.036 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -31.38 64.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.067 -1.02 . . . . 0.0 109.835 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -85.83 -19.64 30.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.836 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.9 ' SG ' HG21 ' A' ' 4' ' ' ILE . 13.0 t -59.14 -42.65 91.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 1.3 m -77.59 -38.62 47.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.995 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -20.92 66.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 -18.03 34.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 110.214 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CB ' HD12 ' A' ' 4' ' ' ILE . 19.1 m80 -111.0 34.93 3.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.09 58.36 7.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.669 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -118.86 -151.71 0.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -1.115 . . . . 0.0 110.243 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.461 ' OG ' ' OXT' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -117.69 -86.99 0.63 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -0.832 . . . . 0.0 110.257 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -144.53 136.4 6.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.553 ' CG ' ' O ' ' A' ' 30' ' ' TYR . 16.1 p90 -43.54 122.73 2.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -1.159 . . . . 0.0 110.253 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.41 -59.56 1.8 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.761 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 8.4 p90 -178.25 151.29 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 110.226 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -93.12 114.0 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.721 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.25 161.82 13.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.389 -0.819 . . . . 0.0 110.31 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.79 122.62 30.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.35 -27.1 9.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 3' ' ' ARG . . . 166.47 176.37 37.56 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.542 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -93.65 165.01 12.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.163 . . . . 0.0 110.023 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.624 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.8 m-85 -138.02 142.81 40.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 2' ' ' VAL . 0.3 OUTLIER -115.55 -175.62 2.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 110.052 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.461 ' OXT' ' OG ' ' A' ' 28' ' ' SER . 4.6 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.207 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.303 0.573 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.833 HG21 ' HG3' ' A' ' 27' ' ' ARG . 31.3 m -131.12 -152.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 6.1 tpt180 -148.23 118.87 7.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.449 -0.782 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.891 HG21 ' SG ' ' A' ' 21' ' ' CYS . 11.1 mm -102.77 153.3 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 109.988 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.73 -68.1 1.65 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.823 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.735 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.5 Cg_endo -75.15 20.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.671 1.353 . . . . 0.0 112.663 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.702 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -94.14 -29.01 15.36 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 107.78 178.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' HB3' ' N ' ' A' ' 38' ' ' MET . 2.5 p30 -85.83 -25.5 26.24 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 tt0 -82.96 -44.32 15.44 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 11.24 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -64.43 -44.01 73.86 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 111.057 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.2 Cg_endo -76.78 5.58 4.76 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.544 1.286 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 14' ' ' ILE . 26.4 mmt180 -85.93 -175.48 5.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.093 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.803 HD11 ' OE2' ' A' ' 17' ' ' GLU . 6.8 pt -53.83 -167.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.763 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.631 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 44.8 t -81.55 -43.16 1.11 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 111.485 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.4 Cg_endo -71.18 -5.22 16.53 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.286 1.15 . . . . 0.0 110.264 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.803 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -87.44 -14.39 40.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.278 179.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 ttm180 -106.26 -49.57 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.474 -0.766 . . . . 0.0 110.021 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 1.7 m-70 -55.01 -38.92 68.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.018 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -79.0 -19.98 50.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.913 . . . . 0.0 110.32 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.891 ' SG ' HG21 ' A' ' 4' ' ' ILE . 18.4 t -59.85 -40.3 88.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.165 -0.959 . . . . 0.0 110.502 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' SER . 1.8 m -75.14 -32.11 61.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 110.241 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mtm-85 -78.61 -16.97 56.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 110.233 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.44 -19.58 29.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.585 ' HB2' HD12 ' A' ' 4' ' ' ILE . 5.8 m80 -115.35 33.5 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 110.292 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . 53.36 71.13 0.74 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.833 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -140.27 -153.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -1.178 . . . . 0.0 110.298 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 84.6 p -120.06 -134.52 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.903 . . . . 0.0 110.159 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.34 135.2 12.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.619 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -46.62 131.76 11.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -1.163 . . . . 0.0 110.332 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.799 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -97.54 -56.22 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.799 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.9 p90 -177.0 -177.49 0.76 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.61 -0.681 . . . . 0.0 109.988 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -125.06 115.25 20.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.507 ' HG ' ' HE1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -107.23 147.62 29.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.212 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.87 127.03 19.12 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.02 -44.9 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.87 169.67 42.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.523 ' N ' ' HB3' ' A' ' 8' ' ' ASP . 0.9 OUTLIER -95.64 163.87 13.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -1.168 . . . . 0.0 110.029 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 82.3 m-85 -134.94 149.2 50.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.316 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.703 ' HB3' HG22 ' A' ' 2' ' ' VAL . 1.1 t -114.84 -175.12 2.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.308 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.352 0.596 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 40' ' ' CYS . 2.6 m -131.93 -168.61 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 110.156 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.52 ' NH1' ' HA3' ' A' ' 37' ' ' GLY . 3.1 tpt180 -147.51 122.33 9.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.868 HG21 ' SG ' ' A' ' 21' ' ' CYS . 10.2 mm -99.26 150.26 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.687 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.54 -67.33 1.89 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.131 -1.033 . . . . 0.0 111.087 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.771 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.1 Cg_endo -74.25 17.81 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.638 1.336 . . . . 0.0 112.804 -178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.715 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.2 m -94.24 -27.13 16.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.642 -1.286 . . . . 0.0 108.031 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.464 ' HB2' ' N ' ' A' ' 38' ' ' MET . 30.0 t0 -86.1 -23.2 26.75 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.412 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 tm0? -88.03 -44.67 10.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -91.12 11.25 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.98 . . . . 0.0 109.598 179.328 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.592 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -64.57 -42.29 64.18 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.777 . . . . 0.0 111.242 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 47.2 Cg_endo -76.58 5.46 4.75 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.456 1.24 . . . . 0.0 110.858 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -85.36 -177.75 6.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 110.18 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.563 HD11 ' CD ' ' A' ' 17' ' ' GLU . 13.7 pt -55.5 -164.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.668 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 46.3 t -81.3 -45.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.528 -0.733 . . . . 0.0 111.497 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -70.37 -4.14 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.272 1.143 . . . . 0.0 110.436 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -89.89 -14.78 33.53 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.241 -0.912 . . . . 0.0 109.307 178.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.55 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -108.12 -42.46 4.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.517 -0.739 . . . . 0.0 110.034 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.436 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -59.17 -32.26 69.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.188 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 37.7 tt0 -86.68 -12.28 48.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.868 ' SG ' HG21 ' A' ' 4' ' ' ILE . 12.8 t -70.67 -36.61 73.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.23 -49.6 13.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.205 -0.935 . . . . 0.0 110.463 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -64.52 -34.5 78.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.21 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -68.13 -18.6 64.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.206 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CB ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -97.87 -74.12 0.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.167 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.84 34.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.546 ' CG ' HD11 ' A' ' 4' ' ' ILE . 2.7 mmt180 -104.4 -153.07 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -1.232 . . . . 0.0 110.125 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -119.57 -43.65 2.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 110.132 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 30' ' ' TYR . . . -169.0 130.63 2.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 30' ' ' TYR . 1.7 p90 -43.9 126.14 4.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -1.137 . . . . 0.0 110.18 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -96.05 -56.63 2.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.809 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.6 p90 -177.7 -175.25 0.51 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.13 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -126.52 114.49 18.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.884 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.32 162.97 12.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 110.278 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.35 116.63 9.31 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.34 -28.87 6.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 171.88 175.26 39.98 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.531 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -99.88 164.25 12.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -1.136 . . . . 0.0 110.126 179.919 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.613 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 46.0 m-85 -134.52 149.73 50.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 110.352 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.514 ' O ' HG22 ' A' ' 2' ' ' VAL . 1.7 t -127.83 171.3 11.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.413 -0.804 . . . . 0.0 110.206 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.242 179.998 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.238 0.542 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.756 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.8 m -144.89 -162.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 110.34 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.504 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 1.5 tpt180 -147.36 121.02 9.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.922 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.0 mm -102.7 148.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.0 -70.85 0.94 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.814 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.742 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -75.72 24.38 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.724 1.381 . . . . 0.0 112.832 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.51 -23.16 17.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.63 -1.294 . . . . 0.0 107.881 178.419 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' GLY . 14.5 t70 -88.56 -28.33 20.8 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.418 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.4 tt0 -79.64 -43.92 21.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.7 p -91.15 11.35 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.453 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 t -65.11 -43.96 68.55 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.537 -0.727 . . . . 0.0 110.965 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 46.6 Cg_endo -76.45 4.71 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.582 1.306 . . . . 0.0 110.697 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HG3' ' CG2' ' A' ' 10' ' ' VAL . 29.3 mmt180 -83.06 -178.65 7.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.944 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' A' ' 17' ' ' GLU . 13.7 pt -54.2 -165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.724 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 54.7 t -81.62 -43.03 1.09 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 111.704 -179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 41.8 Cg_endo -70.91 -11.4 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.191 1.101 . . . . 0.0 110.345 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -82.42 -20.19 37.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.357 -0.839 . . . . 0.0 109.46 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' CZ ' ' O ' ' A' ' 11' ' ' CYS . 4.2 mtm180 -99.02 -49.32 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.463 -0.773 . . . . 0.0 109.888 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.685 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 7.5 m-70 -57.14 -37.36 71.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 109.864 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 53.6 tt0 -77.02 -20.33 56.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.084 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.922 ' SG ' HG21 ' A' ' 4' ' ' ILE . 24.3 t -64.34 -45.84 86.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 0.0 110.161 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 58.8 m -75.87 -40.43 54.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -73.25 -16.22 61.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.175 -0.953 . . . . 0.0 110.366 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.6 -32.55 19.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.282 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.584 ' CB ' HD12 ' A' ' 4' ' ' ILE . 9.2 m80 -94.87 54.48 1.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.296 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.52 26.35 0.65 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -106.11 172.67 6.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -1.196 . . . . 0.0 110.051 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -84.07 -143.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.907 . . . . 0.0 110.167 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -71.17 -151.58 0.9 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.685 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 13.5 p90 -113.94 151.76 31.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -1.169 . . . . 0.0 110.189 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.798 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -110.48 -63.83 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.496 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.798 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 7.2 p90 -178.15 -161.42 0.05 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.276 -178.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' CG ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -138.5 109.3 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -85.82 41.87 0.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.46 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . 77.96 -108.16 2.57 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.83 49.46 4.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.15 102.45 0.16 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.523 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -87.6 169.74 11.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 110.183 -179.853 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.581 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 70.8 m-85 -142.02 146.68 35.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 110.295 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.756 ' HB2' HG23 ' A' ' 2' ' ' VAL . 98.0 m -116.28 149.25 39.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 0.0 110.298 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.248 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.274 0.559 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 40' ' ' CYS . 4.0 m -141.45 -175.23 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -148.33 131.52 16.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.318 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.766 HG21 ' SG ' ' A' ' 7' ' ' CYS . 16.9 mm -110.99 160.84 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.461 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -85.86 -63.37 1.54 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.519 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.779 ' O ' HG12 ' A' ' 10' ' ' VAL . 40.6 Cg_endo -74.6 15.74 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.645 1.339 . . . . 0.0 112.372 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.766 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.3 m -93.25 -22.74 18.83 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.545 ' CB ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 p30 -88.23 -29.61 20.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -79.09 -45.24 20.48 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.302 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.4 p -91.11 13.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.393 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 t -64.43 -44.99 77.21 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.474 -0.766 . . . . 0.0 110.701 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 48.4 Cg_endo -77.13 5.77 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.592 1.312 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 10' ' ' VAL . 4.2 mmp_? -83.29 179.28 7.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 110.064 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.61 HD11 ' CD ' ' A' ' 17' ' ' GLU . 7.6 pt -54.09 -166.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 42.3 t -78.76 -45.71 1.87 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 111.6 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.1 Cg_endo -69.62 -6.82 19.45 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.282 1.148 . . . . 0.0 110.53 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.61 ' CD ' HD11 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -89.18 -19.57 25.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.102 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HG3' ' HA ' ' A' ' 11' ' ' CYS . 7.0 ttm180 -99.31 -52.32 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 109.875 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 19.2 m-70 -57.51 -33.64 68.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.896 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.23 -21.21 46.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 110.179 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.758 ' SG ' HG21 ' A' ' 4' ' ' ILE . 10.0 t -65.42 -45.29 84.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.902 . . . . 0.0 110.205 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -76.91 -43.99 33.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.53 -21.78 66.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.867 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -21.27 25.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.495 ' CB ' HD12 ' A' ' 4' ' ' ILE . 19.7 m80 -102.45 14.91 30.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.266 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 27' ' ' ARG . . . 71.46 64.49 2.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HD3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -134.66 -158.3 0.87 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -1.175 . . . . 0.0 110.159 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 -89.71 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 40' ' ' CYS . . . -145.61 144.87 13.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.686 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 1.4 p90 -42.58 119.86 1.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -1.158 . . . . 0.0 110.2 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.787 ' HB1' ' CD2' ' A' ' 32' ' ' TYR . . . -99.65 -56.18 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.488 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.787 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 13.4 p90 -178.03 129.29 0.14 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.373 -178.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 38' ' ' MET . 0.1 OUTLIER -74.25 115.86 14.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 179.374 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -111.31 167.4 10.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.254 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -49.98 143.29 11.65 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.77 -50.73 2.0 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 8' ' ' ASP . . . -173.09 -139.34 2.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.541 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 9.5 ttt -126.81 162.58 25.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -1.17 . . . . 0.0 109.913 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.711 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.2 m-85 -135.24 148.07 49.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 111.015 -179.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.549 ' HB2' HG23 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -115.97 161.54 18.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.497 -0.752 . . . . 0.0 110.171 -179.842 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.449 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 17.1 t-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.204 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.268 0.556 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.834 HG21 ' HG3' ' A' ' 27' ' ' ARG . 34.5 m -136.6 -155.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.059 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 3.5 tpt180 -146.85 121.16 9.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.924 HG21 ' SG ' ' A' ' 21' ' ' CYS . 6.3 mm -101.17 149.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.557 -0.714 . . . . 0.0 109.545 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.32 -70.51 1.05 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.163 -1.017 . . . . 0.0 110.788 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.3 Cg_endo -76.18 25.66 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.757 1.398 . . . . 0.0 112.746 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -94.78 -26.92 16.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.62 -1.3 . . . . 0.0 107.915 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 37' ' ' GLY . 1.8 t70 -87.32 -24.32 24.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 28.7 mt-30 -84.57 -41.66 16.22 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.6 p -90.66 12.1 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 22.8 t -64.96 -41.37 54.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.721 . . . . 0.0 111.24 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 11' ' ' CYS . 45.0 Cg_endo -76.83 5.28 5.0 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.344 1.181 . . . . 0.0 110.74 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.547 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 2.1 mmt180 -83.25 179.42 7.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.127 -0.983 . . . . 0.0 110.182 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 13.0 pt -54.23 -165.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.652 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.614 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 55.6 t -79.3 -45.19 1.68 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 111.448 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 43.3 Cg_endo -70.99 -4.51 14.99 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.287 1.151 . . . . 0.0 110.361 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 3.1 mm-40 -93.18 -15.74 25.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.558 ' CG ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtm180 -104.85 -50.31 3.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.505 -0.747 . . . . 0.0 110.08 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CE1' ' CE1' ' A' ' 30' ' ' TYR . 19.1 m-70 -61.49 -37.07 82.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.24 -0.913 . . . . 0.0 110.117 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.6 tt0 -74.53 -20.0 60.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.924 ' SG ' HG21 ' A' ' 4' ' ' ILE . 15.5 t -62.0 -40.93 97.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 83.9 m -76.18 -50.18 15.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -14.09 62.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -87.49 -33.27 19.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -0.928 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.607 ' CB ' HD12 ' A' ' 4' ' ' ILE . 11.9 m-70 -96.51 50.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.146 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.83 43.24 6.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.834 ' HG3' HG21 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -119.53 -167.37 1.4 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -1.117 . . . . 0.0 110.216 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.463 ' HB3' ' OXT' ' A' ' 41' ' ' ASN . 4.8 t -102.14 -144.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.19 169.27 53.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.673 ' CE1' ' CE1' ' A' ' 19' ' ' HIS . 17.8 p90 -71.01 147.26 48.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -1.117 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . -113.27 -69.6 0.85 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.741 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 12.1 p90 -178.6 152.19 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.425 -178.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.45 ' SG ' ' SD ' ' A' ' 38' ' ' MET . 91.2 m -97.96 113.09 24.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' GLY . 5.2 p -93.88 30.16 1.91 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -0.934 . . . . 0.0 110.525 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 34' ' ' SER . . . 60.89 127.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.47 -19.75 30.56 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 3' ' ' ARG . . . 177.78 139.41 3.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.534 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 8.4 ttt -103.18 169.9 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -1.13 . . . . 0.0 110.014 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.761 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 25.5 m-85 -134.45 154.2 51.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 70.8 m -113.82 130.22 56.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.584 ' N ' ' HB2' ' A' ' 31' ' ' ALA . 12.9 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.219 0.533 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' A' ' 40' ' ' CYS . 3.7 m -145.06 -160.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.927 . . . . 0.0 110.256 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.494 ' NH2' ' HA2' ' A' ' 37' ' ' GLY . 3.7 tpt180 -147.08 118.26 7.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 110.117 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.907 HG21 ' SG ' ' A' ' 21' ' ' CYS . 7.9 mm -99.85 147.91 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.466 -0.771 . . . . 0.0 109.862 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.467 ' O ' ' OD2' ' A' ' 8' ' ' ASP . . . -64.2 -69.66 1.27 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.391 -0.909 . . . . 0.0 110.953 -179.059 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.694 ' O ' HG12 ' A' ' 10' ' ' VAL . 42.4 Cg_endo -75.26 22.79 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.553 1.291 . . . . 0.0 112.658 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' HG21 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -94.6 -26.14 16.49 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.737 -1.227 . . . . 0.0 107.931 178.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.558 ' CA ' ' HB2' ' A' ' 38' ' ' MET . 2.4 p30 -88.6 -30.19 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 34.6 tt0 -75.92 -43.83 43.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 6' ' ' PRO . 1.1 p -91.2 9.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.417 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.591 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.07 -41.97 57.79 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 111.075 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 11' ' ' CYS . 50.0 Cg_endo -79.42 21.02 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.441 1.232 . . . . 0.0 111.522 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -104.87 -169.59 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.795 -1.191 . . . . 0.0 110.031 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 8.7 pt -52.92 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.279 -0.888 . . . . 0.0 110.641 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.618 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 48.6 t -82.55 -42.87 0.94 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 42.8 Cg_endo -72.06 -7.83 21.76 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.214 1.113 . . . . 0.0 110.278 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -85.95 -15.2 42.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.035 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' CD ' ' HA ' ' A' ' 11' ' ' CYS . 3.8 mtp180 -104.16 -54.02 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.097 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 30' ' ' TYR . 24.5 m-70 -59.43 -35.59 74.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.1 -20.61 57.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 110.095 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.907 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.7 t -67.1 -39.28 86.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.351 -0.843 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 73.0 m -75.1 -29.31 60.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.319 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -87.65 -16.23 35.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.368 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.32 -29.68 21.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.29 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.704 ' CB ' HD12 ' A' ' 4' ' ' ILE . 25.5 m-70 -95.13 45.81 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 25' ' ' HIS . . . 43.84 41.36 5.81 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.753 ' HD3' HD11 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -116.56 -163.34 0.9 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -1.132 . . . . 0.0 110.376 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.487 ' CB ' ' OXT' ' A' ' 41' ' ' ASN . 91.8 p -95.18 -140.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.394 -0.817 . . . . 0.0 110.179 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 22' ' ' CYS . . . -90.2 -146.11 14.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.554 ' CD2' ' HE1' ' A' ' 38' ' ' MET . 1.9 t80 -114.37 124.82 52.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.337 -1.096 . . . . 0.0 110.151 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.822 ' HB1' ' CE2' ' A' ' 32' ' ' TYR . . . -98.86 -57.91 2.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.146 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.822 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 9.3 p90 -178.19 -172.65 0.32 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.323 -178.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.485 ' SG ' ' HG2' ' A' ' 38' ' ' MET . 0.1 OUTLIER -127.22 114.84 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.607 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -94.65 147.92 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 110.336 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.07 104.55 0.83 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.45 -30.19 4.32 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA2' ' NH2' ' A' ' 3' ' ' ARG . . . -170.64 152.02 17.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.558 ' HB2' ' CA ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -93.0 160.53 14.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.157 . . . . 0.0 110.095 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 27.2 m-85 -131.04 140.74 50.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.346 -0.846 . . . . 0.0 110.388 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.801 ' HB2' HG23 ' A' ' 2' ' ' VAL . 95.7 m -106.47 138.83 41.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.119 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.487 ' OXT' ' CB ' ' A' ' 28' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.341 -179.683 . . . . . . . . 2 2 . 1 stop_ save_